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CHAPTER 1 
INTRODUCTION 

INTHODÖCTIOH 
In addition to the ribosomal, transfer and messenger RNAs, all eukaryo-
tic cells contain a number of distinct small RNAs which can be broadly divi-
ded into two classes: the capped small nuclear RNAs (snRNAs or U snRNAs) and 
the non-capped small cytoplasmic RNAs (scRNAs). At present about twelve U 
snRNAs have been identified in manmalian cells, which account for about 1% of 
the total cellular RNA. The U snRNAs are nuclear, metabolically stable RNAs 
and contain unique cap structures at their 5'-ends in addition to several in-
ternal modifications. The most abundant U snRNAs of the interphase nucleus in 
higher eukaryotes are U1, U2, U3, U4, U5, and 136 (the numbers of which were 
designated by order of discovery and not by size, location or abundance). 
They all are organized in ribonucleoprotein particles (U snRNPs). The names 
of the snRNPs are derived from the particular snRNAs they contain. Whereas 
U1, U2, U3, and U5 snRNPs contain just one kind of snRNA, W and U6 usually 
reside together in the same snRNP particle in a base-paired state. 
The nucleoplasmic U1, U2, U4/U6, and U5 snRNPs are involved in the matu-
ration of pre-messenger RNAs. As such, they all are essential conponents of 
the spliceosomes, multicomponent complexes in which splicing takes place. The 
remaining abundant snRNP of manmalian cells, the U3 snRNP, is located in the 
nucleolus and is implicated in processing of pre-ribosomal RNA ( 1 ). Whereas 
the major nucleoplasmic snRNPs share a conmon set of core polypeptides, U3 
snRNP is further excluded from this group of closely related particles by the 
fact that it contains a different set of proteins. Therefore, U3 snRNP will 
not be discussed in this review. Emphasis will be on the four most abundant 
snRNP particles and their five RNA species in higher eukaryotes and in parti-
cular in the human system. 
CONSTITUENTS № THE MAJOR snRNPs 
RNA components of the U snRNPs. 
Early studies on rat Novikoff hepatoma cells (2) and human HeLa cells 
(3) clearly established the existence of distinct anali RNAs in the nuclei of 
these cells. Because of their high content of uridylic acid when conpared to 
ribosomal or messenger RNAs (2), they were termed U snRNAs. Initial studies 
on these U snRNAs, designated U1 and U2, documented their abundance, nuclear 
location and relatively high metabolic stability. In 1979, with the discovery 
that certain human autoantibodies react with RNA-protein complexes containing 
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U snRNAs, three novel human snRNAs were described that were termed W, U5 and 
U6 (4). These U snRNAs have since been shown to be ubiquitous molecules and 
have not only been demonstrated in metazoan cells but also in lower eukaryo-
tes like Tetrahymena (5,6), dinoflagellates (7,8), Plasmodia (9), yeast (10) 
and the slime mold Dictyostelium discoideum (11). Nuclei of higher plants 
also contain the major snRNAs that have been characterised in animal cells 
(for refs. see 12). Recently, even virally encoded U snRNAs were identified 
in Marmoset T-lymphocytes transformed by herpesvirus saimiri (13)· Their pri-
mary sequences, however, are distinct from those of the major or any of the 
minor cellular U snRNAs characterized thus far. 
U1 snRNA, the most abundant of the Ü series of snRNAs, was the first U 
snRNA to be sequenced (14). Since then, the conplete nucleotide sequences of 
the major U snRNAs fron many distant species including human, rodent, avian, 
amphibian, insects, dinoflagellate and plant cells like pea and bean have 
been determined (for refs. see 12). The results indicate that all eukaryotic 
cells contain structurally conserved and functionally homologous U snRNAs. 
Comparison of the primary structures of individual snRNA species revealed 
that some regions are highly conserved through evolution (15). Most striking 
of these conserved domains is the sequence at the 5'-end of the U1 snRNA that 
is completely identical in all U1 sequences elucidated so far. In yeast, in 
which at least two dozen different snRNA species were detected (16,17) the 
equivalents for the metazoan snRNAs U1, U2, U4, U5, and U6 could also be as-
signed as a result of limited primary sequence homologies, despite the fact 
that some of the yeast snRNAs are much larger as their metazoan counterparts 
(18). 
The sequencing of U1 and U2 snRNA (14,19,20) also lead to the first des-
cription of the hypermethylated cap structure at the 5'-end of these snRNAs. 
It turned out to be а соппюп feature of all U snRNAs, except U6 snRNA, and 
now is the most definitive structural criterion for the U series of snRNAs. 
Some of the more recently discovered U snRNAs, which have a much lower abun­
dance as the major snRNPs (21-23), do not contain a high proportion of uridy-
lic acid but nevertheless are added to the U series of snRNAs because of 
their characteristic cap structure. This 5' cap structure consists of the 
highly methylated nucleoside N2,N2,N7-trimethylguanosine (т2>2,7с or тзО 
instead of the 7-methylguanosine (m^G) which is characteristic for eukaryotic 
messenger RNA "caps". Transcription of snRNAs also appears to initiate with 
an m^G-cap formation, but after transcription the monomethyl cap structure is 
modified into its trimethylated form, a process that takes place in the cyto-
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plasm (see below). U6 snRNA is an exception. The initial U6 transcript has a 
5'-triphosphate end which is subsequently modified to a cap structure, the 
chemical nature of which is not known, but it is not a nucleotide (24). Fur­
thermore, the cap structure in U6 snRNA by a blocked pyrophosphate linkage 
is coupled to a guanosine residue, whereas the 5'-end of the other snRNAs 
usually is ra^'fcpppA. Among others, a possible function for trimethylation 
of the U snRNA cap structures could be to distinguish them from the 7-methyl-
guanosine (m^G) capped messenger RNAs, thereby preventing the recognition of 
snRNAs by m^G-cap-binding proteins and the subsequent misdirection of the 
snRNPs to ribosomes. 
Apart from the 5'-terminal cap structure all rfcjG-capped U snRNAs contain 
extensive internal modifications. All these post-transcriptionally added mo­
difications are mainly confined to the 5'-half of the U snRNA molecules. The 
modified nucleosides found in snRNAs are pseudouridines and methylated resi­
dues. Thus nucleotides 1 and 2 of metazoan U1 to U5 snRNAs are always Z'-O-
methylated. This is the only difference with the cap structure of U snRNAs in 
other species, which have unmodified nucleotides at these positions. Apart 
from sugar-methylated nucleosides several snRNA species are also characteri­
zed by base methylations. U2, Ш1, and U6 snRNA contain an N^-methyladenosine 
(m^A) and U6 snRNA in addition has a 2-methylguanosine (n^G; ref. 12). The 
positions of these modifications have been highly conserved during evolution. 
The large number of modifications found at the 5'-end of U2 snRNA (20) clear­
ly distinguishes it from other U snRNAs. 
The phylogenetic conservation of the individual snRNAs which was already 
noticed from their primary sequences and the positions of the modified nucle­
osides therein, became even more obvious when secondary structures for the 
snRNAs were deduced. Sufficient data are now available to support a phyloge-
netically consistent secondary structure for U1 and U5 snRNA. The data avail­
able for U2, W, and U6 snRNA are more limited and alternative structures 
are possible. The consensus secondary structures of U1, U2 and U4 snRNA con­
sist of four stems, designated I to IV, and four loops, designated A to D 
(Figure 1; refs 25-33). In U1 and U4 snRNA the 5"-end is single-stranded (Fi­
gure 1) and available for interactions with other RNAs. In the case of U1 
snRNA the 5'-end is able to base pair with 5'-splice junctions in pre-messen­
ger RNA (see below), whereas the S'-end of U4 snRNA appears to base pair with 
complementary nucleotides in the U6 snRNA molecule with which it co-exists in 
a single snRNP particle (32-35). For U6 snRNA possible secondary structure 
models have been proposed for the snRNA alone (Figure 1) and for the complex 
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Figure 1. Secondary structure models for the major human nucleoplasmic 
snRNAs. The stem regions in U1 and U2 snRNAs are numbered I to IV and the 
loops are designated A to D. The secondary structure of U1 snRNA is based on 
Branlant et al. (25), Epstein et al. (26), Mount and Steitz (27), and Calvet 
and Myers (28). The model of U2 snRNA is based on studies of Reddy et al. 
(29), Branlant et al. (30), and Ares (31). The secondary structure of U5 
snRNA consists of two stem regions, designated I and II, and four loops, 
designated A to D (39). The secondary structures for W and U6 snRNAs are 
those proposed by Rinke et al. (33). The Sm-binding site (see text) in the U 
snRNAs is underlined. 
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of IW/U6 snRNA (24,32,33,36-38). The secondary structure of human U5 snRNA as 
proposed by Krol et al. (39) consists of only two stem regions, designated I 
and II, and four loops, again designated A to D (Figure 1). The secondary 
structures of U5 snRNAs from other sources are identical to the human one. 
The structural variants of U5 snRNA with heterogeneity near the З'-end, that 
are present in human and other cells, also form the same secondary structure 
(39). 
Although each U snRNA has its own distinct secondary structure (Figure 
1 ), many U snRNAs share comion structural features with each other ( reviewed 
in ref. 40). One such structural feature which is shared by thè snRNAs U1, 
U2, U4 and U5, is the so-called danain A (30), a single-stranded region with 
consensus sequence PuA(ü)nGPu (with n>3) that is always found sandwiched be-
tween two double-stranded stems. It has been shown that this single-stranded 
domain serves as a primary binding-site for the core proteins that are ccranon 
to all major snRNP particles (see below). Another common structural feature 
of snRNAs is the fact that the post-transcriptional modifications occur pre-
ferentially in single-stranded regions. 
In conclusion, the results available indicate that all eukaryotic cells 
contain structurally conserved U snRNAs. Furthermore, the presence of the 
сштоп U-rich sequence PuA(U)
n
GPu in most snRNAs, the сопюоп trimethylated 
cap structure, and the involvement of all major U snRNAs in the maturation of 
messenger RNA precursors (see below) strongly point to the origin of all U 
snRNAs fron a coranon progenitor molecule. 
Protein components of the major snRNPs 
Human snRNAs as well as those of other species do not reside in the nu­
cleus as naked RNA molecules but are organized in ribonucleoprotein particles 
(snRNPs). This was first demonstrated by Lerner and Steitz (4), who made the 
important observation that some antibodies found in the sera of patients with 
systemic lupus erythematosus (SLE) are often directed against protein compo­
nents of the U snRNP particles (see below). These antibodies were subsequent­
ly used as tools in the identification and characterization of the protein 
constituents of the snRNPs. Individual intact human snRNPs could be obtained 
by various purification protocols, using biochemical procedures, inmune affi­
nity chromatografy, and antibodies recognizing modified nucleosides of the 
snRNAs, i.e. antibodies raised against the trimethylated cap structure (41-
46). So far, 14 polypeptides have been identified as constituents of the ma­
jor nucleoplasmic snRNPs U1, U2, U5, and U4/U6 from HeLa cells. Initially, 
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six polypeptides with molecular weights on SDS-polyacrylamide gels of 28,000 
Da (B·), 27,000 Da (B), 15,000 Da (D), 12,000 Da (E), 11,000 Da (F), and 
9,000 Da (G) were reported to be present in each of the individual snRNPs 
(41-43,47). More recently, a seventh polypeptide of apparent molecular weight 
14,500 Da, which is shared by all snRNPs has been described by Bringmann and 
Liihrmann (47) and has been denoted D'. 
Fractionation of the individual snRNPs further revealed that in addition 
to the common polypeptides, at least some of the snRNPs contain characteris­
tic proteins. Thus U1 snRNPs contain at least three unique polypeptides with 
molecular weights 70,000 Da, 32,000 Da, and 22,000 Da, which are found in 
this particle only, and were denoted 70K, A, and C, respectively (41-44,47). 
Characteristic of U2 snRNP particles is the presence of two unique proteins 
of 29,000 Da and 27,000 Da, termed A' and B", respectively (41,42,47). The 
exclusive location of proteins 70K, A, and С on U1 snRNPs and of proteins A' 
and B" on U2 snRNPs has also been demonstrated by the selective inmune preci­
pitation of the respective snRNP particles with antibodies directed either 
against 70K, A, and С (4,48-51) or against A' and B" (52-54). 
Two likely candidates for U5 snRNP-specific polypeptides have been des­
cribed but whether they are integral cotiponents of U5 snRNP іь not certain 
yet. The first is a protein of molecular weight 25,000 which co-fractionated 
with U5 snRNA during various purification steps (43). However, in U5 snRNPs 
purified by inmune affinity chromatography using antibodies specifically re­
cognizing the ШзС-сар structure of the Ü snRNAs a protein of similar molecu-
lar weight was not detected (47). The second possible U5 snRNP-specific pro-
tein only remains associated with snRNPs at low concentrations of magnesium, 
which explains why it was not discovered in snRNPs prepared at higher magne-
sium concentrations (41,43,47). It was assigned to U5 snRNA because it comi-
grates with this snRNP particle through several purification steps (55) and 
because it specifically recognizes the 3' splice site of pre-messenger RNA 
introns, the same region where U5 snRNP appears to interact with the messen-
ger RNA precursors (56). So far, two molecular weights have been reported 
for this intron binding protein (IBP), namely 70 kDa (57) and 100 kDa with a 
possible proteolytic cleavage product of about 70 kDa (55). In Saccharoinyces 
cerevisiae a polypeptide of 260 kDa was described that is associated with 
snR7 (58), the yeast analogue of U5 snRNA (59). In HeLa snRNP preparations 
isolated under mild conditions, recently two minor polypeptides larger than 
200 kDa were found, that are possible candidates for the himan homologue of 
this protein (60), suggesting the existence of a third U5 snRNP-specific po-
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lypeptide. 
For the иЧ/иб snRNP particle no unique proteins have been discovered 
yet, limiting the protein composition of this snRNP particle to the presence 
of the seven conrion core polypeptides which are also found in the other 
snRNPs (47). Of course, the possibility that putative U4/U6 snRNP-specific 
proteins could be so loosely bound to the particle that they are lost during 
the purification procedures cannot be ruled out. 
Recently, in rats, the presence of another snRNP-associated protein, 
termed N, was reported by McAllister et al. (61). It is the first snRNP 
protein that was shown to be expressed in a tissue-specific manner, being 
most abundant in brain. The existence of a human counterpart for the N 
protein was demonstrated by the presence of its mRNA in human brain (61,62). 
On SDS-polyacrylamide gels N has approximately the same mobility as the snRNP 
proteins B' and В and also in other aspects the N protein seems to be more or 
less related to the B' and В protein (see below). However, whether the N pro­
tein is camion to all snRNPs or is associated only with a single or with some 
of the snRNA species in brain tissue remains to be elucidated. Nevertheless, 
these data demonstrate that in certain tissues the complement of proteins 
associated with snRNAs may vary. 
Characterization of the human snRNP polypeptides by two-dimensional 
electrophoresis, with nonequilibrium pH-gradient electrophoresis (NEpHGE) in 
the first dimension, followed by SDS-polyacrylamide gel-electrophoresis in 
the second dimension, (Sillekens, unpublished results; ref. 63) revealed that 
most of the snRNP polypeptides are basic with apparent pi values ranging from 
θ to 10. Only protein F is strongly acidic with an apparent pi value of 4.3 
(63). The 1Л snRNP-specific 70K protein separates in at least six isoelectric 
variants with apparent pi values between 6.4 and 8.2. It is possible that 
they represent different states of phosphorylation of this protein, since it 
has been demonstrated that the 70K protein becomes detectably phosphorylated 
in vivo (64). A second snRNP polypeptide that is post-translationally modi­
fied is the U1 snRNP-specific С protein (65,66). The exact nature of this 
modification is not known, but is obvious from a difference in the molecular 
weights of in vivo and in vitro synthesized С protein (66) and a shift in 
mobility for de novo synthesized С protein in pulse-labelled cells within 1 
hr of cold chase (65). 
In spite of the immmological relatedness between some of the snRNP po­
lypeptides A to G and polypeptide N (see below), they all are encoded by se­
parate messenger RNAs (61,67). So far, seven cDNA clones of mRNAs encoding 
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human snRNP proteins have been isolated (66,68-78), in addition to a cDKA 
clone for the 70K protein from Xenopus laevis (79) and a rat cDNA encoding 
the N protein (61,62). The primary structure of these snRNP polypeptides has 
been deduced frem their cognate cDNAs. 
For all three human U1 snRHP-specific proteins 70K, A, and C, cDNA 
clones have been isolated from libraries constructed in expression vectors 
using human autoantisera containing anti-snRNP activities (see below). cDNAs 
encoding either a partial sequence (70) or the entire 70K protein (68,69) 
have been cloned. The human cDNA has an open reading frame coding for 614 
amino acids. However, based on sequence comparison with a Xenopus laevis 70K 
cDNA (79) the methionine-encoding translation initiation codon probably lies 
further downstream in the open reading frame, giving rise to a 52 kDa poly­
peptide (69), which on SDS-polyacrylamide gels migrates as a 70 kDa protein. 
Two hydrophilic regions, containing an extremely high number of arginine 
residues, were identified at the carboxy-terminal half of the polypeptide. 
A cDNA containing the entire coding sequence for the A protein (chapter 
4; ref.71) encodes 282 amino acid residues which give a predicted molecular 
weight of about 31.2 kDa. The amino-termlnal and carboxy-terminal regions 
show a similarity of 31 %, suggesting that during evolution an integral se­
quence duplication has taken place within the progenitor A protein gene. 
Recently, molecular cDNA cloning of the С protein has been reported 
(chapter 5; refs.66,78). The molecular weight predicted from the open reading 
frame of the cDNA (66) was about 17.5 KDa. The disparity with the apparent 
molecular weight of 22 kDa cannot be explained by post-translational modifi­
cation of the polypeptide (65), but like the 70K protein is mainly due to 
aberrant migration on SDS-polyacrylamide gels (66). 
The primary structures of the human U2 snRNP-specific proteins A' (chap­
ter 3; ref. 72) and B" (chapter 2; ref. 73) have also been determined. From 
the polypeptide sequence of the B" protein, which consists of 225 amino acids 
giving a predicted molecular weight of 25·5 kDa, several hydrophylic segments 
distributed over the entire protein were identified. One of these regions 
with a high content in lysine residues could function as an RNA-binding do­
main. By comparison of the deduced amino acid sequence of the U1 snRNP-speci-
fic A protein with that of the B" protein, two regions of extensive similari­
ty were observed, one located in the carboxy-terminal end of the proteins and 
the other in the amino-terminal region. This might infer a comnon evolutiona­
ry origin and identical functions for the two proteins although they reside 
on different snRNP particles. 
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The U2 snRNP-specific A* protein consists of 255 amino acid residues and 
has a predicted molecular weight of 28.5 kDa (chapter 3; ref. 72). Most stri­
king feature of the polypeptide is a leucine-rich region, the function of 
which is not known. The protein contains a total of only three methionine re­
sidues, consistent with predictions from in vivo studies in which the A' pro­
tein in contrast to most other known snRNP polypeptides is hardly labelled by 
[BSsi-methionine (80). 
Of the proteins comnon to all major snRHPs, cDNAs encoding the human po­
lypeptides D (74) and E (75-77,81) have been cloned thus far. The open rea­
ding frame of the cDNA clone for the D protein has coding capacity for a 119-
residue polypeptide with a predicted molecular weight of about 13.3 kDa. At 
the carboxy-terminus the predicted amino acid sequence revealed two hydrophi-
lic domains, one of which is a stretch of nine alternating Gly-Arg repeats 
(74). 
Two partial cDNAs (75,76) and a cDNA coding for the entire human E pro­
tein (77) have been characterized in addition to a gene of the E protein mul-
tigene family (81). The deduced polypeptide sequence revealed a basic protein 
of 92 amino acids with a calculated molecular weight of 10.8 kDa. The poly­
peptide contains several hydrophobic and hydrophilic regions, but has no ob­
vious relation to other nucleic acid-binding proteins. In contrast, several 
of the specific snRNP proteins contain regions with similarity to known RNP 
proteins (Table 1). First, proline-rich regions have been found in the U1 
snRNP-specific proteins A and С (66,71), and less explicit in the ?0K protein 
(68,69). These areas might play a role as RNA-binding domains, since similar 
regions of high proline content have been identified in several single-stran­
ded nucleic acid-binding proteins (82-84). Second, examination of the sequen­
ces of different RNP proteins, including heterogeneous nuclear RNA (hnRNA) 
and messenger RNA (mRNA) binding proteins, revealed two segments of eight and 
six amino acids, respectively, that were highly conserved among these pro­
teins (85). Sequences similar to these two RNA-binding protein consensus se­
quences were also found in the primary structures of snRNP-specific proteins 
70K (68), A (71) and B" (73). Although not proven to be essential for binding 
to RNA, thus far the RNP consensus sequences are diagnostic of proteins di­
rectly associated with RNA, suggesting that the snRNP-specific proteins har­
boring these conserved sequences might have RNA-binding capacity. Finally, 
the 70K protein contained two other regions with homology to known nucleic 
acid-binding proteins (68,69). These regions are the arginlne-rlch areas 
which have considerable similarity to protamines. Such a protamine-like do-
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TABLE 1 : FEATURES OF CLONED HUMAN snRNP-ASSOCIATED PROTEINS. 
Protein 
70K 
A 
С 
A' 
B" 
D 
E 
Molecular weight 
52-57 kDa 
31.5 kDa 
17.5 kDa 
28.5 kDa 
25.5 kDa 
13-3 kDa 
10.8 kDa 
snRNP 
Ш 
UI 
UI 
иг 
U2 
U1-U6 
U1-U6 
Specific features 
-RNP consensus 
-proline-nch region 
-arginine-rich regions 
-cross-reactive epitope with рЗО 8 3* 
-post-translationally phosphorylated 
-RNP consensus 
-proline-rich region 
-two hcmologous regions with B" 
-cross-reactive epitope with B" 
-cross-reactive epitope with B'.B,C.D.N 
-proline-rich region 
-post-translationally modified 
-cross-reactive epitope with Α,Β',Β,ϋ.Ν 
-leucine-rich region 
-RNP consensus 
-two hcmologous regions with A 
-cross-reactive epitope with A 
-Gly-Arg repeated motif 
-none 
References 
68.69.70 
7' 
66,78 
72 
73 
7it 
75,76,77 
main was also found in the D protein (74). It is not surprising though, that 
proteins rich in lysine and arginine would have structural similarities to 
protamines. 
The human snRNP proteins Β', B, and the smaller molecular weight pro­
teins F and G remain to be cloned. However, the primary structures of pro­
teins B' and В frem HeLa cells are strongly related. Comparative partial pro­
tease digestion of both proteins revealed a striking similarity (86). The 
peptide pattern of both proteins obtained after partial chymotrypsin diges­
tion were identical except for two fragments. Thus protein B' may differ 
from the В protein only by a short additional amino acid sequence. 
In addition to the human snRNP proteins, the corresponding protein com­
plement from a wide variety of other cells and organisms, as diverse as non-
human vertebrates, amphibians, insects, unicellular organisms, and plants has 
been studied. These results will not be discussed here in detail (for a re­
cent review see ref. 63) but it can be stated that the number and molecular 
weights of the polypeptides contained in the snRNPs from the various orga­
nisms have been conserved throughout evolution. To a certain extent this may 
also be true for their primary structures. For exanple, the snRNP-specific С 
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protein from Xenopus laevis (Mattaj, personal communication) only differs in 
a few amino acids from its human counterpart (66). In addition, both polypep­
tides have exactly the same length. The Xenopus and human 70K protein se­
quence, though probably having a different length, still show an overall 
identity of 88* (68,79). Elucidation of the primary structure of other non-
human snRNP proteins will probably reveal more structural similarities with 
their human homologs, as suggested by imnunological cross-reactivity of the 
snRNP polypeptides of the diverse organisms with human anti-snRNP autoantibo­
dies (see below). Furthermore, the recent demonstration that oocytes can form 
hybrid snRNP-like particles consisting of U snRNAs from a wide variety of 
phylogenetic sources and the amphibian snRNA binding proteins stockpiled in 
the cytoplasm (87-89) is consistent with the extraordinarily high conserva­
tion of both the proteins and the different snRNAs in snRNP particles. The 
hybrid complexes assembled with human U1 and U2 snRNAs and amphibian proteins 
were even shown to be fully functional in the splicing of messenger RNA pre­
cursors (89). 
BIOGENESIS OF snRNP PARTICLES 
The snRNP particles consist of parts whose synthesis occurs in separate 
subcellular compartments, the snRNAs being made in the nucleus, whereas their 
protein components are synthesized in the cytoplasm. The joining of these 
components takes place in the cytoplasm, and what moves into the nucleus are 
probably complete functional snRNPs. 
Eukaryotic genes are classified into RNA polymerase I, II or III types 
depending on the differential sensitivity of transcription to inhibition by 
ot-amanitin (90,91). The major nucleoplasmic vertebrate trimethylguanosine-
capped snRNAs Ш to Ü5 are transcribed by RNA polymerase II since their 
transcription is sensitive to low levels of a-araanitin, while U6 snRNA is 
transcribed by RNA polymerase III (92-9*»). Like other RNA polymerase II 
transcripts, the primary transcripts of U snRNA genes initially contain a 7-
methylguanosine cap structure (95-97). Furthermore, they are longer by 8 to 
20 nucleotides at their 3' ends when compared to mature snRNAs (98-100). 
These snRNA precursors (pre-snRNAs) are transiently exported to the cytoplasm 
inmediately after, or perhaps even during, synthesis, as demonstrated by 
pulse-labeling experiments in which pre-snRNAs are found almost exclusively 
in the cytoplasm (101-103). 
Once in the cytoplasm, the pre-snRNAs undergo several maturation steps, 
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including 3' exonucleolytic trimming (95,99,100,104), hyperraethylation of the 
5' cap (97) and several internal base modifications. Furthermore, the matu­
ring snRNAs bind snRNP proteins in an ordered fashion (65). Like the situati­
on in Xenopus oocytes (105-10Θ), in mammalian cells a pool of snRNP proteins 
is available to asseirible with the newly transcribed snRNAs (109). In an ini­
tial step the common proteins D, E, F, and G self-assemble into a polyprotein 
complex in the absence of the RNA molecule (65). The other components, the 
сопиюп proteins B' and B, the unique proteins, and the snRNA, add to this 
core structure in an order not yet elucidated. Most proteins already appear 
to associate with the pre-snRNAs, since the 3'-extended cytoplasmic snRNAs 
are inmunoprecipitable with antibodies recognizing snRNP protein components 
(99). Jeanteur and his collaborators assayed for regions of the U snRNAs that 
bind protein by analyzing residual RNP structures of isolated U snRNP partic­
les after digestion with micrococcal nuclease. They found that the conserved 
stretch of consensus sequence PuA(U)
n
GPu (with n>3), coninon to all major 
snRNAs except U6 snRNA, was highly protected, and that the residual RNP 
structures obtained from each particle contained the conmon proteins D, E, F, 
and G (110-112). Mutant U1 and U2 transcripts from which the PuA(U)
n
GPu 
stretch had been deleted, were no longer immunoprecipitable with so-called 
anti-Sm antisera (see below), containing antibodies that recognize some of 
the common proteins (113-115). Furthermore, an artificial RNA which contains 
the PuA(U)
n
GPu sequence but is otherwise unrelated to snRNA sequences, also 
forms anti-Sm precipitable snRNPs upon microinjection in Xenopus laevis oocy­
tes (97). Taken together, these results unequivocally show that the single-
stranded PuA(U)
n
GPu sequence serves as a primary binding site for the conmon 
U snRNP proteins. Since these proteins include those recognized by anti-Sm 
antisera, this region now generally is referred to as Snv-binding site (Figure 
1). The relative short length of this sequence in addition to the formation 
of a protein complex in the absence of RNA, suggests that the core RNP struc­
ture of the snRNPs is dominated by protein-protein rather than by RNA-protein 
interactions. 
U6 snRNA, which by itself does not contain a uridine-rich single-stran­
ded region similar to the Sm-binding site, is present in snRNP particles con­
taining one molecule «ach of IM and U6 snRNA (32,31). In accordance with the 
formation of these UU/U6 particles in human cells, U4 and U6 snRNAs are pre­
sent in equimolar concentrations despite the fact that U6 snRNA genes have 
transcription signals that are distinct from those of the U4 snRNA genes 
(116,117) and IW and U6 genes are not contiguous or even closely linked (9H, 
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118-121). 
Little is known about the RNA binding sites of proteins unique to parti­
cular snRNPs. In vitro assembly of a set of mutant U1 snRNAs designed to lack 
single secondary structural elements (122) revealed that the essential con­
tact points of the U1 snRNP-specific proteins C, A and 70K are localized in 
the S'-most hairpin structure of the U1 snRNA (Figure 1). Data on the increa­
sed protection of Ш snRNA against micrococcal nuclease digestion after bin­
ding of monoclonal anti-70K antibodies to in vitro reconstituted human U1 
snRNP particles (123,124) are consistent with the fact that the 70K protein 
binds to hairpin I (Figure 1). Binding of U1 snRNP-specific proteins is sta­
bilized by protein-protein interactions with the core proteins bound to the 
Sm-binding site (122,124). Recently, the specific binding of proteins С, A 
and 70K has been shown to depend critically on the conserved loop sequence 
of the hairpin I structure (Figure 1) of the U1 snRNA (125). Binding of pro­
tein С to U1 snRNA in the absence of both A and 70K proteins, suggests that 
this protein binds directly to the loop and that the assembly of proteins A 
and 70K into the snRNP requires mainly protein-protein interactions. 
In the case of U2 snRNA the two hairpins towards the 3* end of the RNA 
molecule are required for the interaction of the U2 snRNP-specific proteins 
A' and B " with the RNA (114). In addition, both proteins seem to require the 
Sm-binding site, probably for stabilizing interactions with the proteins 
bound to this region as is the case for the specific proteins in the U1 snRNP 
particle. Whether the RNP core structure in U2 snRNPs is a prerequisite for 
the binding of the unique proteins is not clear. On the one hand, U2 snRNP-
specific proteins A' and B'* cannot form an inraunoprecipitable complex with 
mutant U2 transcripts which lack the Sm-binding site (113,114) whereas on the 
other hand in Vesicular Stomatitis Virus infected cells U2 snRNP precursors 
were preclpitable from virally infected cells by monospecific anti-A' antibo­
dies, despite the absence of core protein binding in these particles (126). 
In the first case, however, the stringent conditions used in the immunopreci-
pitation assay may have failed to detect binding of the U2 snRNP-specific 
proteins. Furthermore, it cannot be excluded that the A' protein in either 
case binds to a different region of the U2 snRNA. 
The exact stoichiometry of the proteins in the individual snRNPs has not 
yet been determined. It is not clear whether all major snRNPs contain just 
one molecule each of all the common proteins or whether in case of U1 and U2 
snRNP particles there is a mixed population, some of which contain all unique 
proteins and others only a subset thereof. From the tissue-specific expres-
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sion of the rat N protein (61 ) it may be concluded that the protein composi­
tion of snRNPs can vary in different cell types. 
Like U snRNP assembly, trimethylation of the monomethyl-guanosine cap 
structure has also been shown, at least in the case of U2 snRNP, to occur in 
the cytoplasm (97). It requires prior binding of the ссяшюп U snRNP proteins 
(97), suggesting that these proteins could play a role in creating the recog­
nition site for the enzymes modifying the cap structure. It is in fact not 
excluded that one of the core proteins harbors the methylating activity. 
Where in the cell the acquisition of the other, internal, modifications takes 
place, is presently unknown. 
One of the last steps in the maturation of snRNPs is the removal of the 
short 3' extensions from the snRNA precursors. The extensions presumably are 
removed by an exonuclease (99,100) or, in the case of U2 precursors, an endo-
nuclease (104,127) either just before or during the process of movement back 
into the interphase nucleus (99,100,128). The snRNP proteins could participa­
te in the transport of the particles frcan the cytoplasm to the nucleus, since 
nuclear accumulation of U snRNAs can only occur when they are complexed to 
the U snRNP proteins (108,113). Once in the nucleus the major U snRNPs func­
tion in messenger RNA processing. 
FUNCTIONS OF THE MAJOR snRNP PARTICLES 
The splicing reaction. 
In higher organisms expression of genes encoding proteins is complicated 
by the presence in DNA of non-coding sequences called introns. Because DNA 
sequences are transcribed wholesale, with no discrimination between introns 
and the coding or exon regions, messenger RNA Is synthesized as a precursor 
containing segments of genetic "nonsense". Before these messenger RNA trans­
cripts are transported into the cytoplasm, introns must be removed and the 
remaining exons have to be rejoined in the same order they occupied in the 
DNA. The removal of introns from a primary transcript and the subsequent 
ligation of the exons is a process called splicing. It is this crucial spli­
cing procedure in which snRNPs participate. The process of splicing requires 
that the sequences at the boundaries of the intron, the 5' and 3' splice 
sites, be correctly cleaved and the two ends accurately joined. In the case 
of manmalian mRNA precursor splicing, evolutionary conserved sequences at the 
two splice sites specify the reaction. In figure 2 the vertebrate consensus 
sequences are shown (129,130). Virtually invariant are the dinucleotides GU 
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5' ΕΧΟΝ INTRON 3' ΕΧΟΝ 
.AG GUAAGU C NA AC (
С)
П
№АС G 
G U G U U n U 
5' splice site branch point 3' splice site 
Figure 2. Consensus sequences at splice sites and branch site in genes of 
vertebrates. Splice site consensus sequences are from Mount (129) and the 
branch point consensus from Green (134). N represents any nucleotide. 
at the 5' splice site and AG at the 3' splice site. The consensus region at 
the 5 ' splice site extends fron the last two nucleotides in the exon through 
the first six nucleotides of the intron. The consensus at the 3' splice site 
extends from the last four nucleotides of the intron through the first nucle­
otide of the exon and is preceded by a polypyrimidine tract of at least 11 
residues. 
The development of cell-free splicing systems (131-133) has greatly con­
tributed to our present knowledge of the splicing reaction. These in vitro 
studies revealed that splicing of individual introns proceeds by a sequential 
two-step cleavage-ligation mechanism (Figure 3; for reviews see refs. 130, 
134)· The first step in the splicing reaction is a cleavage at the precise 5' 
splice site. In either a kinetically rapid second reaction or a mechanically 
coupled reaction, the free 5' end of the intron is joined via a 2'-5' phos-
phodiester bond to an adenosine residue near the 3' splice site to produce a 
lariat or tailed circular RNA molecule containing the intron and the 3' exon. 
RNA molecules containing these branched nucleotides had earlier been observed 
in nuclear RNA by Wallace and Edmonds (135). In the second step this bipar­
tite intermediate is subsequently resolved by cleavage at the precise 3' 
splice site and ligation of the 5' and 3' exons via а З'-З' phosphodiester 
bond. The two products of the splicing reaction are the spliced exons and the 
excised intron in the form of a lariat. The site of branch formation in the 
lariat is typically 20 to 50 nucleotides upstream of the 3' splice site and 
nearly always occurs at an adenosine residue. In higher eukaryotes, the re­
gion surrounding the branch site has only a very limited consensus sequence 
(13^). The two conserved sequence elements at and near the two splice sites 
and the site of branch formation represent regions where snRNPs interact with 
the mRNA precursor (for a review see ref. 136). 
snRNPs and splicing. 
The first connection between splicing and snRNP particles was the hypo-
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5' splice site 
-UGAAUG-P- PA-
Precursor 
I 
-YNRAY Y
n
NCAG-P-
branch site 3* splice site 
1 
-YNGAY -Y
n
NCAG-P· 
1 
m 
щ -p- — _ 3. 
Intermediates 
Spliced product 
-UGAAUG 
I 
Ρ 
I 
YNGAY- -YnNCAG-Œ 
Lariat form of 
intron 
Figure 3. Mechanism of mRNA splicing. Y stands for a purine nucleotide, R for 
a pyrimidine nucleotide, and N for any nucleotide. Phosphate moieties from 
the 5' and 3' splice site are depicted as well as the 2* OH-group at the 
branch site that is used in the 2'-5' phosphodiester bond of the lariat 
structure (after ref. ІЗО). 
thesis of Lerner et al. (137) and Rogers and Wall (138) that the 5' terminal 
region of Ul snRNA recognized sequences at the 5' splice sites by virtue of 
sequence complementarity. Until recently, biochemical evidence in support of 
this hypothesis was only strongly suggestive. Splicing of mRNA precursors in 
in vitro systems could be inhibited by treatment of mammalian splicing ex­
tracts with anti-Sm, an antibody specifically reacting with some of the com­
mon U snRNP proteins (139-140), antibodies recognizing Ul snRNP-specific pro-
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teins (139,141), or antibodies directed against the unique 5' cap structure 
of the snRNPs (140). Partially purified Ш snRNPs selectively bind in vitro 
and protect from RNase digestion RNA fragments that mapped precisely to the 
5' splice site of a mouse ß-globin mRNA precursor (142). Significantly, the 
interaction was dependent on both intact III snRNA and protein moieties, as 
demonstrated by the fact that pretreatment of the purified U1 snRNPs with 
micrococcal nuclease or proteinase К abolished specific association with the 
5' splice site. Specific hydrolysis of the S'-tenninal 8 to 14 nucleotides of 
U1 snRNA, based on the accessibility of the 5' end region of U1 snRNA for 
base pairing with a single-stranded DNA oligonucleotide and subsequent clea­
vage by RNase H (143,144), was also sufficient to abolish splicing in vitro 
(140,145,146). Conclusive evidence that actual base pairing between U1 snRNA 
and mRNA precursors is involved, was provided by the demonstration that the 
splicing efficiency of mutant 5' splice sites can be increased in vivo by 
concomitant expression of mutant U1 snRNA genes with compensatory mutations 
in their 5' sequences (147) or that a natural 5' splice site can be improved 
by increasing the base complementarity to U1 snRNA (148). 
Specific hydrolysis of the 14 to 15 nucleotides from the 5' terminus of 
U2 snRNA (145,146) or of a 15-nucleotide sequence near the 5' end of the mo­
lecule (145) which both are accessible to cleavage by RNase H in the presence 
of a complementary DNA oligonucleotide, drastically inhibits splicing in vi­
tro, demonstrating that also U2 snRNP is required in the splicing reaction. 
The exact molecular nature of the interaction between U2 snRNP and the mRNA 
precursor is still unclear, but it is ATP-dependent and protein-protein, RNA-
protein as well as base-pairing interactions may be involved. Nuclease pro­
tection experiments and iimiunoprecipitation assays, similar to those carried 
out for the U1 snRNP particle (145), revealed that antibodies specifically 
recognizing U2 snRNPs selected fragments of the mRNA precursor containing a 
region of the intron that includes the branch site (145) and at least part of 
the polypyrimidlne tract (149). The binding of U2 snRNP is probably not cri­
tically dependent on specific sequences flanking the branch site, since these 
sequences vary radically among functional introns (150,151)· Furthermore, mu­
tational analyses have shown that the sequence element most critical for the 
U2 snRNP-branch point interaction is not the branch point itself, but rather 
the 3' splice site consensus sequence. Deletion or mutation of the 3' splice 
site region (including the polypyrimidlne tract) severely decreases or elimi­
nates U2 snRNP binding (152,153) and splicing (151,154,155). In contrast, in 
yeast the sequence surrounding the site of lariat formation is rigidly con-
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served and the ability of mutant genes encoding the yeast U2 snRNA analogue 
to suppress otherwise nonfunctional mutations in this conserved branch site 
sequence, demonstrated that the site of lariat formation relies, at least in 
part, on base pairing with the yeast U2-like snRNA (156). These base-pairing 
interactions involved a region which is absolutely conserved between yeast 
and vertebrate U2 snRNA (31). In the light of these results it was proposed 
(156) that base pairing might also participate in the identification or uti­
lization of branch sites in metazoan introns, despite the apparent degeneracy 
of the branch site consensus at the primary sequence level in these species 
ОЗУ). Indeed, base substitutions in the mamalian branch point sequence were 
shown to dramatically reduce the efficiency of pre-mRNA splicing in vitro 
(157). Probably this base-pairing between the branch point region and U2 
snRNP is only required for the splicing reaction, whereas binding to this 
region is primarily determined by its distance from the 3' splice site and is 
mediated by several protein factors (158,159). One of these protein factors, 
termed the U2 snRNP auxiliary factor (U2AF), binds to the 3' splice site re­
gion and binding of this factor is a prerequisite for Ü2 snRNP branch point 
interaction (159). This provides an explanation for the necessity of the 3' 
splice site region in U2 snRNP binding to the branch point. Previous studies 
had already revealed another factor, a polypeptide of 70 kDa (57) or 100 kDa 
(55), that independently interacts with the 3' splice site region. The pro-
tein, designated intron binding protein (IBP; ref. 55), specifically binds 
the polypyrimidine tract between the 3' splice site and the branch point. 
Since binding of the U2 snRNP to the mRNA precursor also depends on the poly-
pyrimidine stretch (160), an interaction between the 3' splice site binding 
components and the U2 snRNP particle can be envisioned. 
In the complexes formed at the 3' splice site also an snRNP is present 
(56). Binding of this snRNP is highly resistant to pretreatment with micro-
coccal nuclease. Of the abundant snRNPs, only the particle containing U5 
snRNA shows the same striking resistance to micrococcal nuclease digestion. 
Thus, in addition to the U1 and U2 snRNPs, also U5 snRNPs appear to partici-
pate in splicing. The intron binding protein may mediate the binding of this 
snRNP particle to the 3' splice site, since it probably is an integral part 
of U5 snRNPs (see above; ref. 55). 
Although there are no definite indications yet of a specific interaction 
of U4/U6 snRNPs with mRNA precursors, a requirement for this dimeric snRNP 
particle in the splicing reaction has been demonstrated by site-directed 
cleavage with RNase H. DNA oligonucleotides complementary to U4 snRNA (161, 
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162) or U6 snRNA (162) sequences which allow selective degradation of their 
target RNAs in an in vitro splicing extract, are strongly inhibitory to spli-
cing. The IM/U6 snRNP particle may not bind directly to the mRNA precursor 
but may instead interact with the other snRNPs to fold the mRNA precursor 
into a specific spatial configuration, which brings the distant splice sites 
into proximity and precise alignment. 
snRNPs and spliceosome assembly. 
The splicing of mRNA precursors occurs in large highly ordered structu-
res which have to be assembled for each intron excision event (151,163-167). 
Assembly of these structures, called spliceosomes, is dependent upon the con-
served sequences located at the 5' and 3' splice sites of the mRNA precursor 
(Figure 2; refs. 154,168-171). It is the sequential binding of the major 
snRNPs to the mRNA precursor which underlies the stepwise assembly of these 
splicing complexes. The ordered and sequential binding of the snRNPs is medi-
ated by additional (protein) factors (172,173), as are the two cleavage-liga-
tion steps of the splicing reaction itself (Figure 3; refs. 146,160,167,174, 
175). However, none of these activities have been substantially purified and 
their roles in spliceosome assembly have not been determined yet. The snRNPs 
U2, U4, U5, and U6 are detected in spliceosomes prior to 5' cleavage and la-
riat formation (149,176,177)· An early step in the pathway of spliceosome 
assembly involves the binding of U2 snRNP to the branch site region. This is 
followed by the apparently simultaneous binding of U4, U5, and U6 snRNPs 
(177). After 5* cleavage U4 snRNP is released, since after the first step of 
the splicing reaction the spliceosome only contains U2, U5, and U6 snRNPs 
together with the RNA splicing intermediates (178). It is not known whether 
U1 snRNP is stably associated with the spliceosome or only transiently binds 
to the mRNA precursor, since the presence of this snRNP depends on the condi-
tions used for spliceosome purification (149,176-180). 
AHTIGENICITY OF THE MAJOR snRNPS 
snRNP proteins and human autoantibodies. 
Autoantibodies against snRNPs occur predominantly in sera from patients 
with systemic lupus erythematosus (SLE) or mixed connective tissue disease 
(MCTD). SLE is the prototype of a systemic autoiimune disease in many res-
pects. It is characterized by an exuberant inmune response which is manifes-
ted by the production of autoantibodies against a variety of nuclear antigens 
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such as DNA, RNA, DNA-histon conplexes and saline-extractable RNA-protem 
complexes and by their presence in high concentrations in many cases (revie-
wed in refs. 181,182). This versatility of the autoinmune response in SLE 
appears to be in contrast to other autounnune diseases where the autoantibody 
response is more restricted and appears to be directed at only one or two mo-
lecular species of antigen(s). One particularly prevalent antibody in SLE 
reacting with RNA-protem conplexes was called anti-Sm after the code name of 
the patient serum used in the study which first described this antibody sys-
tem (183). A related antibody found in SLE patients was called anti-nuclear 
RNP (184). Whereas antibodies to Sm were exclusively found m patients with 
SLE and therefore are disease-specific (185), antibodies to nuclear RNP were 
even more frequently and in much higher titres found in patients with MCTD 
(186), a clinical syndrome which had not been recognized as a distinct entity 
until the "marker" autoantibody had been recognized. The autoimmune manifes-
tation in MCTD is mostly restricted to autoantibody to nuclear RNP, whereas 
the clinical symptoms are a mixture of features fron several connective tis-
sue diseases which are SLE, scleroderma, and polymyositis (187). The precise 
nature of the RNA-protein complexes that were recognized by anti-Sm or anti-
nuclear RNP antibodies was not known, but they were localized in the cell 
nuclei of many manmalian species. In 1979, Lerner and Steitz made the inpor-
tant observation that the anti-Sm and anti-nuc]ear RNP autoantibodies react 
with RNA-protein conplexes containing the U snRNAs (4). They showed that im-
mune precipitates obtained after reaction of nuclear extracts with anti-nu-
clear RNP and anti-Sm sera contained either U1 snRNA alone or else U1 and U2 
SnRNA and by that time three novel snRNAs that were designated 114, U5, and U6 
snRNA. Six to seven polypeptides were also present in the inmune precipita-
tes, which already indicated a complex protein composition of the snRNPs. The 
antigenic determinants reacting with the two antibody systems resided on the 
protein part of snRNPs. The identity of U snRNPs with the Sm and nuclear RNP 
autoantigens prompted a detailed analysis of the pattern of autoantibodies in 
patient sera specific for individual snRNP polypeptides. In addition, it led 
to the use of anti-Sm and anti-nuclear RNP autoantibodies for the identifi-
cation and characterization of the protein constituents of the individual 
snRNPs and for the structure-function relationship of these particles. 
Since the anti-nuclear RNP autoantibody system can be further divided in 
three distinct specificities, at present four human autoantibody specifici-
ties against U snRNP proteins can be distinguished. 
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Figure Ч. Characterization of anti-Sm and anti-nuclear RNP sera by iirnmo-
blotting. Identical blot strips containing HeLa total protein extract were 
incubated with patient sera containing autoantibody specificities directed 
against snRNP proteins. Bound antibodies were detected with 125i_i
a
i}elled 
sheep anti-human Ig. Lanes: (1) normal human serum; (2) anti-Sm serum; (3) 
anti-(U1)RNP serum; (4} anti-(U1,U2)RNP serum. 
Anti-Sm autoantibodies. Most anti-Sm sera contain antibodies reacting 
with proteins B', B, and D, simultaneously (Figure 4). Since these proteins 
are common to all major snRNP particles, anti-Sm antibodies imasunoprecipitate 
the complete set of U1, U2, Ü4, US, and U6 snRNAs (Figure 5). The proteins 
B', B, and D share at least one Sm-afitigenic epitope, as danonstrated by the 
cross-reaction of anti-B'/B antibodies, affinity purified from these sera by 
elution from immunoblotsy with the D protein and vice versa (50). There are, 
however, less frequently occurring sera where no cross-reaction is observed, 
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Figure 5. analysis of RNA. ifflmunoprecipitated by antl-Sm, or anti-nuclear RHP 
sera. Patient sera containing autoantibody specificities directed against 
snRNP proteins were used for liamunopreclpitation of snRNPs fron 32p_iabeiied 
HeLa cell nuclear extracts. The snRNAs present in the imroune precipitates 
were fractionated on Polyacrylamide gels. Lanes: (1) total RNA; {Zi nomai 
human serum; O ) anti-Sm serum; (4) anti-OJDRNP serum; (5) anti~íül,U2)RNP 
зегші. 
indicating that there are at least two distinct Sm-antigenic epitopes on pro­
teins B' and В (50). Anti-Sm. antibodies recognizing only one of the proteins 
B' and В have not been found in patients thus far, which Is consist«!* with 
the strong structural relationship between these two proteins (see above; 
ref, 86). Anti-Sm antibodies to the smaller common snRNP proteins E, F, and G 
also occur in patient sera, but are certainly more rare. At least one Sm-an­
tigenic epitope is also present on the apparently U5 snRNP-assoclated intron 
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splice site of mRNA precursors (57). 
The most recently discovered U snRNP protein, designated N (61,62), that 
is expressed predominantly in brain, also appears to bear an Sm-antigenic 
epitope. Antibodies present in anti-Sm sera that were eluted fron the N pro­
tein, not only reacted with the N protein itself, but also with the structu­
rally related proteins B' and В (62). Surprisingly, the affinity-purified 
antibodies also recognized the U1 snRNP-specific A protein. It could be de­
monstrated that this cross-reaction is due to the proline-rich region of pro­
teins A (71) and К (62) which harbors antigenic sequences that are very simi­
lar in both proteins (chapter 6; ref. 62). The U1 snRNP-specific protein С 
also contains a proline-rich region (66). Indeed, from scene anti-Sm sera an­
tibodies cross-reacting with proteins A, B', B, N, and С could be affinity 
purified from the epitope sequence contained in the proline-rich region of 
the A protein (chapter 6) and sequences resembling this epitope could be de­
tected in the primary structure of the С protein. However, because of the 
mixed population of antibody specificities usually present in patient sera 
(see below), it could not unambiguously be concluded whether the sequence 
that is recognized in all these proteins indeed is an Sm-antigenic epitope. 
Anti-(U1)RNP autoantibodies. Anti-(U1)RNP sera, which selectively preci­
pitate U1 snRNPs (Figure 5 ) , predominantly recognize the U1 snRNP-specific 
polypeptides A and 70K, and with lower frequency also the polypeptide С (Fi­
gure 4). About 60 % of the anti-(U1 )RNP sera also show a weak but evident 
reaction with the proteins B' and В (50). This finding can be explained ei­
ther by assuming that most anti-nuclear RNP sera contain trace amounts of 
anti-Sm antibodies (and would better be referred to as anti-nuclear RNP/Sm) 
or by assuming the presence of cross-reacting antibodies. The relative mono-
specificity for U1 snRNP of such sera may be explained by the weak titres of 
anti-B'/B autoantibodies normally observed in such sera (50,188) or by the 
fact that they recognize epitopes that are buried inside the snRHP complex 
under the conditions of the inmunoprecipitation assay. Although anti-(U1)RNP 
autoantibodies are also found in sera from patients with SLE, albeit in sig­
nificantly lower concentrations, they are strongly associated with MCTD (186, 
189). Whereas anti-Α and anti-C autoantibodies are found in both classes of 
patients, anti-70K autoantibodies in particular are closely associated with 
MCTD, and may therefore be of important diagnostic value (188). Anti-(U1)RNP 
sera of MCTD patients react with three closely spaced polypeptides of 70 kDa 
on immmoblots, especially when peroxidase-conjügated second antibodies are 
used (190,191). Whether the additional protein bands represent splicing va-
riants (69) or post-transcriptionally modified forms of the 70K protein, 
which is known to become heavily phosphorylated in the cell (see above; ref. 
64), has not yet been clarified. 
Anti-(1J2)RNP and anti-(U1 ,U2)RNP autoantibodies. Apart from the anti-Sm 
and anti-(U1)RNP antibody systems two more autoantibody specificities reac-
ting with snRNP proteins have been described to be present in sera of pa-
tients with connective tissue diseases. One antibody precipitates selectively 
U2 snRNPs and reacts with the U2 snRNP-specific A* protein. Antl-(U2)RNP sera 
with high levels of anti-Α' antibodies appear to be very rare and have only 
been described in two cases thus far (52,53). The other antibody system pre­
cipitates U1 and U2 snRNPs simultaneously (Figure 5). Immunoblotting studies 
revealed that this anti-(U1,lJ2)RNP reactivity is due to antibodies that 
cross-react with the Ώ2 snKNP-specific B" protein and the Ш snRNP-specific A 
protein (Figure 4; ref. 53). These cross-reactive anti-(U1,U2)RNP autoantibo­
dies apparently are more coamon as the antl-(U2)RNP autoantibodies and seem 
to be present in about 10$ of all anti-nuclear RNP sera. An epitope recogni­
zed in either protein by cross-reactive antibodies from an anti-(U1,U2)RNP 
serum, could be mapped in the carboxy-terminal region of similarity between 
the two proteins (chapter 6). 
Anti-snRNA antibodies. 
Although nucleic acids are thought to be poor inmunogens (192), antibo­
dies to snRNAs have been experimentally induced (46,193,194) and have been 
obtained from sera of autoimmme patients (195,196). 
Antibodies specific for III snRNA were found to be present in three sera 
which also contained the well-characterized anti-Sm and anti-nuclear RNP au­
toantibody systems which are directed against specific proteins of the U 
snfiNPs (see above; ref. 195). These U1 snRNA-specific autoantibodies recog­
nized deproteinized U1 snRNA from HeLa cells as well as U1 snRNA synthesized 
in vitro (196). The contact site recognized by a U1 snRNA-reactive autoanti­
body from a patient with lupus-overlap syndrome and rheumatoid arthritis was 
determined to be located on the predicted middle stem-loop В region of the Ш 
snRNA (Figure 1) and depends on the RNA conformation of this hairpin structu­
re (196). Since the ссшпюп proteins of the U1 snRNP particle are associated 
with the single-stranded Sm-binding site and the Ш snRNP-specific proteins 
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most likely bind to loop A of the hairpin I structure (see above), the stem-
loop В region may not be decorated with protein. Thus antibodies against this 
imnurtoreactive RNA domain of the Ш snRNP particle could be elicited by di­
rect inmunological presentation. On the other hand, as suggested by Deutscher 
and Keene (196), anti-U1 snRNA autoantibodies could also be anti-idiotypic in 
origin. This idiotype/anti-idiotype networking mechanism, which has been im­
plicated in autoiranune diseases such as myasthenia gravis (197), systemic 
lupus erythematosus (198), and rheumatoid arthritis (199), is consistent with 
the fact that the presence of antibodies specific for U1 snRNA appears to be 
associated with anti-Sm or anti-nuclear RNP autoantibody specificities (196). 
In this hypothesis the anti-idiotypic anti-U1 snRNA antibodie are formed 
against an idiotypic autoantibody that may have been directed against an RNA-
binding domain of a U1 snRNA-associated protein (196). 
Two antibody specificities to snRNAs could be induced experimentally. 
Rabbits imnunized with bovine serum albumin conjugated т2>2>7с produced anti­
bodies that specifically recognize the cap structure of U snRNAs (46,193)· It 
could be demonstrated that the т2'2>7с cap structure of all snRNAs was acces­
sible for the antibody in intact snRNPs (46,200). Ever since, anti-trimethyl-
cap antibodies have been used in a broad range of experiments, varying from 
purification of the nucleoplasmic snRNPs from nuclear extracts by inmune af­
finity chromatography or identification of U snRNAs by anti-cap immunopreci-
pitation to the inhibition of splicing in in vitro splicing extracts. A se­
cond nucleoside-specific antibody was raised against N°-methyladenosine (m"A; 
ref. 194), One m 6A residue is present in each of the snRNAs U2, U4, and Ü6 
and the antibody reacts selectively with the snRNPs U2 and U4/U6. However, 
other RNA species in the eukaryotic cell also contain m^A residues, like 
transfer RNAs, mRNA precursors (present in the cell as heterogeneous nuclear 
RNA) and ribosomal RNAs. 
snRNPs and etiology of autoinmunity. 
In conclusion, there is a great diversity in snRNP-specific antibody po-
pulations produced by patients with connective tissue diseases. Almost any 
snRNP polypeptide may eventually become the target of the inmune system. In 
most of the patient sera, multiple autoantibody specificities against several 
snRNP polypeptides occur simultaneously. As already mentioned, anti-(U1)RNP 
sera often contain antibodies to the cannon proteins B' and В (50). On the 
other hand, there is hardly any anti-Sm serum which does not also contain 
antibodies to the Ü1 snRNP-specific proteins A or C. On several of the snRNP 
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polypeptides two or more distinct epitopes are recognized by different auto­
antibody populations. At least two distinct epitopes were identified on the 
U1 snRNP-specific A protein by subcloning randan DNA fragments of its cDNA in 
an expression vector and screening for recombinants encoding an iimunoreac-
tlve fusion protein (chapter 6). In the U1 snRNP-specific 70K protein, by a 
similar approach, multiple overlapping and non-overlapping autoepitopes were 
identified on fragments derived from several domains of the polypeptide (70, 
201). The autoimnune response to the various epitopes is remarkably heteroge­
neous and differs qualitatively from patient to patient (201). Thus even at 
the level of the individual proteins, the inmune response apparently is poly­
clonal and directed against more than one determinant. Taken together, the 
data indicate that the snRNPs are targeted by the patients' immune system as 
a physical entity rather than as individual snRNP proteins. Furthermore, they 
indicate strongly that whatever nature of the disturbance in iranunoregula-
tion, the anti-Sm and anti-nuclear RNP autoantibodies are also produced by 
the patients as a result of specific antigen drive. The distinctiveness of 
the inmune response to snRNPs, which in one instance called forth antibody 
production primarily against Ш snRNP, mainly associated with a disease re­
cognized clinically as MCTD, whereas, in another instance, an immune response 
was generated not only to U1 snRNP but also to other snRNPs, associated with 
the disease known as SLE, further underscores that it must be either antigen 
driven or at least antigen directed. The hypothesis that the anti-Sm and 
anti-nuclear RNP autoimmune response is driven or directed by endogeneous U 
snRNP particles is supported by a study of the humoral inmune response of 
genetically non-iimune mice that were imnunized with purified human U1 snRNP 
particles (51). The antibody pattern produced by the mice was found closely 
to resemble the anti-nuclear RNP and anti-Sm autoinmune response in SLE pa­
tients. Moreover, caipetition studies between monoclonal antibodies derived 
from the iimunized mice and patient sera, showed that the mice produced anti­
bodies to the same regions on the individual snRNP proteins as patients do 
during the autoimmune response. 
The concept of molecular mimicry, which proposes that an autoantibody 
arises as a result of an immune response to an exogeneous agent which bears 
an epitope identical or similar to the host protein, has until now been sug­
gested for only a single species of snRNP autoantibody. An antigenic region 
of the Ш snRNP-specific 70K protein is similar to a sequence of the р30ва8 
proteins of most manmalian type С retroviruses (70). These proteins show im­
munological cross-reactivity, since antibodies to this viral coat protein re-
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cognized a recombinant 7ÛK protein and were able to precipitate U1 snRNPs. It 
was further demonstrated that the region of honrology encompasses the site of 
cross-reactivity. On the basis of these observations, a role for retroviruses 
in the pathway of anti-U snRNP autoimmunity was suggested (70). Anti-p30Sag 
antibodies raised against the expressed retroviral protein could cross-react 
with U1 snRNP-associated 70K proteins at the site of homology, producing a U1 
snRNP inmune complex that would then be presented to the іішшпе system. Sub­
sequently, imnune recognition could expand to other 70K epitopes and, in some 
cases, progress to epitopes of other U1 snRNP proteins, such as the Sm-anti-
genic proteins. Finally, amplification of high-affinity IgG antibody produ­
cing В cells would generate high-titer autoantibodies. The model proposed is 
interesting although it does not explain all aspects of autoimmunity, like 
imnune functions involving Τ cell interactions, idiotypic antibody networ­
king, polyclonal activation, and tolerance. Autoimnunity is probably a multi­
functional disease, and no single etiology is likely to operate alone. 
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ABSTRACT A U2 отіаіі nuclear RVA-assodated protein, 
designated B", was recently Identified as the target antigen for 
autoimmune sera from certain patients with systemic lupas 
erythematosus, and other rhcumatk disease«. Such antibodies 
enabled us to isolate cDNA done AHB'-l from a phage Xgtll 
expression library. This done appeared to code for the B" 
protein as established by м vitro translation of hybrid-selected 
mRNA. Theidenlit) of clone λΗΒ'-1 was further confirmed by 
partial peptide mapping and anal j sis of the reactivity of the 
recombinant antigen with monospecific and monoclonal anti­
bodies. Analysis of the nuUeotidc sequence of the 1015-basi-
pair cDN A insert of clone λ.ΗΒ"-1 revealed a large open reading 
frame of 800 nucleotides containing the coding sequence for a 
polypeptide of 25,457 daltons. In vitro transcription of the 
λΗΒ "-1 cDNA insert and subsequent translation resulted in a 
protein product » ith the molecular size of the B" protein. These 
data demónstrate that done λΗΒ"· 1 contaras f he complete coding 
sequence of this antigen. The deduced polypeptide sequence 
contain·, three very hydrophilic regions that might constitute RNA 
binding sites and/or antigenic determinants. These findings might 
have implications both for the understanding of the pathogenesis 
of rheumatic diseases as well as for the elucidation of the biological 
ftinctkm of autoimmune antigcm. 
Sera from certain patients with л connective tissue disease 
contain antibodies agamst a variety of small nuclear nbomi-
cleoprotem particles (snRNPs. rifs 1 and 2) In particular, 
sera containing antibodjus directed against proteins unique 
for Ш RNP [anti (UljRNPÎ and thnse againbt common 
determinants on Ul U2, U4 US and Ш snRNPs (anti Sm) 
have been extensively used to study assembli structure, and 
function of U snRNPb (reviewed in refs 3 and 4) 
Recently we described an auUMHtjbod} specificity termed 
anti-(Ul Ú2)RNP, reactive with polypeptides present in Ш 
and Ш RNPs (?) These sera greatly facihlated investigations 
towards the fine structure of U2 RNP (6, 7) Data obtained 
from such immunological studies, together with the results of 
earlier nudease-digestion experiments (8) revealed that Ul 
and U2 RNPs both contain a common protein core consisting 
of polypeptides В /B. D, E, F, and G as well as several unique 
protems, Ul RNPs have been described to contain additional 
Polypeptides called 'ЧОК" (70-kDa) A, and С (9-14), whereas 
U2 RNPb are characterized by the presence of at least two 
unique polypeptides. A' and B" (5, 9, 10,13,15) 
Both Ul and U2 RNP particles are involved in the splicing 
process of mRNA precursors Ul RNP has been shown to 
bind to the 5' splice site of precursor mRNAs ш vivo and in 
rhe риЫи-аІюп costs of îhis article were defra>cd inpartby page charge 
payment This article musi therefore be hereby market) advertisement 
in accordance with IB V S С Ç1734 ьоіеіу to indicate this fact 
\iiro (16-21), whereas U2 RNP was shown lo associate with 
the so-called branch point of Ihe lanat-shapcd intron, an 
intermediate in the cascade of splicing events (21) Whether 
MiRNA-associated proteins plav an active (enzymatic) mìe in 
this process or are merely essentia! for the structural integrity 
of the snRNP particles has not >u been established 
Recently, successful attempts have been described to 
partially characterize cDNA clones of autoimmune antigens 
or their asbociated proteins bv making use of patients' sera 
(22,23) Here we describe the isolation and characterization 
of a cDNA clone containing the complete coding sequence 
for the U2 RNP-specific B* protein 
MATERIAl^S AND METHODS 
Bacterial Strains and Phage Xgtll Expression Library-
bsihimhia colt strains Y1089 and Y1090 were purchased 
Irom Promcga Biotec (Madison, WI) A phage Xgtll expres-
sion library (24) was constructed from human KG1 cells as 
desenbed (25) 
Antibody Screening. Antibody screening was performed by 
using the human <mti-(bl,U2)RNP serum V2(i (S) essentially 
as desenbed by Huynh el al (26¡ 
Por immunoblotting, bacterial Iv sates were prepared by 
quick-freezing isopropyl /3-D-thiogalactoside-induced lyso-
genic bactena carrying the recombinant phage (26) Protein 
1> sates were fractionated on a NaDodSOa/10% acrylamide 
gel and then electroblotted onto nitrocellulose Immunoblots 
were probed with antisera as described (27) 
Partial Peptide Mapping. Slices containing A or B" antigens 
»ere excised from preparative NaDodSO,i/159i acrylamide 
gels, and proteins were recovered by electroelution (28) 
Cross contamination of both samples was checked by immu-
noblotting with serum V26 and monoclonal anti-A and anti-B" 
antibodies i29, 30) These samples and the recombinant 
antigen, affinity-punfied by using ami-ß-galactosidase col-
umns (Promega Biotec), were translerred into sample wells of 
a NaDodSOj/18% acrvlamide gel together with vanous 
amounts of SrapWococtut aureus V8 protease Digestion 
was allowed to proceed by shutting off the power for 10 mm 
after the samples had concentrated in the stacking gel (31) 
After electrophoresis, the gel was blotted onto nitrocellulose 
and epitope bearing peptides were detected with scrum V26 
RESULTS 
Isolation of Clone λΗΒΜ. A cDNA library m the phage 
Xgtll expression vector was screened by using the human 
Abbreviation snRNP, small nuclear nbonucleoproiein pamele 
+
 1ο whom reprint lequests should be addressed 
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anti-(Ul,U2)RNP serum V26, which contains antibodies 
directed against the Ul RNP-specific 70-kDa protein as well 
as two distinct antibody specificities directed against U2 
RNP-specific proteins A' and B". The latter specificity 
erossreacts with the Ul RNP-specific A protein (5). Screen­
ing of about 600,000 plaques resulted in a positive recombi­
nant carrying a 1.0-kilobase (kb) cDNA insert in the £coRl 
cleavage site of the /acZgene of the Xgtll vector. This clone 
will be referred to as clone λΗΒ"-1 hereafter. 
\HB"-1 was introduced as a lysogen in E. coli strain Y1089. 
Phage production was induced at 450C, and isopropyl 0-D-
thiogalactoside was added to induce the production of fusion 
protein. Bacterial lysates were analyzed by immunoblotting 
for reactivity with murine anti-/3-galactosidase antiserum and 
the anti-(Ul,U2)RNP serum V26 used for the screening 
procedure. Both sera positively identified a fusion protein 
with an apparent molecular mass ofl45kDa (Fig. ILeft), =30 
kDa larger than /j-galactosidase, next to some major degra­
dation products (indicated by an asterisk). 
Immunological Identification. To establish the identity of 
clone λΗΒ"-1, nitrocellulose filters containing plaques with 
the expressed recombinant antigen were prepared. The filter 
shown in Fig. 1 Right was cut into 12 pieces and analyzed 
with 11 different human autoimmune sera and a normal 
human serum control. The four sera that reacted positive 
(P21, G18, B25, and V26) were previously identified as 
anti-(Ul,U2)RNP sera, and all four were then shown to have 
only one specificity in common—namely, antibodies against 
the U2 RNA associated B" antigen (5). None of the control 
sera containing anti-(Ul)RNP, -Sm, -Ro, -La, Jo-1, -Scl-86, 
or -centromere antibodies showed any specific staining. It 
also should be noted that it was the serum with the highest 
anti-B" titer on immunoblots (V26) that produced the strong­
est signal in this plaque-screening assay. 
Additional evidence for the identity of cDNA clone λΗΒ"-1 
was obtained from experiments performed with monoclonal 
Jo-t Sc(~86 
' 8 3 АСА NHS 
FIG. 1. Partial identification and characlerization of clone λΗΒ"-
1. (Left) Immunoblots of proteins isolated from lysogenic bacteria 
carrying either wild-type phage Xgtll (BNN 97. lane 1), or the 
λΗΒ'-l recombinant (lanes 2 and 3) were probed with antibodies to 
ß-galactosidase (lanes 1 and 2) or with serum V26 (lane 3). Asterisks 
indicate the major degradation products of the fusion protein. Other 
faint bands are considered to be nonspecific background, as they 
were occasionally observed when normal control sera were used. 
Lane M shows molecular mass markers in kDa run in an adjacent 
lane. Position of the 0-galactosidase marker is indicated. (Right) 
Clone λΗΒ'-Ι expressed as \gtll plaques on nitrocellulose filters 
was probed with 11 different sera from patients with connective 
tissue diseases and 1 normal serum control as indicated. Sera V26. 
B25. G18, and P21 are anli-(Ul,U2)RNP sera and have been 
described elsewhere (5). The identity of the other sera was estab­
lished on immunoblots containing HeLa nuclear and cytoplasmic 
proteins (33, 34). 
and monospecific antibodies. Therefore, the three autoanti­
body specificities contained in serum V26 (see above) were 
separated by affinity purification from stained bands on HeLa 
nuclear immunoblots as described (5, 34). After their 
monospecificity was confirmed (not shown), these antibodies 
were used as probes on immunoblots of bacterial lysates 
containing the /3-galactosidase fusion protein. Only mono­
specific anti-B" antibodies identified the recombinant anti­
gen, regardless of whether they were purified from A or B" 
polypeptide bands (Fig. 2, lanes 5 and 7). Anti-Α antibodies 
as contained in anti-(Ul)RNP sera showed no reaction with 
the fusion protein (Fig. 2, lane 2). When these experiments 
were repeated with monoclonal anti-Α and monoclonal anti-
B" antibodies (15, 30), again, only anti-B" antibodies reacted 
with the fusion protein (not shown). The reverse was also 
found to be true; i.e., when immunoblots of bacterial lysates 
were probed with serum V26 and antibodies were eluted from 
the recombinant antigen, they exclusively identified A and B" 
antigens on HeLa nuclear blots (Fig. 2, lane 10). These 
antibodies were able to precipitate exclusively Ul and U2 
RNPs from HeLa nuclear extracts (not shown). 
In conclusion, the data described above indicate that only 
two possibilities for the identity of clone λΗΒ"-1 have to be 
considered: (i) λΗΒ"-1 contains coding capacity for part of 
the A antigen, including the epitope this antigen shares with 
the B" antigen but excluding the epitope reactive with 
anti-(Ul)RNP sera; and (ii) λΗΒ"-1 contains genetic se­
quences encoding the B" antigen. The experiments described 
below will show the latter possibility to be true. 
Partial Peptide Mapping. In a first attempt to discriminate 
between these two possibilities, λΗΒ"-1 was identified as a B" 
clone by partial peptide mapping. Therefore, protein frac­
tions containing A or B" antigens were digested with various 
amounts of S. aureus V8 protease, and immunoreactive 
M 
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ΓΡ 
Ш 
bäcfenal lysate 
— «fc — 
HeLâ nucííM 
« β * * « « « « « · · 
M 
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3 0
 В' 
î 2 3 4 5 10 
FIG. 2. Immunological identification of XHB"-l-encoded recom-
binant antigen. {Left) Immunoblot strips containing bacterial lysate 
from a λΗΒ'-Ι lysogen were probed with normal human serum (lane 
1). an anti-(Ul)RNP serum (lane 2), and with serum V26 (lane 3). 
Strips from the same blot were also incubated with monospecific 
antibodies affinity-purified from HeLa nuclear blots probed with 
serum V26: monospecific antibodies affinity-purified from the 70-
kDa antigen (lane 4), from the A antigen (lane 5), from the A' antigen 
(lane 6). from the B" antigen (lane 7), and from a nonstaining region 
on a HeLa nuclear blot (lane 8). (Right) Hela nuclear blots incubated 
with serum V26 (lane 9) or with antibodies affinity-purified from 
serum V26, eluted either from the /3-galactosidase fusion protein 
(lane 10) or from native /S-galactosidase (lane 11). Lane M shows 
positions of molecular mass markers (kDa) run in an adjacent lane. 
Position of the fusion protein (F.P.) and A and B" antigens are 
indicated. 
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peptides in their digestion patterns were compared with those 
obtained with immunopurified fusion protein. 
Even without addition of V8 protease, some degradation 
products were found reproducibly in the fraction containing 
the A antigen, possibly as a result of some endogenous 
proteolytic activity (Fig. ЗД). The B" fraction did not show 
such a phenomenon, but here (Fig. ÌB) a minor band just 
above B" was present. This band was not always found and 
certainly is not the A antigen, since it showed no reaction 
when the same blot was reprobed with monoclonal anti-A 
antibodies (not shown). The digestion pattern of the fusion 
protein (Fig. 3C) remarkably resembled that of the B" 
protein. In the lanes containing 1000 ng of V8 protease, three 
identical, epitope-containing peptides could be seen (indicat-
ed by arrows in Fig. 3) that were absent in the digestion 
patterns of the A antigen. 
Hybrid Selection and in Vitro Translation. Two micrograms 
of the cDNA insert of clone λΗΒ "-1, subcloned into a pUC18 
vector, was immobilized on nitrocellulose and hybridized 
with 100-Mg of oligo(dT)-selected роІу(А)* RNA from HeLa 
cells (32, 35). Hybrid-selected mRNA was eluted and trans­
lated in vitro in an exogenous message-dependent rabbit 
reticulocyte lysate in the presence of ["Slmethionine. As a 
control, translations were performed with total poly(A)+ 
RNA. Upon immunoprecipitation with V26 serum and frac­
tionation on NaDodS04/13% acrylamide gels, the A and B" 
polypeptides could easily be identified in the translation 
products of the lysate programmed with total poly(A)+ RNA 
(Fig. 4, lane 4). Only the B" band appeared in the immuno-
precipitate of the lysate programmed with mRNA, hybnd-
selected by clone \HB"-1 (Fig. 4, lane 6). This polypeptide 
comigrated with in vivo labeled B" protein—i.e., in between 
polypeptides B' and В (Fig. 4. lanes 5 and 8). From these data 
it may be concluded that the cDNA insert of clone XHB'-l 
contains coding sequences for the Ш RNP-specific B" 
protein. 
Nucleotide Sequence of Clone Ml B"-l and Identification of 
λΗΒ"· I-.Specific mRNA. Each SauiA fragment of the XHB"-1 
cDNA insert (restriction sites indicated in Fig. 5) was 
subcloned into M13mp8 and МІЗтрЮ, and its nucleotide 
sequence (Fig. 5) was determined by the Sanger dideoxynu-
cleotide chain termination method (36, 37). 
Because clone λΗΒ"-1 was isolated by virtue of its ability 
to produce a fusion protein, the reading frame of the cDNA 
insert must be in phase with that of the /acZgene of the Xgtll 
vector. In good agreement with this consideration, clone 
M XRNA 
hybr select 
RNA 
FIG. 3. Partial peptide mapping of λΗΒ"-1-encoded recombinant 
antigen. Samples containing eukaryolic A (A) or B" antigen (B) or the 
recombinant fusion piotem (C) were digested with various amounts 
(in ng) of 5. aureus V8 protease as indicated. After electrophoresis 
and blotting, immunoreactive peptides were visualized by im­
munodetection with serum V26. Arrows indicate identical peptides 
in B" and fusion protein digests. 
92-
69-' 
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FIG. 4. In vitro translation of hybrid-selected mRNA. Lanes: 1, 
molecular mass markers (kDa): 2-4. NaDodS04/15% acrylamide gel 
electrophoresis of immunoprecipitates from a rabbit reticulocyte 
lysate programmed with total HeLa ро1у(АГ RNA {X RNA) in the 
presence of ["S]methioninc : 2, immunoprecipitate obtained with 
normal human serum (NHS): 3, same with an anti-Sm serum; 4, same 
with serum V26; 6 and 7. clone XHB"-I hybrid-selected (hybr. select.) 
mRNA translated in vitro and immunoprecipitated with serum V26 
(lane 6) or normal human serum (lane 7): 5 and Й, immunoprecipitate 
from an in vivo "S-labeled HeLa nuclear extract obtained with an 
anti-Sm serum. Lane 8 is a 6 times longer exposure of the same 
sample as shown in lane 5 to visualize the A' antigen. Positions of the 
snRNA-associated polypeptides are indicated at the right of lane 8. 
\HB"-1 was found to contain only one large open reading 
frame which starts immediately after the EcoRI cleavage site 
at the 5' end of the insert and is terminated by a TAA codon 
at positions 801-803. Polyadenylylation signal AATAAA is 
present at positions 992-997 but the poly(A) tail was not 
present in this cDNA clone. The length of the B" encoding 
mRNA was determined by blot-hybridization analysis. RNA 
isolated from HeLa and KG1 cells was glyoxylated and 
subjected to gel electrophoresis on a 1% agarose gel. After 
blotting and hybridization, the 32P-labeled λΗΒ"-1 insert 
identified a single transcript of 1.3 kb in both cell lines (not 
shown). 
Deduced Complete Amino Acid Sequence of B". Because 
clone XHB"-1 comprised about 90% of the B" mRNA exclud­
ing the poly(A) tail, the possibility that it contains the 
complete coding sequence was investigated. Therefore, the 
£coRI insert was recloned into a pSP65 vector and tran­
scribed in virro. The resulting RNA was purified by gel 
electrophoresis and subsequently was translated in vitro in an 
exogenous message-dependent rabbit reticulocyte lysate 
supplemented with [35Slmethionine. Three major products 
appeared in the lysate programmed with \HB"-l-encoded 
RNA (Fig. 6). These polypeptides were immunoprecipitable 
with serum V26 (Fig. 6, lane 4), indicating that they originate 
from the same reading frame that constitutes the B" 
epitope(s). The presence of other polypeptides than the 
full-length translation product could be the result of in vitro 
proteolytic degradation or alternatively might represent ini­
tiation at different ATG codons. The latter explanation is the 
more favorable one, since no such degradation occurs when 
a reticulocyte lysate is programmed with genuine B" mRNA 
(Fig. 3). 
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FIG. 5. Nucleic acid sequence of the cDNA insert of clone 
λΗΒ"-1 and the predicted amino acid sequence of B" protein. 
Numbers at the right refer to the last nucleotide of every line starting 
with the first nucleotide of cDNA clone ШВ"-! after the fcoRI linker 
sequences. 5aw3A restnction sites are indicated. *** indicates a 
termination signal; the polyadenylylation signal is underlined. 
Since the largest of these three products has the same 
electrophoretic mobility as in vivo labeled B", it can be 
concluded that the cDNA of clone λΗΒ"-1 harbors the 
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FIG. 6. In vitro translation of XHB"-l-encoded RNA. The cDNA 
insert of clone AHB"-1 was recloned into a pSP65 vector and 
transcribed in vitro (38). The resulting RNA was purified by gel 
electrophoresis and after electroelution was translated in vitro in a 
rabbit reticulocyte lysate. Lanes: 1, anti-Smimmunoprecipitateof an 
in vivo 3îS-labeled HeLa nuclear extract; 2, in vitro translation of 
XHB"-encoded RNA; 3, in vilro translation without XHB'-encoded 
RNA; 4, immunoprecipitate of translation products in lane 2 with IgG 
from anti-(Ul,U2)RNP serum V26; 5, molecular mass markers 
(kDa). 
complete coding sequence for the B" protein. The isoelectric 
point of the deduced polypeptide (Fig. 5) was estimated (39) 
to be =8.0, a value in good agreement with the experimental 
data described earlier for the B" protein (5). The deduced 
polypeptide contains several hydrophilic regions, and com-
puter analysis revealed that three of these regions (around 
amino acids 20,105, and 200) have a high probability of being 
exposed at the surface of the protein (40, 41) and, therefore, 
may represent RNA-binding sites or antigenic sites, or both. 
DISCUSSION 
Several lines of evidence support our conclusion that we have 
isolated a cDNA clone expressing the human U2 snRNA-
associated B" protein. Because this protein shares an epitope 
with the Ш RNP-specific A antigen, the immunological 
evidence left room for the alternative possibility that λΗΒ"-1 
encodes part of the A antigen. However, further character­
ization by hybrid selection and partial peptide mapping 
eliminated this alternative. Translation of RNA transcribed 
from a pSP65 vector carrying the λΗΒ"-1 cDNA insert 
revealed that this insert contained the complete coding 
sequence for the B" protein. 
Characteristics of Clone λ MB' -1 cDNA. The molecular mass 
of the native B" polypeptide was originally estimated to be 
=28.5 kDa (5), but recalculation using the molecular mass 
markers shown in Fig. 2 revealed a molecular mass of 26.5 
kDa. Considering this and the finding that \HB"-1 cDNA 
contains the complete coding sequence for B" terminating at 
nucleotides 801-803, and given an average of 115 Da per 
amino acid, synthesis of the B" protein theoretically may be 
expected to start somewhere around position 110. The first 
ATG codon at positions 126-128 is, therefore, the most likely 
candidate, use of which would result in a 25,457-Da protein. 
However, the in virro translation of XHB"-l-encoded RNA 
(Fig. 6) also revealed the presence of an additional, slightly 
smaller polypeptide. If this is also a primary translation 
product, it possibly initiated at the ATG codon at positions 
165-167. Both ATG codons are in the correct reading frame, 
but comparison with the consensus translation initiation 
sequence fjNNATGG (42) reveals that the first ATG codon 
has a higher probability to be used in vivo. Use of such a first 
ATG is commonly found for eukaryotic genes (43). Definite 
proof for the in vivo use of this initiation codon, however, has 
to await direct biochemical characterization of the NH2-
terminus of the cellular B" protein. 
Deduced Amino Acid Sequence of the B" Protein. Computer 
analysis of the distribution of hydrophobic and hydrophilic 
segments along the protein sequence (Fig. 5) revealed several 
hydrophilic regions, three of which have a high probability of 
being recognized as an antigenic site (40, 41). One of these 
sites (around amino acid 105) contains an extraordinary 
amount of lysine residues and shows extensive (11 from 13 
identical amino acids) homology with the charged region of 
the circumsporozoite protein of the malaria parasite 
Plasmodium knowlesi (44, §). The significance of this finding 
is presently difficult to evaluate, but it is tempting to 
speculate about a link between infection with a malaria 
parasite and the autoimmune phenomena observed in rheu­
matic diseases. However, a direct relation does not seem 
very likely because P. knowlesi is known as a monkey 
parasite, but a common mechanism of (auto)antibody pro­
duction in both diseases seems a testable hypothesis. Re­
markable in this respect is the observation that anti-nuclear 
antibodies of the anti-RNP and -Sm type are frequently found 
in patients with malaria (45, 46). 
SProtein Identification Resource (1985) Protein Sequence Database 
(Natl. Biomed. Res. Found., Washington, DC), Release 8.0. 
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Immunology Habets ei al Proc Nati. Acuii Sci. USA 84 (1987) 
Only a very small number of anti-(L4,U2)RNP sera have 
been described (5, 13, 47) Therefore, it has not yet been 
possible to establish clearly whether presence of anti-B" 
antibodies in sera from patients with autoimmune diseases is 
associated with a particular clinical syndrome Preliminary 
data obtained from a routine immunoblottmg screening 
performed in our laboratory indicate that апП-(иі,Ш)К1ЧР 
antibodies are not as rare as originally assumed, but that they 
occur m about ІШ of autoimmune sera containing anti-
(UDRNPand/or anti-Sm antibodies (unpublisheddata) The 
main reason why this has not been recognized earlier prob­
ably lies within the fact that interpretation of the character­
istic staining of A' and B" bands on immunoblots is rather 
difficult, especially when additional antibody specificities are 
present in the serum. Therefore, the recombinant fusion 
protein might be particularly useful as antigen in a specific 
ELISA to screen a large number of sera from patients with 
rheumatic diseases 
The mechanisms by which an autoimmune response is 
induced and maintained are not yet understood Some the­
ories presuppose an invading microorganism to account for 
the production of antibodies able to crossreact w ith host-
specific antigens. Studies as (he one presented here may 
address such questions and contribute to the understanding 
of the pathogenesis of rheumatic diseases. 
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MOLECULAR CLONING OF THE cDNA FOR THE HUMAN U2 snRNA-SPECIFIC 
A' PROTEIN 
Peter T.G. Slllekens, Ria P. Beijer, Winand J. Habets, 
and Walther J. van Venrooij 
ABSTRACT 
The A' polypeptide is one of the protein constituents of the U2 snRNP 
particle. A potentially full-length cDNA clone containing the complete coding 
sequence for this U2 snRNP-specific protein was isolated by screening of a 
human Xgt11 expression vector library with an autoinmune anti-(U1,U2)RNP se­
rum. Monospecific antibodies, eluted from the 140-150 kD fusion protein of 
this cDNA recombinant, specifically recognized the A' protein on iimunoblots 
and iimiunoprecipitated U2 snRNP particles from nuclear extracts. The identity 
of the clone was confirmed by in vitro translation of hybrid-selected mRNA or 
an RNA transcript synthesized from the cDNA insert. RNA blot analysis showed 
strong hybridization to a single polyadenylated transcript of 1.3 kb in human 
cells. The nucleotide sequence of the 1054 bp cDNA contains an open reading 
frame of 756 bp encoding a polypeptide of 255 amino acids with a predicted 
molecular weight of 2 8 . W D. The coding sequence is preceded by a 49 bp 5'-
untranslated region and followed by a 226 bp 3'-untranslated region contai­
ning a single polyadenylation signal. Most striking feature of the deduced 
primary structure for the A* protein is a leucine-rlch region in the amino-
terminal half of the polypeptide. In contrast to the other U2 snRNP-specific 
protein B", the A' protein does not contain segments hosnologous to the RNP 
consensus sequences RNP1 and RNP2, common amino acid motifs found in several 
RNA-binding proteins. In the A' protein, however, the extremely hydrophilic 
carboxy terminus may constitute an RNA-binding moiety. 
INTRODUCTION 
U2 snRNA belongs to the family of abundant small nuclear RNAs of the U 
snRNA class which are found in the nucleoplasm of eukaryotic cells (1). In 
the nucleus, however, it does not function as a naked RNA molecule, but is 
organized in a ribonucleoprotein particle (U2 snRNP). In human cells at least 
nine polypeptides are associated with purified U2 snRNP, termed А', В, B', 
B", D, D \ E, F and G (2). While the proteins B, B', D, D', E, F and G are 
also present in the other abundant nucleoplasmic snRNPs U1 and U5 and the di-
meric snRNP particle U4/U6, the A' and B" polypeptides are unique to the U2 
snRNP species (2-5). All these snRNPs appear to participate in the splicing 
of nuclear messenger RNA precursors (pre-mRNAs), which takes place in a large 
multicomponent complex termed spliceosome (for a review see 6). In this spli­
cing complex U2 snRNP interacts with the branch point (7). This central area 
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in the intron where lariat formation takes place is primarily selected by its 
distance from the 3' splice site. In contrast to U1 snRNP whose binding to 
the 5' splice site is largely determined by sequence conplementarity between 
the 5' end of the U1 snRNA and the 5' splice junction of the pre-mRNA (8,9), 
the requirements for U2 snRNP binding are more complex since only a weak and 
limited consensus seems to exist for mammalian branch points. Still base-
pairing between U2 snUNA and the degenerate sequences surrounding the branch 
point appear to play a role in the selection of the branch-site nucleotide in 
metazoan splicing (10,11). Furthermore, U2 snRNP binding is ATP-dependent and 
a purified U2 snRNP alone cannot bind to its cognate pre-mRNA binding site. 
At least two protein factors, involved in the complex formation at the 3' 
splice site are also necessary for a productive association of U2 snRNP with 
the branch point region (12). One of these protein factors might be identical 
to the intron binding protein (IBP) that was shown to specifically interact 
with pre-mRNA substrates at the 3' end of the intron (13,14), whereas the 
other component coelutes through several purification steps with the auxili­
ary protein splicing factor, U2AF, that binds to the polypyrimidine stretch 
at the 31 splice site and is necessary for the U2 snRNP branch point inter­
action (12,15). To what extent the protein components of the U2 snRNP par­
ticle itself contribute to this or any of the following events that take 
place at the branch point or the nearby 3' splice site remains unclear. It is 
thought, however, that the unique polypeptides A' and B" are responsible for 
the function of U2 snRNP in pre-mRNA splicing and make up essential elements 
for the specific interactions between U2 snRNP and pre-mRNA or other compo­
nents of the splicing machinery. 
Apart from their cellular function, the U2 snRNP-specific polypeptides 
A' and B" also play a role as antigens in autoimnune diseases, since both 
proteins carry antigenic determinants for autoantibodies. Like anti-Sm auto­
antibodies, which have been mainly assigned to the common polypeptides В, B' 
and D, or anti-(U1)RNP autoantibodies, which recognize the U1 snRNP-specific 
proteins 70K, A and C, these antinuclear antibodies with specifity for the U2 
snRNP-specific proteins are found in sera from patients with systemic lupus 
erythematosus (SLE) and other related disorders (16). The determination of 
the primary structure and the identification of immunoreactive epitopes in 
the snRNP proteins are a prerequisite for the elucidation of the cellular 
function and the role these polypeptides play in autoimmune disease pathoge­
nesis. As the first step in a study of the A' protein we report here the mo­
lecular cloning and sequencing of a human cDNA clone containing the complete 
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coding sequence for this U2 snRNP-specific protein. 
MATERIALS AND METHODS 
Cell labelling and preparation of Ifela cell total protein extracts or nuclear 
extracts 
HeLa S3 cells were grown in suspension at 370C at densities ranging from 
0.2x106 to 0.5x106 cells/ml on Suspension Minimal Essential Medium (SMEM) 
supplemented with 10 % newborn calf serum. Labelling of cellular protein with 
t35s]methionine and preparation of total protein fractions was performed as 
previously described (17). Labelling of the cells with [32p]orthophosphate 
and preparation of nuclear extracts was carried out as described by" 
Bringmann et al. (18). 
Antibody screening, ijmunoblotting and imnunoprecipitation 
A patient's anti-(U1,U2)RNP serum, termed V26 (¿0, was used (diluted 
1:500) to screen a human teratocarcinoma cDNA library constructed with the 
Agtll vector (a gift from J.Skowronski, NCI/NIH, Bethesda) as previously 
described (17). To detect specifically bound antibody, Mislabelled sheep 
anti-human Ig [F(ab)2 fragment] was used. 
For imnunoblotting, bacterial lysates were prepared essentially as des-
cribed by Adam et al. (19) from lysogens prepared in E. coll strain Y1089 
(20), Proteins were fractionated on SDS-polyacrylamide gels and electro-
blotted onto nitrocellulose sheets as described (21). For the detection of 
antigens the protein blots were treated and processed according to the method 
of Habets et al. (22). 
Inmunoprecipitation of proteins from 353_iat>elled HeLa cell extracts or 
from cell-free translation mixtures was carried out as previously described 
(17). Precipitation of 32р_і
а
ь
е
п
е
£} snRNP particles from nuclear extracts was 
performed as described by Bringmann et al. (18). 
DNA sequence analysis 
For sequence analysis, suitable cDNA fragments were ligated into M13 
mp18 or inpig (23), grown in JM109, and subjected to dideoxy chain termination 
reactions (24). 
Hybrid selection, RNA transcription and in vitro translation 
Plasmid pHA' was digested with EcoRI. The isolated cDNA insert was 
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denatured by boiling and treatment with 0.5 M NaOH, neutralized, and applied 
to nitrocellulose. Hybridization selection was performed essentially as 
described by Quax-Jeuken et al. (25). 
RNA transcripts were synthesized in vitro from Hindlll-digested pHA1 DNA 
in the presence of the dinucleotide primer G(5')ppp(5')G and SP6 RNA polyme­
rase (26). 
In vitro translations in a nuclease-treated reticulocyte lysate 
(Amersham, UK) were performed for 90 min at ЗО'ЭС in 25 ul reaction mixtures. 
RNA blot analysis: Total RNA was isolated from Hela cells (17) and poly(A)+ 
RNA was selected by oligo(dT)-cellulose chromatography. Ten ug of poly(A)+ 
RNA was glyoxalated, fractionated on a 1.0% agarose gel and transferred to 
Hybond-N (Amersham, UK)(27,28). Concurrently electrophoresed 18S and 28S 
ribosomal RNAs fron HeLa cells were used as molecular weight markers. 
Hybridization of Northern blots was performed as described by Church 
and Gilbert (29). After hybridization, filters were washed twice with 0.5 M 
sodium phosphate, pH 7.0, 1% SDS, 1 mM EDTA at 650C for 30 min and once with 
0.25 M sodium phosphate, pH 7.0, 1% SDS, 1 mM EDTA at 650C for 30 min. 
RESULTS AND DISCUSSION 
Isolation and identification of a full-length cDNA clone for the U2 snRNP-
specific A' protein. 
Serum V26, an anti-(Ul,U2)RNP serum containing antibodies against the U2 
snRNP-specific proteins A' and B" (ref. U and Figure 1A, lane 1) was used to 
screen a human teratocarcinoma cDNA library constructed in the phage vector 
Xgtll for the selection of recombinants expressing the A' antigen. Initial 
screening of approximately 600,000 independent plaques yielded several anti­
gen-producing clones. Among these, clones containing coding sequences for the 
Ш snRNP-specific proteins 70K (unpublished results) and A (17) and the U2 
snRNP-specific B" protein (30) were identified. In addition, one putative A' 
clone was selected. After plaque purification this positive clone, designated 
λΗΑ', was first characterized by immunoblot analysis. Therefore, λΗΑ' phage 
was transferred to a lysogenic host and bacterial lysates, prepared after in­
duction of the phage 0-galactosidase gene by isopropyl-$-D-thiogalactopyrano-
side (IPTG), were fractionated on a 7-5 % SDS-polyacrylamide gel and blotted 
onto a nitrocellulose filter. A single polypeptide of approximately 1UO-150 
kD in the bacterial lysate of λΗΑ' was specifically recognized by antibodies 
from the anti-(U1,U2)RNP serum. This hybrid protein was absent fremi the ly-
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Figure 1. Inmunoblotting (A) and iiraiunopreclpitation of snRNPs (B) with anti­
bodies affinity-purified from AHA' fusion protein. (A) A strip of an inmuno­
blot containing total lysate of AHA'-Infected cells was processed for the de­
tection of antigens and the area of the blot containing the fusion protein 
was excised. This region was used to adsorb antibodies specific for the fu­
sion protein from the human anti-{Ul,U2)RNP serum V26 containing antibodies 
against the U1 snRNP-specific proteins 70K and A and the U2 snRNP-specific 
proteins A' and B" (4). The antibodies were eluted and re-used to probe an 
immunoblot of HeLa total protein extract. Lanes: (1) total human anti-(U1,U2) 
RNP serum; (2) affinity-purified antibody from the fusion protein of AHA'. 
(B) Antibodies affinity-purified from the region containing the fusion pro­
tein or from a non-reactive control region of an inmunoblot as described 
above were re-used for inmunoprecipitation of snRNPs from 32p_i
a
|
:
ielled HeLa 
cell nuclear extracts. snRNAs present in the immune precipitates were 
fractionated on Polyacrylamide gels. Lanes: (1) total human anti-(U1,U2)RNP 
serum; (2) affinity-purified antibody from the control region; (3) antibody 
affinity-purified from the fusion protein. 
sate of wild-type Agt11-infected cells (data not shown). The region of a pre­
parative inmunoblot containing the expressed fusion protein or a non-reactive 
control region were used to immunoselect antibody from the polyvalent autoan-
tiserum. The eluted antibodies were assayed for their reactivity with intact 
U snRNPs or snRNP proteins. As shown in Figure 1, antibody affinity-purified 
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from the fusion protein precipitated U2 snRNPs (Figure IB, lane 3) and on an 
immunoblot of HeLa total protein extract specifically recognized the A' pro­
tein (Figure 1A, lane 2). Background levels of Ш and U2 snRNPs, as seen in 
the inmunoprecipitation with antibodies eluted frcen the control region of the 
immunoblot (Figure IB, lane 2), probably are due to non-specific binding of 
antibodies to nitrocellulose. 
To exclude the possibility that we had cloned a cross-reacting polypep­
tide sharing at least one epitope with the A' protein, the identity of clone 
λΗΑ' was confirmed by hybrid selection of HeLa poly(A)+ RNA and subsequent in 
vitro translation. cDNA insert of λΗΑ' was isolated by digestion with EcoRI 
and spotted onto nitrocellulose. After hybridization with HeLa poly(A)+ RNA, 
filter-bound mRNA was eluted and translated in vitro in the presence of 
[35s]methionine using a rabbit reticulocyte lysate. The hybrid-arrested mRNA 
specifically translated in vitro two polypeptides of approximately 28 kD and 
13 kD, which both were inmunoprecipitable with the anti-(U1,U2)RNP serum V26 
initially used for the isolation of the λΗΑ' recombinant (Figure 2, lane 3). 
The 28 kD protein comigrates with the U2 snRNP-specific A' protein derived 
from in vivo [35s]methionine labelled HeLa protein extract (Figure 2, lane 1) 
or fron an in vitro translation reaction directed by total HeLa poly(A)+ RNA 
(Figure 2, lane 4), respectively. Since Northern blot analysis revealed only 
a single mRNA species when probed With the cDNA insert of XHA' (Figure 3), 
the extra polypeptide band of 13 kD, which was also specifically inmunopre-
cipitated frcen the translation reaction directed by the hybrid-selected mRNA 
(Figure 2, lane 3), presumably results from anomalous translation initiation 
at some site in the same reading frame or, alternatively, represents a degra­
dation product of the A' protein. 
The λΗΑ' clone contains an insert of about 1.1 kb as determined by res­
triction mapping and sizing of the DNA fragments on agarose gels. The size of 
the homologous mRNA was determined by RNA blot analysis. Probing of a blot 
containing total HeLa poly(A)+ RNA with the nick-translated 1.1 kb cDNA in­
sert of λΗΑ' resulted in cross-hybridization to a single mRNA species of 1.3 
kb (Figure 3). Assuming an average length of approximately 150 residues for 
the poly(A) tail of a eukaryotic mRNA, the λΗΑ' cDNA insert is close to full-
length and might well contain the entire coding region for the 28 kD A' poly­
peptide. To experimentally verify this assumption, the cDNA insert was isola­
ted from λΗΑ' by digestion with EcoRI and recloned into the SP6 bacteriophage 
promoter plasmid, pSP65, to yield pHA'. Plasmid DNAs, containing the insert 
in either orientation, were linearized by digestion with Hindlll and used as 
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Figure 2. Hybrid-selection translation of HeLa mRNA with pHA'. HeLa poly(A)+ 
RNA was hybrid selected and translated in a reticulocyte lysate as described 
in Materials and Methods. Irmiunoprecipitation of the translation products of 
mRNA selected on the pHA' cDNA fragment was performed with the anti-(U1,U2)-
RNP serum described in Figure 1. Immunoprecipitation of U snRNP proteins from 
in vivo [35s]methionine labelled HeLa total protein extract or from a trans­
lation reaction directed by HeLa total poly(A)+ RNA were carried out with a 
mixture of the anti-(U1,U2)RNP serum and a human anti-RNP/Sm serum recogni­
zing on an inmunoblot the snRNA-associated proteins 70K, A, B', B, C, and D. 
Lanes: (1) Immunoprecipitation of U snRNP proteins from in vivo [35s]methio-
nine labelled HeLa protein extract; (2) immunoprecipitation of translation 
products from a control translation (no mRNA added); (3) immunoprecipitation 
of translation products from pHA' hybrid-selected mRNA; (4) immunoprecipita­
tion of translation products from total HeLa poly(A)+ RNA. The position of 
the A' protein in lanes (1) and (4) was determined from the autoradiogram 
after a longer exposure time. Molecular weights (in kD) of protein standards 
are indicated on the right (M). 
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Figure 3. Northern blot analysis of poly(A)+ RNA from HeLa cells probed with 
32p_iabelled nick-translated cDNA insert from the pHA' clone. The size of 
concurrently electrophoresed ribosomal RNAs from HeLa cells is indicated on 
the left. 
templates in in vitro transcription reactions with SP6 RNA polymerase. The 
resulting RNAs, representing sense and anti-sense RNA copies of the clone, 
were translated in a rabbit reticulocyte translation system employing [35$]-
methionine and subsequently subjected to SDS-polyacrylamide gel analysis. Two 
prominent labelled species were observed in the translation reaction directed 
by the sense RNA (Figure 4, lane 2). The longest polypeptide synthesized had 
the same mobility as the cellular A' protein (Figure 4, lanes 3 and 6). This 
primary translation product could also be immunoprecipitated from the trans-
lation mixture (Figure 4, lane 5), together with the same additional polypep-
tide of lower molecular weight that was already observed in the hybrid selec-
tion experiment. Taken together, these results demonstrate that RNA transcri-
bed from the pHA' cDNA insert encodes for the same polypeptides as the au-
thentic A' protein mRNA. 
Nucleotide sequence and deduced amino acid sequence of the A' protein. 
The complete nucleotide sequence of the human A' protein cDNA contained 
in pHA' was determined according to the strategy outlined in Figure 5. The 
sequence so obtained is shown in Figure 6 and covers 1054 nucleotides (EcoRI-
linkers included). The only large uninterrupted reading frame starts at the 
beginning of the sequence and terminates at position 822. Remarkably, this 
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Figure Ч. In vitro translation of pHA' encoded RNA. Immunoprecipitation of 
the translation products was performed with the same anti-(U1fU2)RNP serum 
and anti-RNP/Sm serum that were used in the hybrid selection experiment (Fi­
gure 2). Lanes: (1) translation products of pHA' encoded anti-sense RNA; (2) 
translation products of pHA' encoded sense RNA; (3) and (6) inmunoprecipita-
tion of U snRNP proteins from in vivo [35s]methionine labelled HeLa protein 
extract with a mixture of the anti-(U1 ,II2)RNP serum and the anti-RNP/Sm se­
rum; (4) immunoprecipitation of translation products encoded by anti-sense 
RNA from pHA' with anti-(U1 ,U2)RNP serum; (5) irmiunoprecipitation of transla­
tion products encoded by sense RNA from pHA' with anti-(Ul,U2)RNP serum. The 
position of the cellular A' antigen in lanes (3) and (6) was determined from 
the autoradiogram after a longer exposure time. Molecular weights (in kD) of 
protein standards are indicated on the left (M). 
reading frame is not in register with the ß-galactosidase coding sequence. 
Still detectable quantities of antigen are produced as a 140-150 kD fusion 
protein. Therefore, internal initiation of protein synthesis at some site(s) 
within the insert, as has been observed in other systems (31.32), could be 
ruled out. To explain this phenomenon it was necessary to assume the presence 
of three EcoRI-linker sequences instead of one. Incubation of an immunoblot 
with anti-ß-galactosidase revealed only a relatively low quantity of the 140-
150 kD fusion protein, whereas a hybrid protein with approximately the size 
-67-
1 „ _ 1 -, i 
ι • >· I »I 
I 
I »I -I • I » 
i 1 . „ I ' • • ' Ι ι 1 
ÍV ' r !0u -iD·^  'ΰΰ bj. "0Г 800 iOC 'OOi^  
bp 
Figure 5. Partial restriction map and sequencing strategy for the full-
length cDNA clone pHA'. The thick bar represents the protein coding region. 
of wild-type e-galactosidase was detected in large amounts (data not shown). 
The latter protein does not react with antibodies from the anti-(U1,U2)RNP 
serura. These findings could be explained by the fact that the putative 
stretch of EcoRI-linkers takes the configuration of a stem-and-loop 
structure causing termination of transcription. Only occasionally the RNA 
polymerase can pass through this multi-linker-region and reach the cDNA 
insert sequence for transcription. 
The designated ATG initiation codon in the open reading frame is located 
at position 57. resulting in a translational unit which encodes 255 amino 
acids (Figure 6). In most eukaryotic mRNAs no extraneous ATG triplets are 
found upstream of the functional initiation codon for protein synthesis. In­
deed, the designated methionine-encoding initiation site of this protein co­
ding region also is the 5'-proximal ATG codon occuring in the sequence. Fur­
thermore, with an A residue at position -3 ând a G residue at position +4 it 
exists within a sequence which fits the optimal context for translation ini-
tiation at the most crucial positions (33). Starting with a TGA translational 
stop codon at position 822 the sequence terminates with a 3' non-coding re-
gion of 212 nucleotides. At the 3' end a stretch of 14 adenines is found, 
which is preceded by the consensus polyadenylation signal AATAAA (34) located 
22 nucleotides upstream from the start of the polyadenylate tract. 
The deduced amino acid sequence for the A' protein is shown in Figure 6. 
The molecular weight calculated f rem this primary structure is 28,444 D, 
which is in good agreement with the observed molecular weight of 28 kD for 
the A' protein on SDS-polyacrylamide gels. The polypeptide contains a total 
of only three methionine residues, located at positions 1, 161 and 246 in the 
amino acid sequence (Figure 6). This rather low content of methionine is con-
sistent with predictions fron in vivo studies in which the A' protein in con-
trast to most other known snRNP proteins is hardly labelled by [35s]methioni-
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Figure 6. Nucleotide sequence of pHA' and deduced amino acid sequence of the 
encoded A' protein. The predicted amino acids are shown below their triplets. 
The polyadenylatlon signal is underlined and the stop codon is marked by as-
terisks. 
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ne (Figure 3. lane 4 and réf. 35). Most striking feature of the polypeptide 
is the high content of leucine residues (13 % of all amino acids). Most of 
the leucines are clustered in a region spanning amino acids 57-122 (Figure 
6). Recently, the periodic array of leucines was noted in segments of several 
DNA binding proteins with a predicted α-helical conformation. This hypotheti­
cal structure was referred to as the "leucine zipper" and may represent a 
characteristic property of a certain category of DNA binding proteins (36). 
The secondary structure of the A' protein, however, as predicted by the Chou-
Fasman algorithm (37) did not unambiguously reveal α-helìces in any region of 
the protein nor does the leucine-rich region show a periodic repetition of 
this amino acid. 
It was previously shown that the so-called Sm binding site in U2 snRNA 
Is a prerequisite for binding of the U2 snRNP-specific proteins. In addition, 
RNA structure 3' to this segment is required (38). The A' protein therefore 
appears to interact both with the so-called Sm core protein complex (proteins 
D, E.F and G) and directly with RNA in the 3' half of the U2 snRNA molecule. 
This direct association of the A' protein to the RNA moiety of the U2 snRNP 
particle was experimentally demonstrated in VSV-infected cells, where A' pro-
tein is bound to precursor U2 snRNA transcripts at times when binding of the 
core protein complex is blocked 139). In this respect computer-derived hydro-
pathy plots of the amino acid sequence (data not shown) revealed a strongly 
hydrophilic carboxy terminus which might reflect an RNA binding region of the 
A' protein. No similarities to the recently described RNP consensus sequences 
RNP1 and RNP2, that are stretches of 8 and б amino acids, respectively, and 
represent conserved parts of an RNA-binding domain (40,41), were found in the 
deduced amino acid sequence of the A' protein. In the primary structure of 
the snRNP core proteins D (42) and E (43) and the Ш snRNP-specific protein С 
(44,45) the RNP consensus motifs are also absent. Still all these polypepti­
des may interact with RNA because the RNP consensus is not a general property 
of all RNA-binding proteins (38). It can be speculated that the interaction 
of these proteins with RNA is mere structural, whereas the RNP consensus seg­
ments might be involved in more specific RNA-protein interactions, which in 
U1 snRNP would then be reserved for the 70K and A protein and in U2 snRNP for 
the B" protein. 
The availability of a full-length cDNA clone for the A· polypeptide 
opens the way to a detailed study of the function and expression of this 
snRNP protein and its assembly in U2 snRNP particles. Furthermore, it 
provides a means to investigate its antigenic structure, especially the 
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epitopes that are the molecular targets for antibodies raised against this 
protein in autoimnune disorders. 
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cDNA cloning of the human Ш snRNA-associated A protein: 
extensive homology between Ul and U2 snRNP-specific proteins 
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Sera trom patients with connective tissue diseases often con-
tain antibodies against snRNA-associated proteins. Using one 
of the» sera In an immunological screening of a human Xgtll 
expression vector cDNA library, two cDNA clones for the Ul 
snk\P-sji«cifk A protein, termed λΗΑ-l and λΗΑ-2, were 
isolated, Munosptciik antibodies, eluted from the 0-galacto-
sidase fasion protein of either clone reacted with the Ш 
snRNP-spcclflc A antigen. The Identity of the clones was 
confirmed by in vitro translation of hybrid selected mRNA. 
RNA blot analysis revealed a single polyadenylaied transcript 
of about 1.4 kb in human cells. A cDNA of 1.2 kb, Isolated 
from the same Xgtll expression library by cross-hybridization 
with a λΗΑ-2 restriction fragment, covered the complete 
coding MH|uence of the A protein as demonstrated by in vtino 
translation of an RNA transcript synthedzed tram this cDNA. 
The deduied amino acid sequence contains one very hydro-
pJiilk region, an internal sequence duplication and a region 
highly homologous to the RNP consensus sequence that seen» 
to be common lo RNA binding proteins. Sequence comparison 
with the recently cloned U2 snRNP-spedflc В" protein re­
vealed two extremely homologous regions located in the 
carboxy-teraünal (homology of 86%) and amino-termbml part 
(homolog) of 77%) of the proteins. This structural relation-
ship indicates that proteins A and B", although located in dif-
ferent snRNP partlclei, may have Identical functions. 
Kt\ ivords autoimmunity/cDNA clonmg/RNP antigens/small 
nuclear nbonucltxiprotems 
liitioriiiction 
All uikjootii cells contain a group of small ribonucleic acids, 
among whiLh the most abundant are the V series small nuclear 
RNAs i l snRNAs) They reside in the nucleus of the cell as 
RNA - ¡жнет сотріехин (RNPs for reviews see Rcddy and 
Busdi, ШЮ Brunei el el, 1985) Since the discovery that Sm 
and RNP serological spceificities seen in systemic lupus eryth­
ematosus (SLE) and other disorders (Tan, 1982) recognize pep­
tides ot these U snRNPs (Lerner and Steitz, 1979), a number 
oí Uitlerent classes of these particles have been distinguished 
(Hmterbcrger et al, 1983, Kinlaw et al, 1983) on the basis of 
the 1 ' snRNA species they contain The exact number of distinct 
aiRMPs m mammalian cells is still unlöiown, but until now the 
u iy abundant Ul аші Ъ"2 snRNPs, the slightly less abundant 
tVSNPs conummg U4/U6 snRNAs and U5 snRNA, and several 
Í w abundance snRNPs conummg other U snRNAs have been 
described (Strab « at , 1984, Reddy « of, 1985) The U2 
II4/U6 and US snRNA-contammg particles are recognized by 
anti-Sm autoimmune sera and contain at least seven common 
peptides, called В , В, D, D', E, F and G (Hmterberger et al. 
1983, Kinlaw er al, 1983, Billings and Hoch, 1984, Pcttersson 
« al, 1984, Habets if a i , 1985a, Bnngmann and Luhmann, 
1986) The til snRNA-contammg particles are composed of the 
same seven proteins and therefore are also immunoprecipitatcd 
by anö-Sm sera In addition, however, they are recognized by 
anli-RNP sera, due to the presence of at least three additional 
proteins, called 70K, A and С which are unique to the Ul snRNP 
species (Billings and Hoch, 1984, Pettersson et al, 1984, Habets 
et at, 1985a) U2 snRNP particles also contain at least two unique 
proteins called A' and В ', which are recognized by antibodies 
present in anti-(Ul,U2)RNP sera Anti-B" antibodies in these 
sera were shown to crossreact with the U1 snRNP specific A 
protem, suggesting a structural relationship between these proteins 
(Habets et al, 1985b) 
Although the exact function(s) of the various snRNP particles 
in the nucleus is still largely unknown, there is mounting evidence 
that most of them are essential cofattors for mRNA processing 
reactions (for a review see Mamaus and Reed, 1987) A critical 
role for snRNPs in thepre-mRNA splicing process was first pro­
posed for the Ul snRNP particle (Lemer and Steitz, 1979, Rogers 
and Wall, 1980) and was based on complementarity in nucleotide 
sequence between the 5' end of the Ul snRNA and the 5' splice 
junctions of pre-mRNA Experimental evidence for this idea was 
found in the inhibition of RNA splicing either by antibodies 
directed against Ul snRNPs (Yang et al, 1981, Padgett et al, 
1983, Kramer et al, 1984) or by removal of the 5' end of the 
L'l snRNA (Krtmer ft αϊ, 1984, Kramer and Mamaus, 1985, 
Black et al. 1985) The latter observation suggests that the RNA 
moiety is essential for an interaction between the Ul snRNP 
particle and the 5' splice site The ability of a mutant Ul snRNA 
gene to suppress a 5' splice site mutation (Zhuang and Werner, 
1986) also demonstrates the involvement of the RNA component 
of U1 snRNP ш the association of the particle with the 5 ' splice 
site The Ul snRNP peptide components also appear to be re­
quired for binding (Mount et al, 1983) but to what extent they 
contribute to this or any of the tollowmg events that take place 
at the 5' splice junction during the splicing reaction is presently 
unknown A first step to a better understanding of the biological 
role of these proteins, which based on immunological entena 
show strong evolutionary conservation, is the elucidation of their 
primary structure 
Recently the molecular cloning of several autoimmune antigens 
has been reported (Chambers and Keene, 1985, Wieben et al, 
1985, Theissen et al, 1986, Habets et al, 1987) Here we de­
scribe the isolation, characterization and sequencing of four 
cDNA clones containing coding capacity for the human Ul 
snRNP-associated A protein The longest of these cDNA clones 
contains the complete coding sequence for the A protein 
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n g . l . immunoDlot analysis of the fusion proteins produced by the lysogens 
of \HA-1 and XHA-2 Purified fusion protein was resolved on a 7 5% 
SDS-Polyacrylamide gel along with total lysate from Xgtll-infected cells 
and transferred lo nitrocellulose Identical immunoblots were probed with 
either the patient anii-(Ul)RNP seram with which the clones were isolated 
from the Xgtl I library or a monoclonal antibody specific for /3-galactosidase 
Bound antibodies were detected with l25I-labelled sheep anti-human Ig or 
sheep anti-mouse Ig respectively Lanes: (A) total lysate from XgtII-infected 
cells, (B) punfied fusion protein from clone XHA-1, ÍC) purified fusion 
protein from clone XHA-2 
Results 
Isolation and identification ofcDNA clones for the Ul snRNP-
specific A protein 
An anti-(Ul)RNP serum was used to screen a Xgtl 1 expression 
library containing cDNAs prepared from human teratocarcinoma 
cells for clones encoding the Ul snRNP-specific A antigen. In-
itial screening of about 600 000 recombinants identified eight 
putative A protein clones. Upon several rounds of purification 
and rescreening two clones which possibly contain coding 
sequences for the A polypeptide could be identified. Both clones, 
referred to as XHA-l and XHA-2, reacted with a panel of nine 
sera from different autoimmune patients, all containing antibodies 
against the A antigen, whereas the reaction with normal human 
control sera was negative (not shown). 
To demonstrate that the reactivity of the phage clones with the 
antibodies was due to antigenic determinants encoded by the 
cDNA inserts, XHA-l and XHA-2 were transferred to a lysogenic 
host. Lysogens were induced by temperature shift and addition 
of isopropyl-|3-D-thiogalactopyranoside (IPTG) allowing maximal 
fusion protein synthesis. Immunoblots of the lysogen proteins 
were probed separately with a monoclonal anti-/3-galactosidase 
antibody and the anti-(Ul)RNP serum used for the initial selec-
tion. Lysogens containing phage λΗΑ-l produced a fusion protein 
with an apparent mol. wt on an SDS—Polyacrylamide gel of about 
126 kd, which was reactive both with antibodies to 0-galacto-
sidase and with antibodies from the patient seram (Figure 1, lane 
B). The fusion protein of phage XHA-2, giving the same immuno-
Fig, 2. Immunoblomng with anubodies affinity-punfied from fusion proteins 
(A) or from UI snRNP-specific proteins (B) . (A) Purified fusion proteins 
from the induced phages XHA-l and XHA-2 were resolved on a 7.5% 
SDS-polyacrylamide gel and transferred to nitrocellulose A stnp of the 
immunoblots was processed for the detection of antigens and the area of 
each blot containing the fusion protein was excised These regions were 
used to adsorb antibodies specific for the fusion proteins from a human anti-
(Ul)RNP serum containing antibodies against the 70K, A and С proteins 
The antibodies were eluted (Smith and Fisher, 1984) and re-used to probe 
an immunoblot of HeLa total protein extract Lanes: (1) total human anti-
ÍU1)RNP seram, (2) affimly-punfied antibody from the fusion protein of 
λΗΑ-Ι, (3) affinity-punfied antibody from the fusion protein of \HA-2 
(B) HeLa total protein blots were incubated with the human anti-(Ul)RNP 
serum of lane 1 in (A) Reactive regions of the proteins 70K, A and С 
were excised and bound antibodies were eluted These fractions were re­
used to probe an immunoblot containing punfied fusion protein of XHA-l. 
Lanes: (1) total human anli-{Ul)RNP seram, (2) affinity-punfied antibody 
from the 70K protein, Í3) affinity-punfied antibody from the A protein; 
(4) affinity-punfied antibody from the С protein 
logical response as the XHA-l fusion protein, had a mol. wt of 
about 138 kd (Figure 1, lane C). 
To identify the antigenic specificity from the anti-(Ul)RNP 
serum which is responsible for a positive immunoreaction, anti­
bodies specifically reacting with the fiision proteins were affinity-
purified from total seram and used to probe an immunoblot of 
HeLa total protein extract. As shown in Figure 2A, antibodies 
affinity-purified from both fusion proteins reacted only with the 
Ul snRNP-specific A protein. When the reciprocal experiment 
was carried out, a similar result was obtained: antibodies eluted 
from the region of an immunoblot containing the in vivo synthe­
sized A polypeptide stained the fusion protein band of XHA-l 
and XHA-2, whereas no reaction was observed with the other 
affinity-purified anti-(Ul)RNP antibodies (anti-70K, anti-C). The 
results for the XHA-I clone are shown in Figure 2B. 
Hybrid selection and in vitro translation 
The identity of cDNA clones XHA-l and XHA-2 was confirmed 
by hybrid selection of HeLa poly(A)+ RNA and subsequent in 
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Fig. 3. Hybnd-selection translation of HeLa mRNA with pHA-2 HeLa 
poly(A)+ RNA was hybrid selected and translated in a reticulocyte lysate as 
described in Materials and melhods Immunoprecipitation of the translation 
products of mRNA selected on the pHA-2 cDNA fragment was carried out 
with a human anti-RNP/Sm antiserum recognizing on an immunoblot of 
HeLa total protein extract the snRNA-assoctated proteins 70K, A, BIB'. С 
and D The same serum was used for an immunoprecipitation of U snRNPs 
from m vivo lì5S]niethionine labelled HeLa total рпнеіп extract 35S-labelled 
translation products were analysed on 15% SDS-Polyacrylamide gels and 
visualized by fluorography Lanes: (1) background translation without 
addition of exogenous RNA, (2) translation products of mRNA hybnd 
selected on pHA-2, (3) immunoprecipitation of U snRNP proteins from m 
vivo S-labelled HeLa protein extract. (4) immunoprecipitation of translation 
products from the background translation, (5) immunoprecipitation of 
translation products from pHA-2 hybnd selected mRNA 
(6) immunoprecipitation of translation products from total HeLa po!y(A) + 
RNA Mol wt (in kd) of protein standards are indicated to the left (M) 
vitro translation. The cDNA inserts of XHA-l and XHA-2 were 
recloned into the vector pSP65, resulting in the plasmid clones 
pHA-1 and pHA-2, cDNA inserts were isolated by digestion with 
EcoRl and subsequently spotted onto nitrocellulose. After hybrid­
ization with HeLa poly(A)+ RNA, filter-bound mRNA was 
eluted and translated in vitro using a rabbit reticulocyte lysate. 
In Figure 3 the results for pHA-2 are shown. A 32 000 dalton 
protein was synthesized by the hybrid selected mRNA (Figure 
3, lane 2), which on an SDS—Polyacrylamide gel comigrates 
with the in vivo labelled Ul specific A protein immunoprecipitated 
by a human serum containing both Sm and RNP serological 
specificities (Figure 3, lane 3). When the same serum was used 
in an immunoprecipitation of an in vitro translation directed by 
total HeLa poly(A)+ RNA, every Ul snRNP protein could be 
shown to be synthesized in an immunoprecipitable form in vitro, 
except for the 70K protein, which in vivo as well as in vitro seems 
to be hardly labelled by [35S]methionine. The 32 000 dalton 
translation product of the pHA-2 selected mRNA was also found 
to be immunoreactive with this semm. The immunoprecipitated 
protein (Figure 3, lane 5) comigrates with the in vitro labelled 
A polypeptide (Figure 3, lane 6). In addition, two lower mol. 
wt polypeptides were also specifically immunoprecipitated (Fig-
pHA 4 
pHA-3 
pHA.2 
pHA-l 
Fig. 4. Schematic representation of the cDNA clones pHA-1. pHA-2, 
pHA-3 and pHA^l The relative positions of the cDNA inserts of the A 
protein clones are shown Regions coding for the A protein are indicated by 
solid bars The 5' and 3' noncoding regions are indicated by thin lines 
ure 3, lane 5). Since Northern blots revealed only one mRNA 
species (see below), these extra protein bands are more likely 
to be degradation products from the A protein, rather than trans­
lation products from additional mRNAs hybrid selected by the 
cDNA insert of the A clones. 
In conclusion, these results together with the immunological 
data presented demonstrate that the XHA-l and XHA-2 clones 
contain coding capacity for the Ul snRNP-specific A protein. 
Isobtion of α full-length cDNA clone of the A protein 
Determination of the insert size revealed a 0.6 kb cDNA insert 
for the XHA-1 clone, whereas the XHA-2 clone contained an insert 
of 0.9 kb. Partial restriction analysis and DNA sequencing of 
both cDNA inserts established that we had isolated two over­
lapping clones, showing in addition that the sequence of the insert 
of XHA-l is ftilly contained in the XHA-2 cDNA insert. The 
relative position of the two cDNAs is shown in Figure 4. 
The size of the homologous mRNA was determined by RNA 
blot analysis. Hybridization of a blot containing poly(A)+ RNA 
from HeLa cells to the nick-translated 0.9 kb cDNA insert of 
XHA-2 revealed a single band at about 1.4 kb (not shown). Taken 
together, these data show that the cDNA insert of the XHA-2 
clone comprises only about 60% of the total message for the A 
polypeptide. Therefore, attempts were made to isolate a full-
length cDNA clone. The Xgtl 1 expression library, originally used 
for screening with an anti-(Ul)RNP serum, was now rescreened 
with a nick-translated EcoRl/Sphl fragment covering the 5'-term­
inal 216 nucleotides of the XHA-2 insert (nucleotides 342-557 
of the cDNA, as presented in Figure 5). Out of 300 000 plaques, 
30 hybridized to this probe. Size analysis of the inserts revealed 
two phages with inserts longer than the 0.9 kb insert of the XHA-2 
clone, the longest insert having a size of about 1200 bp. Assuming 
an average length of about 150 residues for the poly(A) tail of 
a eukaryotic mRNA, this cDNA insert matches well with the 
size of the homologous mRNA. The other insert was about 
1150 bp in size. The cDNA inserts of both phage clones isolated 
by cross-hybridization were subcloned in the vector pSP65. The 
relative position of these cDNAs (pHA-3, рНА-4), established 
by Southern blotting and restriction enzyme maps, is shown in 
Figure 4, together with the two cDNAs isolated via immuno­
logical screening with the anti-(UI)RNP serum. 
Nucleotide sequence and deduced amino acid sequence of the 
A protein 
The nucleotide sequence of the cDNA inserts of all four clones 
was determined by the dideoxy method (Sanger et al., 1977). 
The combined nucleotide sequence is shown in Figure 5 and 
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covers 1209 nucleotides It should be mentioned that no differ 
enecs between corresponding parts of the four A protein dones 
were found There is only one large uninterrupted open reading 
frame {covering nucleotides 81-971) encoding 297 amino «ids 
(Figure 5) I he designated ATG translation initiation todon is 
located at position 126 and is the firn ATG codon occurring 
It exists vuthm a sequence which only diverges in position - 3 
(3 nucleotides upstream of the ATG codon) from the optimal 
context for initiation ACCATGG (Kozak 1986) The TAG 
translational stop signal at position 972 is followed by a non-
coding region of 223 nucleotides At the 3 end a stretch of eight 
adenines is found, which is preceded by the hexamer ATTAAA 
This sequence is known as a functional polyadenylation signal 
(Leff ft al 1986) though it is slightly altered from the con 
served AATAAA hexamer normalty found in eukaryotic mRNAs 
(Proudfbot and Brownlec 1976) 
The predicted amino acid sequence for the A protein (Figure 
5) indicates that the mol wt of the polypeptide is 31 243 dallons 
This is in good agreement with the observed mol wt of 32 kd 
tor the A protein on an SDS-Polyacrylamide gel Ίο verify 
experimentally whether the nucleotide sequence presented m 
Figure 5 indeed contains the complete coding sequence for the 
A protein the following expenmenl was conducted The pUsmid 
pHA-4 (Figure 4) containing the SP6 promoter immediately 
upstream of the с DNA insert was linearized by digestion with 
Wimim and the cDNA insert was transenbed in virro The result 
ing RNA when translated in a rabbit reticulocyte lysate yielded 
three major products (Figure 6 lane 2) the longest of which 
had the same size as the m vno synthesized A protein (Figure 
6 lane 3) This primary translation product could also be un 
munoprccipitated from the translation mixture (Figure 6 lane 
5) together with two polypeptides of lower mol wt The same 
additional polypeptides were also found in the immunoprecipi 
talion of the m vitro translation reaction programmed with hybrid 
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selected A protein mRNA (Figure 3, lane 5) and may either be 
degradation products of the A protein or alternatively represent 
incomplete translation products onginating from the same reading 
frame 
Discussion 
Using autoantibodies from a patient with mixed connective tissue 
disease (MCTD), we have isolated two human cDNA clones for 
the Ul snRNA-associated A protein from a Xgtll expression 
library. Screening of the same library with restriction fragments 
of these clones revealed two additional recombinants with longer 
cDNA inserts. The identity of the cDNAs was established by 
hybrid selection and subsequent translation of the selected mRNA 
(Figure 3) and by in vitro translation of an RNA transcript syn­
thesized from the longest cDNA insert (Figure 6). Several im­
munological experiments also confirm the identity of the isolated 
cDNAs: the ß-galactosidase fusion protein of the Xgtl I recombi-
nants was recognized by anti-A antibodies from several patients' 
sera (not shown) and antibodies affinity-purified from the fusion 
proteins exclusively recognized the A antigen on an immunoblot 
of HeLa total protein extract (Figure 2A). 
The longest cDNA identified covered the complete coding 
sequence and 3' noncoding region of the A protein mRNA. In 
addition, it contained 125 nucleotides upstream of the putative 
initiation codon. In most eukaryotic mRNAs no extraneous ATG 
triplets are found upstream of the functional initiation codon for 
M 1 P 3 4 5 
93-. 
41 
30-
-C 
-О 
143-
-ε 
-ρ 
-G 
Fig. 6. In vitro translation of pHA-4 encoded RNA Plasmid pHA-4 was 
linearized by digestion with НшаШ and transenbed in vitro with SP6 RNA 
polymerase The RNA was gel purified and translated in a reticulocyte 
lysate tmmunoprecipitauon of the translation products was performed with 
the same anti-RNP/Sm antiserum that was usai in the hybnd selection 
experiment (Figure 3) Lanes: (1) background translation without addition of 
exogenous RNA. (2) translation products of pHA-4 encoded RNA 
(3) immunoprecipitation of U snRNP proteins from in ww^S-labclled 
HeLa protein extract- (4) immunoprecipitation of translation products from 
the background translation. (5) immunoprecipitation of translation products 
encoded by RNA from pHA^l Mol wt (in kd) of protein standards are 
indicated to the left (M) 
protein synthesis. Indeed, the first ATG codon occurring in the 
long open reading frame of this clone is at the same time the 
5'-proximal ATG of the entire nucleotide sequence. Furthermore. 
this designated initiation codon exists in a fairly strong consensus 
sequence (Kozak, 1986). Only the highly conserved purine in 
position —3 is replaced by a uridine residue, possibly resulting 
in a somewhat weaker initiation signal. The primary translation 
product consists of 282 amino acids, resulting in a protein with 
a predicted mol. wt of 31 243 daltons. This is in good agreement 
with the apparent mol. wt of 32 kd for the A protein, as estimated 
from SDS-Polyacrylamide gels. 
The amino acid sequence of the A protein deduced from the 
nucleotide sequence of the cDNA inserts (Figure 5) has an in­
teresting distribution of charged and aromatic amino acids. They 
are organized in two distinct domains, separated by a segment 
of very high proline content (amino acids 140-206 in Figure 
5). Most of the charged and aromatic amino acids are located 
in the amino-terminal part of the protein. In this domain a cluster 
of 11 charged amino acids represents the most hydrophilic region 
of the entire protein (amino acids 103 — 112 in Figure 5). Due 
to the absence of negatively charged amino acids, the middle part 
of the protein, containing the proline-rieh region, also has an 
overall positive charge. Though not common to all RNA binding 
proteins, similar regions of very high proline content and an 
overall positive charge have been identified in several single-
stranded nucleic acid-binding proteins (Garoff et ai., 1980; 
KruijerrtaA, 1981; Adam «α/. , 1986; Theissen e/a/., 1986). 
The Ul snRNP-specific A polypeptide has at least one epitope 
in common with the U2 snRNP specific B" protein, as was dem­
onstrated by a crossreactivity of monospecific anti-B" antibodies 
with the A antigen (Habets et al., 1985b) Monoclonal antibodies 
that recognize an epitope shared by these two proteins could also 
be produced (Reuter and Lührmann, 1986; Reuter et al., 1986). 
Protease digestion of proteins A and B" suggests that the two 
proteins share a similar structural domain which is even larger 
than just an epitope (Reuter et al., 1987). Therefore, the amino 
acid sequence of the A protein was compared with that of the 
earlier reported B" protein (Habets et al., 1987) for sequence 
homology. Two regions of extensive homology were found. In 
Figure 7 the A protein sequence is shown in the upper line and 
the aligned sequence of the B" protein in the bottom line. Hom-
ology is highest in the carboxy-part: out of the 78 carboxy-
terminal residues of both proteins, 67 are identical, resulting in 
a homology of 86%. The second region of homology is found 
near the amino-terminal end. Here, in the region that spans amino 
acids 7 -101 of the A protein, only 22 residues deviate from 
amino acids 4—98 in the B" protein. Though somewhat less 
extensive than in the carboxy-part, the degree of homology in 
this region is still 77%. Recently a segment. LYS/ARG-GLY-
PHE-GLY/ALA-PHE-VAL-X-PHE/TYR, has been described 
as a common context found in the amino acid sequence of several 
RNA binding proteins (Swanson et al., 1987), including the 
Ul snRNA-associated 70K protein (Theissen et al., 1986). 
The amino-terminal domain of the A protein also contains a 
fragment which is highly homologous to this RNP consensus 
sequence. The segment ARG-GLY-GLN-ALA-PHE-VAL-ILE-
PHE (amino acids 5 2 - 5 9 in Figure 5) diverges only in the third 
amino acid from the RNP consensus sequence. Considerable 
sequence homology with other RNA binding proteins extends 
also beyond the RNP consensus sequence, over a domain of 
80-100 amino acids (Sachs et al., 1986). Since the RNP con-
sensus sequence is located in a region of the A protein which 
is homologous with the B" protein, a similar sequence was ex-
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К I TQ Ν N A 
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Flg. 8. Comparison ol ammo-tenmnal and caïboxy temuaal ends of proteins A and B" The amiwo-termmal residues of ihe A protein ÍA-NÍ and В" рпмеш 
(Β "-Ν) іНаЬек « а!, Ш7) are displayed in Ihe upper lines, and the carboxy-terminiil residues of elfter protein ( λ - C and B"-C) m the bouom lines 
Alignment was aLhEe\ed by the program of Wilbur and bprmtn 1198^1 and аь fe* as posible dcietrons or insertions 4re assumed Amino acids shared by 
both regions of the proteins are enclosed in boxes For the A protein the homology between the amimMemnnal and carboxv terminal regum is M% For the 
B" protein this homology is 35% 
peeled to be present in this protem Indeed, this putative RNA 
binding domain is completely conserved in the B" protein (ammo 
acids 4 9 - 5 6 in Figure 7) Even the ammo acid in position 3, 
which in the A protem deviates from the RNP consensus sequence 
of Swanson etat (19S7), and the undefined amino acid at pos­
ition 7 are identical m both proteins 
Another salient feature oi the denved ammo acid sequence of 
the A protem is a significant sequence homology between two 
parts of the protem itself Alignmemt of the airano-terrmnai and 
carboxy-terrninal region of the protem shows a homology of 31% 
Because of the extensive homology between both proteins the 
corresponding regions ol the B" protein were also compared, 
resulting in a homolog)' of 35 % Alignment of the amino-teraunal 
regions from the A and B" proteins with the càrboxy-parts of 
both proteins is shown In Figure 8 From the RNP consensus 
sequence found in the amino-termmal part of both proteins, only 
four amino acids are conserved m the carboxy-tcrminal parts 
From this extensive structural relationship between the poly-
peptides A and B" it is quite obvious that the gcnen encoding 
these proteins have emerged from a common ancestral gene The 
internal sequence homology suggests that prior to this gene dupli-
cation event a sequence duplication within the precursor gene 
itself probably took place During the evolution of the separate 
genes the sequence of these duplicated gene elements has been 
highly conserved between proteins A and B" It is tempting to 
speculate that these evoluhonanly conserved regions reflect func-
tional domaim, implying that the A and B" proteins fulfill iden-
tical functions. They could either participate m the biological role 
of respectively, Ul and Щ snRNP in pi^-mRNA splicing, or 
alternatively be involved in the morphogenesis of these •inRNP 
species In either process, RNA-protein interactions probably 
play a crucial role In this regard the highly hydrophibc stretch 
of amino acids, the sequence homologous to the RNP consensus 
sequence and the prolme-nch region of the A protem repre!>ent 
structural domains which render these proteins suitable to associ­
ate with RNA The availability of a fiill-length cDNA clone for 
the A protein as well as for äie В" protem (Habeis er al, 1987) 
opens the way tor a more detailed study of the interaction between 
these proteins and their respective U snRNA or defined RNA 
sequences 
Another interesting aspect of the A protem is the presence of 
at least two different epitopes that are recogm/ed by anti-RNP 
autoantibodies One of these reacts with antibodies from anti-
(Ul)RNP sera, whereas the second is recognized by the cross-
reacting anti-B" antibodies from anti-(Ul,U2)RNP sera (Habcts 
et at , 1985b) Since both types of antisera react with the fusion 
protein of λΗΑ-l as well as λΗΑ-2, these epitopes must be 
located in the overlapping carboxy-terminal part of the poly-
-80-
cDNA of the 11 snRNP A proiebi 
peptides encoded by these cDNA4 (amnio acids І72—282 m 
Figure 5) Evidence tor an additional epitope emerged from an 
experiment with a patient serum containing anti-Sm antibodies 
This antiserum onl} recogmased tite ftision protein of λΗΑ-2* 
showing thdt аперШфе recognized by antibodies in this anti-Sm 
anteicrum is located m the region of the A protein additionally 
encoded by λΗΑ-2 as compared with ХНА*! (amtno at ids 73 — 
171 m bigurc 5)i It will be of interest to invesngate the antigenic 
structure of the A protein in more detail, aiv antibodies against 
particular epitopes on the A protein may be related to certain 
clinical symptoms 
Materials and methods 
Screwang ftfa \gifJ ¿хргетоя Itbrary wiift UWtbodyртЬел 
A palieni anlt-tl 1 )KNP senim (dituted 1 50O) *as used lo screen a human terato-
urtmitma cDîsA Шщту UHUvtructed with ihc \ptl 1 vecinr (¿ gift fmni J Sito* 
ranski NC 1 ΜΗ Belhésda) аь |)ге юиі.1> desenbed (H^fets et al ІЩ7) using 
the method ot Young and Davis ( ІЩЗ) Fo deieit ipetihcaH) Ьошкі antibo^ 
, ? 4 1 labelled ^іеер stnh human lg (Habi2 fragment] was us«) 
PunßttüHifi otfiistm pnytem 
Lysogen* *еге pjcpared m Fwhtnchta coit stnim Y1089 iH^ph « ¿J/ 1985» 
A 50 nd culture of fciogemc tcJls w*. gnw^n to OD^-, = ÖJÏ ai ІЗ^С and tytH. 
replication was induced bv a ten^craftire shiñ ЦДХ И mïnji Isopropvl-tf !> 
thiogalKt^ranoside iSi^ma)»a|.adífcdtoa final соплпітаіюпof 10 івЧ Md 
the volture wa^ incubated fiv an addiiiotral hour at ^80С рп«г to han^c^mg the 
ссйь bv ceWnfiigatioo. Afer 1>*й. of the ecJU bv repeated (геек lha*ing fusion 
protcm *as prepare емсіиіаііу ж· dcistribcd by Adam et td 11986) Uwing ƒ wiBer 
gent 3 14 {Calbwchem Bwingï 
Celi ìabellmi! and preparaìim of f felá tait &ЖЕ ргслет fhioton 
Heta S3 cclU *егс gn)wn ín stispcitóion at ^7 Ci«denytKbrangtng*Tüm0 2 > 
IO6 to О Ч х Ufi ceils ml on Suspension Mïîumat bsentiaj Medium iSM^M) 
sujipkiiieiited with ШЧ newborn calt serum Cdluíar protein was h411ed b\ 
mrubatmg tìw celb for J6 h with Ì0 feCt/mi f3SSìmctìKOiHHe (Amenham 1 К 
1000 Ci/mnKitl 1 or the first 2 h the cells were incubated m medium without 
urtabeiîad roethttwine Then 0 í Ы at едгф&я medium wag. added (van bektlen 
and van VenroiMj 1981) 
bor ¡naraiw^tottiTig and ¡іташткіргссіріЬйіогі assays іоЫ ргсяст iracüoas fnttn 
HcLa cells were used tHdbetb rf al ІОДЭі Cells were pelteted Ъ ccntnhigatuwi 
(lOminatgOOi·! «ashedowtewith TBS IVO mM NaCl 40mMTm'-HAc 
(pH 7 4>ì and squn down again SufcftBqttsml> the cell pell« was ituispendcd 
ιηΤΒ5(ί ν 10 ccïli/mlïand thecefls were sonitated three Urnci (40 ч^опне 
u«h a nacrotip wmficr (model B-W Branson fnar tnc Conncctiait USA) 
Tbe su4pc№(oft of sonicated ССНУ was centntuged tor Ttí mm at 16 000 g 1 he 
supernatant was either used immediate!ν for нштшпоргес^чшюп (labelled extract) 
or diluted with 1 vol of 2 χ ЫА &d wmjAe. buffer [ 125 mM 1m HAs (pH 
e.S) 4 ^ SDS, 205Í g lycol 0 01 % biwnophcnol blue \№ 2 mercaptoethanolî 
and boilea tor ](> min 
del ríntrophorfs¡\ protew Mffamg and detertwn of аппрет 
Praiems were analysed ічі SDS -polyau) lanude ueh mmit the Laemmti iW70) 
buffer s>s£em Transfer of proteins onto nitroccllult»c snects was performed as 
<te*Lnbed by Habets et at (І98'1) For the dela-ütni of autigensllK protein blots 
were treated and proceded as described (Habets er ai 198Sa) As pnmary anc 
bodiev human autoiiraraJHt stia (diluted [ UXï) u-erc UKd The anutwdy- antigen 
complexes were, detected with ι · 5 ί labelled anti human Ig ír<m sheep [Ffah^ 
frngnwnti 
РапГкаІкт of antibodies from tutmcelblfwe bliHs w^, perfomied as desenbed 
by Srrtitíi and ?-Ыжг ί19ΐΐ4) 
Ргерагшит ofJÍ\A 
Нсіл. cells were harvested bv centntugatacHV and wtóhed once wtth eotonK NKM 
sohitton (141 mM N'aO 50 mM КСІ I 11 mM MgCt
a
) After pejíeting (hey 
w-enïrciu^endedinRSBnemMNsC) lOmMTns-HAcípH? 4) t 4 mM 
MgCljl ai a densuv of 4 χ 10 ceUs/ml and 0 1 voi ьжЬшп tteoAycíhiíale/ 
Nontdet Ρ-40 mixture (5% each f was added The suspension was gendy swirled 
and left tm KS for 10 mm Sabsetpientiy, the тк-кз woe renwvfe! b> centnfugaiton 
аіІЮО^йігІ mm The supematant wasmadeOS* in àDS and total RNA was 
ï&olated by phenol -chloroiorro txtiaUioo PoljiA)4 RNA wafc selected by 
oligotdO^elluliìse chromatogra(rfty (Maiuatn. et ai 1Ш2і 
WA bUx hyhndizen&tt 
ren^gof рЫ>(А)'к RNA was gtyoxalated fractionated on I 0% agarose·geb 
andlRmiïfeiTedtoHyt»ndN(Ametxham UK) (Carroichaeî and McMaster 1980 
Thofíiai 1980) As. тЫ wt markers /JîfMÏlIi-digested X DNA fragments were 
used DenaturaUonof ÖKro4AtnarkMs wiis.pcrffflEtnediiS 1ea:nbcdfttrRNA 
HybndizaiKm of the Northern blob was earned out as tteüinbed by Ctttitch and 
Gilbert (1984) 
tfybrui teteaion RNA tmnst nptìtm ned m vttro ttvnslatiön 
Plasmid pHA I or ptíA 2 «rib dígeMed with ScoRi The isolated cDNA insert 
wasdenaturedby bodmgandttcattnent withO 5 M NaOH neutralized andap-
phcd lo nttroceHukise HybrwKzaütsi seleöic« wi& pwformed esucrÄially as tteserib-
ed by Qtax Jeuken et ai (1984) 
RNA trpmmpt was synthesized in viim from AÜedlIWigeitcd pHA 4 Ï>NA 
m ιΐκ presence of SP6 RNA polymerase and fte ibnudeoode prana- G(5 )ppp(^ )G 
(Konarafca ¿г (tí №5} 
In и/гоігашЫюпг. m a micleaEse-troattd r^iculoc)te tysalc (Amersham UK) 
were performed for 90 min at WC in 15 /il reaction mixtures and aisdysed by 
SDS - PAGE Gels containing "Vlabelted pmtcms were imprcignated with 2 5 
diphenyloxazofc ίΡΡίϊ) before being dried and flunrograpby wa& performed with 
Kodak XAR S X-ray filia (Lutey and Mills 1975) 
АпЫуm i*f цшітфгесіріиаЫ promns 
For the immunoprcupitation of prtHeins from a ^S labelled HcLa celt extract 
the procedure desutbed by Mtroort ft td (198*ί) was used Inununiiprecip«ated 
proteins were analvs«! (Mi ïS^f SDS -polyscrylanwfc gels 
Cell free mnsbtian mivtufui WÎÎÏ adjusbxi to t % ιν/ν) ΤηϊΟη λ J0Û 100 mM 
SaCl 25 mM Т ш - Н А с ίρΚ 7 4) 5 mM EDTA 2 5 mg of ovalbumm per 
ml 2 S$ (v/v)Trasyíol in a total volume of 100 ¡td Tnuislation pnxlucfe were 
immunoprecipitated a;, described by bisher et al (ШЗ) 
IWA seqtimce шкі/ яи 
tDNA fragments were digeüied wtth a variti ot re&nchon ewymes having 4 or 
6-bp reaignitKW ьециелсеь DNA tragmentí. were ligated imo ihe poh linker region 
0*МПпч>18огтрІ*НМеА$т& 1^13) Sö^uenceanalj^isctflheDNAftagmenb 
was performed by the dideoxy thatn terminât »m method ('Sanger el ut 1977) 
The gel reading» were recorded edited and umipired by the Staden programs-
(14791 
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ABSTRACT 
A conplementary DNA c l o r e for the human U1 snRNP-specific С p r o t e i n has 
lirr i s o l a t e d . The n u c l e o t i d e sequence of the 733 bp cDNA i n s e r t i n c l u d e s a 
55 t p ' ' - u n t r a n s l a t e d r e g i o n , an open r e a d i n g frame of 477 bp c o r r e s p o n d i n g 
t o 159 amino ac ids (M
r
-17,373 D), and a 223 bp 3 ' - u n t r a n s l a t e d r e g i o n . The 
i d e n t i t y of the clone was confirmed by i n v i t r o t r a n s l a t i o n of h y b r i d - s e l e c ­
ted IBRNA or an RNA t r a n s c r i p t s y n t h e s i z e d from t h e cDNA. The i n Vi tro syn­
t h e s i z e d С p r o t e i n has a s l i g h t l y g r e a t e r m o b i l i t y on SDS-polyaorylamide 
g e l s , i n d i c a t i n g t h a t the in vivo product i s p o s t - t r a n s l a t i o n a l l y modif ied. 
Ths deduced primary s t r u c t u r e conta ins a segment of high p r o l i n e and methio­
nine c o n t e n t . A reg ion homologous t o t h e RNP consensus sequence, found i n t h e 
o t h e r two U1 snRNP-specific p r o t e i n s 70K and A, i s a b s e n t . Analys is of geno­
mic DNA r e s t r i c t i o n enzyme d i g e s t s shows h y b r i d i z i n g fragments in t h e genome 
of a l l v e r t e b r a t e c l a s s e s . The r e s u l t s a r e c o n s i s t e n t wi th mult i-copy r e p r e ­
s e n t a t i o n of t h e С p r o t e i n gene i n mammals, whereas i n t h e o t h e r v e r t e b r a t e 
c lashes the r e l a t e d p r o t e i n seems t o be encoded by a s ing le-copy gene. 
raTRODUCTION 
Small nuclear r i b o n u c l e o p r o t e i n s (snRNPs) a r e a c l a s s of RNA-containing 
p a r t i c l e s in t h e nucleus of e u k a r y o t l c c e l l s ( 1 ) . They c o n s i s t of an u r i -
d y l a t e - r i c h small RNA (U snRNA) complexed wih s e v e r a l p r o t e i n s . The U snRNAs 
are s y n t h e s i z e d i n t h e nucleus as p r e c u r s o r s t h a t a r e t r a n s p o r t e d t o t h e 
cytoplasm where they a r e processed t o t h e i r mature s i z e s , assembled i n t o 
snRNPs, and then t r a n s p o r t e d back t o t h e nucleus (for a review see 2 ) . With 
about 1θ6 copies per c e l l the U1 snRNP p a r t i c l e i s the most abundant among 
t h e s e snRNP s p e c i e s . So f a r , ten polypept ides have been i d e n t i f i e d as c o n s t i ­
t u e n t s of the U1 snRNP p a r t i c l e . Seven of t h e s e po lypept ides with approximate 
molecular weights 29 kD ( B · ) , 28 kD (B), 16 kD (D), 15.5kD ( D · ) , 12 kD (Ε) , 
11 kD (F) and 10 kD (G) make up the RNP core s t r u c t u r e , which i s a l s o found 
i n t h e o t h e r major monomeric snRNP s p e c i e s U2 and U5 and i n t h e dimeric snRNP 
p a r t i c l e Uit/U6 ( 3 ) . The smal ler core p o l y p e p t i d e s D, E, F and G f i r s t assem­
ble i n t o an RNA-free 6S h e t e r o o l i g o m e r i c complex ( I ) , which s u b s e q u e n t l y 
binds t o an i n t e r n a l s i n g l e - s t r a n d e d sequence of the type A(U)
n
G (with n>3) 
£ IRL Press Limited, Oxford, England. 
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t h a t i a conserved among snRNAs Ul, U2, 'Jb and U5 ( 5 ) . Fur ther i i e thy ia t ion of 
the 7-methylguanosine cap s t r u c t u r e of the RNA polymerase I I t r a n s c r i b e d U 
snRNAs i s depenctent on the presence of these core p r o t e i n s ( 5 ) . 
In a d d i t i Q t ^ t o the common po lypep t ides , Ul snSNP con ta ins a t 2east t h r e e 
cha rac t e r t - á t i o p r o t e i n s with apparent molecular welgths 70 kD (70Ю, 31 kO 
(A) and 22 k0 (C) ( 3 , 6 , 7 ) . These unique po lypept ides may be involved In t h e 
f i n e t u n i n g of the f u n c t i o n t h a t Ul snBNP has in t h e s p l i c i n g of nuclear pre­
c u r s o r s t o mature messenger RNAs, a process which o c c u r s m a l a r g e multicom-
ponent complex termed a spl iceosome (for a review see 8 ) . Ul snRNP s p e c i f i ­
c a l l y r e c o g n i z e s t h e 5' s p l i c e s i t e s of these pre-mRNAs. Although t h i s i n t e r ­
a c t i o n i s mediated by RNA base p a i r i n g between the complementary n u c l e o t i d e 
sequences of t h e 5 ' end of t h e Ul snRNA and t h e 5 ' s p l i c e j u n c t i o n of the 
pre-mRliA ( 9 , 1 0 ) , t h e s p e c i f i c i t y of t h i s a s s o c i a t i o n appears t o be guided by 
t h e Ul snSNA p r o t e i n components ( 1 1 ) . The p r e c i s e r o l e of t h e i n d i v i d u a l pro­
t e i n s i s s t i l l unknown. 
The snRNP p r o t e i n s a r e not only of i n t e r e s t because they p a r t i c i p a t e m 
t h e p r o c e s s i n g of n u c l e a r pre-mRNAs, but they a l s o p l a y a r o l e as a n t i g e n s i n 
t h e autoimmune response of p a t i e n t s with connect ive t i s s u e d i s e a s e s ( 1 ? ) . The 
use of t h e s e s o - e a l l e d anti-Sm and anti-RNP s e r a has g r e a t l y f a c i l i t a t e d the 
s t u d y of anRNPs and t h e i r p r o t e i n components. The Ul snRNP-specific p r o t e i n s 
70K and A, and wi th a lower frequency also po lypept ide C, a r e t h e t a r g e t an­
t i g e n s recognized by anti-RNP a u t o a n t i b o d i e s . Using human autoimmune s e r a 
c o n t a i n i n g t h e s e anti-RNP a c t i v i t i e s , cDNA clones encoding t h e human 7QK 
p r o t e i n (13,14) and A p r o t e i n (15) have been i s o l a t e d from l i b r a r i e s con­
s t r u c t e d in e x p r e s s i o n v e c t o r s . I n t h i s s tudy we d e s c r i b e t h e molecular c l o ­
ning and sequence a n a l y s i s of a f u l l - l e n g t h cDNA c lone encoding the human Ul 
snfiNP-speeific p r o t e i n C. In v i t r o t r a n s l a t i o n of an SP6 t r a n s c r i p t der ived 
from t h i s cDNA r e v e a l e d t h a t t h e С p r o t e i n i s p o s t - t r a n s l a t i o n a l l y modi f ied. 
I n Southern b l o t a n a l y s i s t h e С p r o t e i n shows DNA sequence c o n s e r v a t i o n in 
the genome of a l l v e r t e b r a t e c l a s s e s . Furthermore, t h e r e s u l t s i n d i c a t e t h a t 
i t i s encoded by a member of a mult igene family i n mammals. 
MATERIALS AND METHODS 
Antibody s c r e e n i n g , inuminoblotting and immunoprec ip i ta t lon: A p a t i e n t a n t i -
(UI)RNP serum ( d i l u t e d 1:500) was used t o sc reen a human t e r a t o c a r e i n o m a cDNA 
l i b r a r y c o n s t r u c t e d w i t h the Agtll vector (a g i f t from J .Skowronski , MCI/NIH, 
Bethesda) as p r e v i o u s l y descr ibed ( 1 5 ) . To d e t e c t s p e c i f i c a l l y bound a n t i b o ­
dy, 1 2 5 i - i
a
b e l l e d sheep anti-human Ig [F(ab)2 f r a g s e n t ] was used. 
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Par immun о blot t ing, fusion protein was prepared essential ly as deserlbed 
by Adam et a l . (16) trom lysogens prepared m t, coll s t ra in Ï1089 (17). 
Proteins were fractionated on SDS-polyacrylamide gels and electroblotted onto 
nitrocellulose sheets as described (18). For the detection of antigens the 
protein blots were treated and processed according to the method of Habets et 
a l , (19). 
Imnunoprecipitation of proteins from SSs-iaueHed HeLa cell extracts or 
from cel l-free t ranslat ion mixtures was carried out as previously described 
(15). 
OKA bequence analysis; For sequence analysis , sui table cDNA fragments were 
ligated into M13 mpl8 or mp19 (¿0) , grown in JM101, and subjected to dideoxy 
chain termination reactions (21). 
Hybrid seleotion, ЯМА transcription and m vitro t rans la t ion: Plasmid pHC-1 
was digested with EcoRI. The isolated eDNA insert was denatured by boiling 
and treatment w^th 0.5 M NaOH, neutralized, and applied to n i t roce l lu lose . 
hybridization selection was perforied essential ly as described by Quax-Jeuken 
et э і . (22). 
«A transcr ipts were synthesized in v i t ro from Hindlll-digested pHC-1 ША 
in the presence of the dinucleotide primer G(5 ,)ppp(5 ! )G and SP6 RNA polyme­
rase (23). 
In v i tro t rans lat ions in a nucloase-treated reticulocyte lysate (Amersham, 
UK) were performed for 90 mm at 30oC in 25 til reaction mixtures. 
RKA and DMA blot analysis: Total RNA was isolated from Hela cel ls (15) and 
poly(h)+ RNA was selected by oligo(dT)-cellulose chromatography. Ten us of 
DOly(A)+ RNA was glyoxalated, fractionated on 1.0Î agarose gels and transfer-
red to Hybond-N (Amersham, υκ)(2ή,25). Hmdlll-digested i-DNA fragments were 
used as molecular weight markers . Denaturation of the DNA markers was 
performed as described for RNA. 
Total genomic DNA was i s o l a t e d from diverse tissues of a l l species 
described using standard methods (26). Ten-microgram amounts were digested, 
electrophoresed on 0.7Í agarose gels and transferred onto ni t rocel lu lose . 
Hybridization of Northern and Southern blots was performed as described by 
Church and Gilbert (27), except that for Southern blott ing tOO yg of herring 
sperm single-stranded DNA was added in the prehybridizatlon and hybridization 
mix. After h y b r i d i z a t i o n , f i l t e r s were washed twice with 0.5 M sodium 
phosphate, pH 7.0, 1£ SDS, 1 mM EDTA at бЗ^ for 30 mm and once with 0.25 M 
sodium phosphate, pH 7.0, i% SDS, t mM EDTA at 650C for 30 min. 
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Figure 1. Immunoblot a n a l y s i s of the fusion p ro t e in produced by the lysogen 
of XHC-l (A) and immunoblotting wi th an t i bod i e s a f f i n i t y - p u r i f i e d from AHC-1 
fusion p ro t e in (B). (A) Pu r i f i ed fus ion p ro t e in was reso lved on a 7.5% SOS-
poly a or у lami áe gel along with t o t a l l y s a t e from Xgt l1- in fec ted c e l l s and 
t r a n s f e r r e d t o n i t r o c e l l u l o s e . I d e n t i c a l immunoblots were probed e i t h e r wi th 
the p a t i e n t antl-(U1)RNP serum with which the c lone was i s o l a t e d from the 
Agtll l i b r a r y or a monoclonal ant ibody s p e c i f i c for ß - g a l a c t o s i d a s e . Bound 
a n t i b o d i e s were de tec t ed wi th 1 2 5 i - i a b e l l e d sheep anti-human Ig or sheep 
a n t i - m o u s e I g , r e s p e c t i v e l y . Lanes: (A) t o t a l l y s a t e from Xgt l1- infeo ted 
c e l l s ; (B) p u r i f i e d fus ion p r o t e i n from clone XHC-1. (B) A s t r i p of an immu-
noblot as descr ibed above was processed for the d e t e c t i o n of an t igens and the 
a rea of the b lo t con ta in ing the fus ion p ro te in was exc i sed . This region was 
used to adsorb an t i bod i e s s p e c i f i c for t he fusion p r o t e i n from a human a n t l -
CU1)RNP serum conta in ing a n t i b o d i e s aga ins t the 70K, A, and С p r o t e i n s . The 
a n t i b o d i e s were e l u t e d and r e - u s e d t o probe an immunoblot of HeLa t o t a l pro­
t e i n e x t r a c t . Lanes: (1) t o t a l human anti-(U1)RNP serum; (2) a f f i n i t y - p u r i ­
f i e d antibody from t h e fusion p r o t e i n of XHC-1. 
RESULTS 
I s o l a t i o n and i d e n t i f i c a t i o n of a f u l l - l e n g t h cDNA clone for the U1 snRNP-
s p e c l f l c С p r o t e i n . 
An antl-(Ul)RNP serum c o n t a i n i n g a high t i t e r of antibody a g a i n s t the Ul 
snRNP-specific С p r o t e i n (Figure IB, lane 1) was used t o screen a human t e r a -
tocarclnoma cDNA l i b r a r y c o n s t r u c t e d i n the vector Xgtll for recombinants ex­
p r e s s i n g t h i s a n t i g e n . I n i t i a l s c r e e n i n g of about 600,000 i n d i v i d u a l plaques 
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Figure 2 . H y b r i d - s e l e c t i o n t r a n s l a t i o n of HeLa mRNA with pHC-1. Immunopreci-
p i t a t i o n s were performed with a human anti-RNP/Sm serum r e c o g n i z i n g on an im-
munoblot of HeLa t o t a l p r o t e i n e x t r a c t the snRNA-associated p r o t e i n s 70K, A, 
B', B, C, and D. Lanes: (1) I ramunoprecipi tat ion of U snRNP p r o t e i n s from in 
vivo 35s-methionine l a b e l l e d HeLa p r o t e i n e x t r a c t ; (2) i ramunoprecipitat ion of 
t r a n s l a t i o n products from a c o n t r o l t r a n s l a t i o n (no mRNA added); (3) iramuno­
p r e c i p i t a t i o n of t r a n s l a t i o n p r o d u c t s from pHC-1 h y b r i d - s e l e c t e d mRNA; (1) 
immunoprecipi tat ion of t r a n s l a t i o n products from t o t a l HeLa poly(A)+RNA. Mo­
l e c u l a r weights ( i n kD) of p r o t e i n s t a n d a r d s a r e I n d i c a t e d on the r i g h t (M). 
y ie lded a s i n g l e c l o n e , des ignated XHC-1, which poss ib ly conta ined coding s e ­
quences for t h e С p o l y p e p t i d e . 
To confirm r e a c t i v i t y with a n t i g e n i c d e t e r m i n a n t s encoded by the cDNA i n ­
s e r t , XHC-l and wi ld-type Xgtll were used t o i n f e c t l y sogenic s t r a i n Y1089. 
B a c t e r i a l l y s a t e s were prepared a f t e r i n d u c t i o n of the phage ß - g a l a c t o s i d a s e 
gene by i sopropy l -B-D- th ioga lac topyranos ide (IPTG) and analyzed by immuno-
b l o t t i n g (Figure 1A). The 116 kD ß - g a l a c t o s i d a s e present in the wi ld - type 
c u l t u r e was rep laced by a 126 kD fusion p r o t e i n in the AHC-l c u l t u r e , which 
was r e a c t i v e both wi th an t i bod i e s to ß - g a l a c t o s i d a s e and with an t ibod ie s from 
the anti-(U1)RNP serum. No r e a c t i o n was observed with serum from normal i n d i -
v i d u a l s . 
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Figure 3. Korthern blot analysis of polyU)* RNA Ггші HeLa ce l i s probed with 
32p-labelled nick-translated cDNA insert from the pHC-1 clone. The size of 
corourrently electrophoresed ribosomal RNA from HeLa ce l l s is indicated on 
the l e f t . 
The antibodies from the anti-(U1)RNP serum specif ical ly reacting with the 
fusion protein were eluted from a preparative immunoblot (28) and assayed for 
their react iv i ty with U1 snRNP prote ins . As shown in Figure IB (lane 2), an­
tibodies affinity purified from the λΗΟ! fusion protein exclusively recog­
nized the U1 snRNP-specific С protein. 
The cDNA i n s e r t . Isolated from the λΗΟΙ phage by digestion with EcoRI, 
was recloned into the SP6 bacteriophage promoter plasmld, pSP65, to yield 
pHC-1. To confirm the identi ty of the cDNA clone, mRNA specifically hybridi­
zing to the pHC-1 cDNA insert was selected from total HeLa poly(A)+ RNA and 
subsequently translated in v i t ro using a rabbit ret iculocyte lysa te . The 
hybrid-selected mRNA translated in v i t ro two major polypeptides with apparent 
molecular weights of about 21 kD and 11 kD, respectively, and a minor product 
of approximately 12.5 kD, which a l l were immunoprecipitable with the ant i-
(Ul)RNP serum that was i n i t i a l l y used for- the i solat ion of the XHC-I phage 
(Figure 2, lane 3). The 21 kD protein comigrated with the in vitro synthesi­
zed С protein (Figure 2, lane 1), which on an SDS-polyacrylamide gel had a 
s l ight ly greater mobility than the in vivo labelled С protein (Figure 2, lane 
1). This shi f t in mobility was estimated to correspond to approximately 1.0 
kD. The fact that the 12.5 and 11 kD polypeptides were also specifically 1m-
munoprecipitated from the t rans la t ion reaction directed by the hybrid-selec­
ted iiRNA, implies that they originate from other m-phase AUG codons errone­
ously used for i n i t i a t i o n of t rans lat ion (see below) or, a l t e r n a t i v e l y , 
represent degradation products of the С protein. In fact , they also appeared 
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in the immunoprecipitation of snRKP proteins synthesized m vi tro by t ransla­
ting tota l poly(A)+ RNA (Figure 2, lane k) . Since Northern blots containing 
total HeLa poly(A)+ RNA revealed only one mRNA species when probed with the 
nick-translated CDNA insert of pHC-1 (Figure 3), the poss ibi l i ty that these 
additional t ranslat ion products originate from a contaminating mRNA could be 
ruled out. 
Restriction mapping of the cDNA insert of pHC-1 showed that i t was approx­
imately 750 bp in length. Assuming an average length of about 150 residues 
for the poly(A) t a i l of a eukaryotlc mRNA, th i s cDNA matches well with the 
size of the homologous mRNA which was determined by Northern blot aralysis to 
be about 0.9 kb (Figure 3). To determine whether the cDNA insert i s indeed 
close to ful l-length, a primer extension experiment was carried out. An end-
labelled Sl^residue oligonucleotide primer complementary to nucleotides 61-87 
as presented in Figure IB, w s hybridized to HeLa poly(A)+ RNA and used as a 
primer for reverse transcript ion. The primer was extended about 60-70 nucle­
otides (data not shown), meaning that the cDNA insert of \HC-] lacked at most 
a few bp, if any, of the S'-untranslated end of the С protein mRNA. Also re-
soreening of thfe Xgtll expression l ibrary with a 32p-i
a
belled піск-translated 
S'-terminal fragment of the iHOI insert did not yield recombinants with in­
serts longer than that of the λΗΟΐ phage clone. 
Nucleotide sequence and complete deduced amino acid sequence of the С pro­
te in . 
The nucleotide sequence of the С protein cDNA contained in clone iHC-1 was 
determined by the dideoxy method (21) according to the strategy outlined m 
Figure ¡SA. The sequence i s shown in Figure liB and covers 733 nucleotides. At 
the 3' end i t contains the consensus polyadenylation signal AATAAA (29) 25 
nucleotides upstream of the terminating poly(A) t r a c t . The reading frame, 
which is in reg is te r with the junctional ß-galactosidase sequence of Agtll 
and therefore is expressed in AHC-1, extends from the f i r s t nucleotide to 
nucleotide 493, where a TAA stop codon i s encountered. The f i r s t putative ATG 
in i t i a t ion codon i s found at position 16 and i s located within a sequence 
segment which f i t s the in i t i a t ion codon rules of Kozak (30), Experimental 
evidence that the designated ATG codon indeed encodes the in i t i a t ion methion-
ine was obtained from the in vi t ro t ranslat ion of an SP6 RNA transcript of 
the pHC-1 inse r t . The plasmid pHC-1, containing the SP6 promoter Immediately 
upstream of the cDNA inse r t , was transcribed in vi t ro after l inear izat ion of 
the circular DNA by Hindlll digestion. In vi t ro translat ion of the resul t ing 
RNA yielded three major products (Figure 5, lane 2) . The longest polypeptide 
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1 met pro Іуз phe tyr oys asp tyr cys asp thr tyr leu thr his aap ser pro ser val 20 
во ιoo ι го 
aga aag аса cao t g o a g t gga agg aaa cae aaa gag aat g t g asa gao t a t t a t oag aaa 
2t a r g l y s t h r h l s оуз ser g l y a r g l y s m a l y s g l u asn v a l l y s aap t y r t y r g i n l y s 40 
1 M 160 180 
t g g a t g gaa gag oag got oag ago c t g a t t gac aaa аса acg g o t gea t t t oaa câa gga 
M t r p net g lu g l u g i n a la g i n ser l e u l i e asp l y s t h r t h r a l a a l a phe g in g in g ly 60 
200 220 240 
aag ata ce t cet ac t oca t t c t c t got ce t cet cet gea ggg geg a t g ata oca cet oec 
61 l y s l i e pro pro t h r pro phe ser a l a pro pro pro a la g l y a l a met l i e pro pro pro Θ0 
260 280 300 
ecc age o t t cog ggt oct c o t ogc e o t g g t atg a t g oca gea ceo oat a t g ggg gge c o t 
81 pro ser l e u pro g l y pro pro a r g pro g l y met met pro a l a pro h i s met g l y g l y pro 100 
320 340 360 
occ a t g a t g oca a t g a t g ggo c e t cot cet cet ggg a t g a t g oca g t g gga cet get eot 
101 pro met met pro met met g l y pro pro pro pro g l y met met pro v a l g l y pro a l a pro 120 
380 400 420 
gga a t g agg ccg cec a t g gga ggc c a t a t g cca a t g a t g cet ggg eco oca a t g a t g aga 
121 g l y fflet a r g pro pro met g l y g l y h i s met pro met met pro g l y pro pro met met a r g 140 
440 460 480 
oct cet gee c g t coo a t g a t g g t g occ a c t egg eco gga a t g a c t cga cea gac aga t a a 
141 pro pro a l a a r g pro met met v a l pro t h r arg pro g l y met t h r a r g pro asp a r g *** 
500 520 540 
gga t a g agg gga ggc o t t a t t g t a t e g g t t t t a t a t tac c t g t t c t g c t t o aco agg aga 
560 580 600 
tea t g o t g o t g t gat a c t gag t t t t o t aaa oag c a t aag gaa gac t t g etc coo t g t eot 
620 640 660 
a t g aaa gag aat a g t t t t gga ggg gag aag t g g gac aaa aaa g a t gca g t t t t c o t t t g t 
680 700 720 
a t t ggg aaa t g t gaa aat aaa a t t g t c aac t c t t t c agt taa aaa aaa aaa gga a t t с 
Figure 1). (A) Part ial r e s t r i c t i o n map and sequencing strategy for the ful l-
length cDNA clone pHC-T. The thick bar represents the protein coding region. 
(B) Nucleotide sequence and deduced amino acid sequence of the encoded С pro­
t e i n . The predicted amino acids are shown below the i r t r i p l e t s . The polyade-
nylation signal is underlined and the stop codon is marked by as ter i sks . 
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Figure 5 . In v i t r o t r a n s l a t i o n of pHC-1 encoded RNA. Immunoprecipi ta t ion of 
the t r a n s l a t i o n products was performed with the same anti-RNP/Sm serum t h a t 
was used i n t h e hybrid s e l e c t i o n experiment (Figure 2 ) . Lanes: (1) c o n t r o l 
t r a n s l a t i o n without a d d i t i o n of exogenous RNA; (2) and (9) t r a n s l a t i o n pro­
ducts of pHC-1 encoded RNA; (3) and (7) immunoprecip i ta t i on of U snRNP p r o ­
t e i n s from In vivo 35s-methionine l a b e l l e d HeLa p r o t e i n e x t r a c t ; (4) immuno-
p r e c i p i t a t i o n of t r a n s l a t i o n products from the c o n t r o l t r a n s l a t i o n ; (5) im­
munoprecipi t a t i o n of t r a n s l a t i o n products encoded by RNA from pHC-1; (6) im-
m u n o p r e c i p i t a t i o n of t r a n s l a t i o n products from t o t a l HeLa poly(A) + RNA; (8) 
t r a n s l a t i o n products of RNA der ived from pHC-1 a f t e r d e l e t i o n of t h e f i r s t 87 
n u c l e o t i d e s of the cDNA by p a r t i a l P s t I d i g e s t i o n . Molecular weights ( in kD) 
of p r o t e i n s t a n d a r d s are i n d i c a t e d on the l e f t (M). 
had e x a c t l y the same s i z e as the С p r o t e i n s y n t h e s i z e d in v i t r o by t h e bona 
f i d e С p r o t e i n mRNA (Figure 5, lane 6 ) , demonstrat ing t h a t t h e cDNA sequence 
presented in Figure 46 conta ins the e n t i r e p r o t e i n coding r e g i o n . As a l ready 
observed in t h e hybrid s e l e c t i o n experiment the i n v i t r o t r a n s l a t i o n product 
had a s l i g h t l y smal ler molecular weight as the in vivo s y n t h e s i z e d С p r o t e i n . 
The primary t r a n s l a t i o n product could a l s o be immunopreoipitated from t h e 
t r a n s l a t i o n mixture (Figure 5, l a n e 5 ) , t o g e t h e r with t h e two p o l y p e p t i d e s of 
lower molecular weight , i n d i c a t i n g t h a t t h e s e a d d i t i o n a l products o r i g i n a t e 
from the same r e a d i n g frame. The l o n g e s t of the incomplete t r a n s l a t i o n pro­
ducts r e s u l t s from i n c o r r e c t i n i t i a t i o n of t r a n s l a t i o n a t t h e ATG codon a t 
-93-
Nucleic Acids Research 
M
1 1 2 3 4 S 6 7 8 9 10 11 12 13 14 tS 
23 1 -
9 4-
4 3 -
2 3 -
2 0 -
Figure 6. Detection of С protein gene sequences in vertebrate DNAs. Ten-
microgram amounts of genomic DNA were digested with EcoRI, run on a 0.7Ï 
agarose gel , transferred to nitrocellulose, and hybridized with SSp-ia^elled 
nick-translated insert of pHC-1. Lanes: The DNAs were extracted from the 
following species: (1) Drosophila; (2) Tilapia, a oichlid teleost fish; (3) 
Xenopus; (4) Varan ( l izard) ; (5) chicken; (6) duck; (7) rabbit; (8) r a t ; (9) 
mouse; (10) hamster; (11) mole; (12) mole ra t ; (13) calf; (11) monkey; (15) 
man. As markers, Hindlll digested λ-DNA fragments were run in parallel (M). 
position 139, since translat ion of an SP6 transcript of the pHC-1 insert from 
which the f i r s t 87 nucleotides had been deleted by part ia l PstI digestion, 
s t i l l yielded the two smaller polypeptides while the full-length С protein 
was no longer synthesized (Figure 5, lanes 8 and 9) . Taken together, these 
resul ts unambiguously identify the ATG codon at position 16 as the transla-
tional i n i t i a t i o n codon. 
Southern blot analysis of the gene encoding the С protein. 
Southern blot analysis was performed to test different vertebrate genomes 
for the presence of sequences homologous to the cDNA of the human Ul snRNP-
specific С protein. EcoRI-digested genomic DNAs of different species were 
hybridized using the 32p-i
a
belled nick-translated EcoRI insert of pHC-1 as 
probe. Representatives of a l l vertebrate classes, including fish, amphibia, 
r e p t i l e s , b i rds, and mammals, showed hybridizing bands under the moderate 
conditions of stringency used (see Materials and Methods). Whereas only two 
or three fragments in the genomic DNA of Tilapia, Xenopus, Varan, duck and 
chicken were detected in the original of Figure 6, multiple bands of widely 
different in tens i t ies cross-hybridized in the genome of mammals, with the 
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exception of calf genomic DNA which exhibits a simpler pa t te rn . Genomic 
insect DNA sequences homologous to the cDNA of the С protein could not be 
detected, as no significant cross-hybridization with Drosophila DMA fragments 
(Figure 6, lane 1) was found. Southern blot ar.alysis of human genomic DNA 
with other r e s t r i c t i o n enzymes confirma the data obtained with EcoRI (Figure 
6, lane 15). One o** two strong hybridizing bands in addition to a varying 
multiband pattern of lower intensity were detected in re s t r ic t ion digests 
produced with S t u l , SphI, Pvull, Ps tI , Kpnl, Hpal, Hindll l, Bglll, and 
BamHl (data not shorfn). 
DISCUSSION 
The proteins of the snRNP par t ic le s are of considerable interest because 
they are target antigens for the so-called anti-3m and arti-RNP autoantibo­
dies in sera from patients with connective t issue diseases (reviewed in 1¿) 
and because they participate m the splicing of pre-mRNA (8,11). We describe 
here the characterization of a cDNA clone for the human U1 snRNP-speoific С 
protein. Northern blot analysis (Figure 3) and p n r e r extension data indicate 
that the insert oí 7í3 bp of this clone i s close to ful l - length. I t covers 
the complete coding and B'-untranslated region of the С protein irRNA m addi­
tion to 15 nucleotides upstreasti of the designated i n i t i a t i o n codon (Figure 
ЧВ). T'-is rather short 5'-noncoding region might explain why rifcosomes i n i t i ­
ate at tne f i r s t and second AUG codon when an SP6 transcr ipt of the cDNA in­
sert is translated in vi tro, producing long and snort forms of tne encoded 
polypeptide (Figure 5). When the authentic mRMA encoding the С protein i s 
translated in v i t ro (Figure 2 and Figure 5, lane 6), the same additional po­
lypeptide i s found, indicating that in t h i s case the i n i t i a t i o n codon also i s 
located close to the cap a'-d therefore i s recognized less efficiently in vi­
t r o . Other examples of cel lular mRNAs exhibiting t h i s phenomenon have been 
described (for references see 31). 
The derived С protein primary s t ructure is composed of 159 amino acida 
(Figure i)B) and has a calculated molecular weight of 17i373 D. The deduced 
molecular weight does not agree with the 22 kD estimate for the С protein as 
determined from SDS-polyacrylamide gelelectrophoresis (Figures 2 and 5). How­
ever, anomalous migration of polypeptides on SDS-polyacrylamide gels i s more 
often observed, the reason for th i s abnormal mobility being unknown (13,32). 
Recently experimental evidence has been provided by Fisher et a l . Ci) that 
the С p r o t e i n Is post-translat ionally modified in vivo. When cel ls were 
pulse-lâbelled with 35s-methionìne, a sh i f t in mobility for de novo synthe-
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sized С protein was observed within 1 hr of cold chase. SDS-polyacrylamide 
gel analysis suggested a modification corresponding to approximately 1.0 kD. 
In accordance with t h i s finding a similar discrepancy in molecular weight was 
found between the С protein synthesized in vitro m a reticulocyte t r a n s l a t i ­
on system and the in vivo labelled protean. Prelitcinary two-dimensional gel-
electrophoresis data indicate that the overall charge of the polypeptide i s 
not affected by the post-translat ional modification. The exact nature of the 
modification, however, remains to be elucidated. Specific oxidation of seve­
ral of the numerous methionine residues of the С protein i s a possibi l i ty be­
cause complete oxidation of either the m vitro or in vivo synthesized С pro­
tein by performic acid r e s u l t s in a retarded migration of the oxidized pro­
teins on SDS-polyacrylamide gels {data not shown). 
A second feature demonstrating the aberrant behaviour of the С protein on 
SDS-polyacrylamide gels i s the finding that i t sometimes separates into two 
faint bands which s l ight ly differ in molecular weight. An example is shown in 
Figure 5. Since the in v i t ro synthesized С protein separates in a similar 
doublet , though with a s l ight ly smaller apparent molecular weight, t h i s 
effect cannot be due to the p o s t - t r a n s l a t i o n a l modi f ica t ion . I n t r i n s i c 
disulfide bridge formation between cysteine residues could also be ruled out . 
Extensive heating of the С protein in the presence of $-mercaptoethanol did 
not affect the mobility of either of the doublet bands (data not shown). 
When the nucleotide sequence of the pHC-i insert was aligned with that of 
the recently reported pS2 DMA (33), which contains a par t ia l sequence of the 
human С protein, differences were observed at seven posit ions. At position 86 
a base change from С ir pS2 to Τ m pHC-1 i s observed and A to G changes are 
found at positions 94 and £95 (Figure HB). These non-silent base changes 
could indicate that there Is genomic polymorphism in the С protein at the DhA 
and amino acid level . Furthermore, а С residue around positions 301, 318 and 
400, and a G residue around position 311 are absent in the pS2 nucleotide se­
quence. All these deletions are located within regions of the cDNA sequence, 
that are rich in G and С residues. In dideoxy sequencing analysis such r e ­
gions are notorious for the fact that they give r i se to compression a r t i ­
fac t s . While the nucleotide differences only resul t in a switch to other ami­
no acids, the deletions each time eause a shift to another amino acid reading 
frame, the l a t t e r giving r i s e to a completely different oarboxy-terminal end 
for the С protein as the one reported by Yamamoto et a l . (33). Comparison 
with a cDNA sequence encoding the Xenopus homologue for the human С protein 
revealed an identical open reaaing frame for the Xenopus protein as the one 
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presented in Figure ΊΒ for i t s human counterpart. Both proteins have exactly 
the same length and of the 159 amino acids of either protein only a few 
residues are different ( I . Mattaj , personal communications). 
The ammo acid composition of the С protein deduced fron the nucleotide 
sequence of the cDNA (Figure kB) is noteworthy for i t s extremely high content 
of proliP«1 residues (35% of a l l ammo acids) . Analysis of the prmary sequen­
ce reveals thdt most of the proline residues are clustered in a region span­
ning ammo acids 63-159 (Figure ΊΒ). Methionine is also enriched in th i s 
carboxy-termmal part of the С protein: out of the 97 aiiinc acids епсотіраз-
sing the proline-rich region, 20 are methionine residues. Due to the absence 
of negatively charged amino acids, the pro lme-nch region has ач overall 
positive charge. Insofar, this portion of the С protein resemble the segment 
of high proline consent in the III snRNP-specifle A protein CS), which аізо 
has a net positive charge and an over-representation of methionine res idues. 
tor the A protein i t was suggested that the proline-rich portion might con-
s t i t j t e an RNA binding domain, since similar regions have been identified in 
several smgle-strpnded nucleic acid-binding proteins О б , S O S ) . However, 
unllxe the other Ы srRNA-specific proteins 7CK (131 ard A ('5) and the U2 
snRNP-spëclfie В" protein (36), the С protein does not contain a fragment 
homologous to the so-called RNP consensus sequence, a common motif of eight 
amino acids that seems to be diagnostic of RNA binding proteins f 16,37,38). 
Tnis could suggest that irstead of binding direct ly to the snRNA molecule, 
the С protein i s incorporated into the Ш snRNP complex by virtue of i t s 
interaction with other snRNP protems. 
The genomic blot containing DNA of a number of present-day species showed 
hybridizing r e s t r i c t i o n fragments in a l l vertebrate DNAs, indicating a con­
servation of the sequence of the corresponding gene. This evolutionary con­
servation on the DNA level was also observed for other snRNA-âssociated pro-
teins ("ef. 39 and data not shown). For the A protein genomic fragments hy-
bridizing v,ith a human cDNA probe encoding th is U1 snRNA-speclf 1c protein 
coula even be detected in the invertebrate species Drosophila. Using similar 
hybridization conditions, however, we were not able to detect cross-hybridi-
zing fragments in the genome of this species when the Southern blot was 
probed with the С protein cDNA. In concert with t h i s finding a protein with 
immunological re la t ion to the human U1 snRNP-specific С protein has not been 
reported for Drosophila (ЧО.ИІ). However, the poss ibi l i ty remains that the 
mammalian mRNA sequence can have diverged signif icantly during vertebrate 
evolution and antigenicity of the С protein may not be conserved among inver­
tebrate species. 
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As far as the gene copy number i s concerned t h e s i t u a t i o n appears t o be 
d i f f e r e n t for mammals as compared t o t h e other v e r t e b r a t e c l a s s e s . With t h e С 
p r o t e i n probe a l l genonic BNAs of mammals d i s p l a y m u l t i p l e bands. Sotre of 
t h e s e bands may r e s u l t from fragments of t h e С p r o t e i n gene, but i t i s more 
І і к е і у t h a t m u l t i p l e f u n c t i o n a l genes e x i s t or t h a t some òf the hybr id i z ing 
fragments r e p r e s e n t pseudogenes, t he presence of which i s a general f e a t u r e 
in mammalian mult igene f a m i l i e s (¡12,43). In ca l f the number of hybr id i z ing 
bands was found to be s m a l l e r . In t h i s ca se , however, sequence divergence 
n ight be r e s p o n s i b l e , s i nce t he i n t e n s i t y of t h e h y b r i d i z i n g fragments a l s o 
seems to be lower . Hybr id iza t ion of the С p r o t e i n probe with genomic DNA of 
t h e o t h e r v e r t e b r a t e c l a s s e s , i n c l u d i n g f i s h , amphibia, r e p t i l e s and b i r d s , 
g ives a q u i t e d i f f e r e n t p a t t e r n . Only a few fragments c ross-hybr id ized in the 
EcoRI r e s t r i c t i o n d i g e s t s , sugges t ing t h a t i n t h e s e s p e c i e s t h e r e l a t e d pro­
t e i n i s encoded by a l e s s complex number of genes or ever» by a s i n g l e gene. 
Sequence a n a l y s i s of t h e homologous DNA fragments i n the d i f f e r e n t s p e c i e s 
w i l l g ive more i n s i g h t i n the e v o l u t i o n of the С p r o t e i n genes . 
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SMALL NUCLEAR RNA-ASSOCIATED PROTEINS ARE IMUNOLQGICALLY RELATED 
AS REVEALED BY MAPPING OF AUTOIMMUNE REACTIVE В CELL EPITOPES 
Winand J. Habets, Peter T.G. Sillekens, Margot H. H œ t , 
George McAllister, Michael R. Lerner, and Walther J. van Venrooij 
ABSTRACT 
Autoantibodies from a patient with systemic lupus erythematosus (SLE), 
which recognize U1 and U2 snRNP particles, were used to map В cell epitopes 
on the U1 snRNP specific A protein. This protein contains two regions that 
are highly similar to regions in the U2 snRNP specific B" protein. A site 
termed epitope 2 maps in one such region and was found to react with anti­
bodies cross-reactive between A and B". A second site, epitope 1, is situ­
ated in a proline-rich region that shows no homology with B". This epitope 
can bind three different autoantibodies with distinct specificities. Epitope 
1-affinity purified antibodies fremi different patients react either with i: 
the A protein exclusively, ii: proteins A, B'/B, a synthetic peptide for part 
of N and an unidentified protein with a molecular weight of 50,000 or iii: 
proteins A, B'/B, С and the N derived peptide. Conparison of the primary 
structures of proteins B'/B, N and С reveals multiple epitope l-like sequen­
ces in all of them. The possibility that these repeating regions act as immu-
nogens in patients with autoimnune diseases is discussed. 
INTRODUCTION 
The U small nuclear RNA (snRNA) containing small nuclear ribonucleopro-
tein particles (snRNPs) play key roles in the maturation process of pre-mRNAs 
(1). The five most abundant nucleoplasmic U snRNAs are organized in four dif­
ferent snRNP particles: U1, U2, U4/U6 and U5 (U1-U6) snRNPs. All four snRNP 
particles contain the so-called Sm core complex, consisting of proteins cal­
led B', B, D, D', E, F and G. In addition to this core, U1 snRNPs contain 
three specific polypeptides, 70K, A, and C, whereas U2 snRNPs are characteri­
zed by the presence of two unique proteins, A' and B" (2). Very recently, 
another snRNP-associated polypeptide, designated N, was identified, which is 
expressed predominantly in brain (3). 
Autoantibodies against snRNPs often spontaneously occur in sera from pa­
tients with connective tissue diseases (reviewed in 1). The primary event 
that triggers autoantibody production is not known, but there is increasing 
evidence that this reaction might be antigen-driven (4,5). 
Recently we described the molecular cloning of a cDNA containing the en­
tire coding sequence for the U1 snRNP-specific A protein (6). This protein 
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presents an excellent model for studies of autoimmune phenomena in SLE and 
related diseases because at least three different autoantibody responses 
against this protein have been described. Anti-Α antibodies occur in (i) 
anti-(U1)RNP sera conmonly obtained from patients with mixed connective tis­
sue disease (7,8), (ii) in anti-Sm (anti-{U1-U6)RNP) sera (6,9), almost ex­
clusively obtained from patients with SLE, and (iii) in anti-(U1,tJ2)RNP sera 
(10) which do not show a strong correlation with disease. Information on the 
exact structure of B-cell epitopes recognized by antibodies in these three 
classes of sera might provide insight into the nature of the autoinmune ab­
normalities. 
We describe here three different populations of autoantibodies that 
cross-react with proline-rich regions in the snRNP proteins A, B'/B, N, and 
C, and with a yet unidentified 50K protein. Our results support the hypothe­
sis that autoantibody production is antigen-driven and show that the inmune 
response against individual snRNP proteins can differ from patient to pa­
tient. 
MATERIALS AND METHODS 
Construction and screening of a λΗΑ-4 DNAse fragment library 
One microgram of the EcoRI cDNA insert of the previously described clone 
λΗΑ-H (6) was digested with 2 ng DNAse I in 10 ul 20mM Tris 7.1 in the pre­
sence of 1.5 mM Mn 2 + at room temperature (11). Three ul aliquots were taken 
at 3, it, and 5 minutes and pooled. DNA was made blunt ended with ТЧ polymera­
se, dialysed against H2O and ligated to phosphorylated EcoRI linkers (12). 
The material was digested with EcoRI and fractionated on 8% acrylamide gels 
to remove unligated linkers. Fragments of 50-250 base pairs were eluted and 
200 ng of the DNA was ligated into XgtH arms and packaged into phage heads 
(Promega Biotec). Recombinant phages were amplified in E. coli Y1090 (13) and 
plated at a density of 3x1O4 per 150 cm 2 plate. Screening with the previously 
characterized (10) human autoimmune serum V26 was performed as described 
(14). 
Characterization of autoinmune sera 
The autoinmune sera used in this study were analyzed by imainoblotting 
with nuclear extract from Hela cells (15), by counter inmuno-electrophoresis 
(16) and by inmunoprecipitation from radiolabeled cell extracts (10). Classi­
fication of sera was done as follows. Sera that precipitated exclusively U1 
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snRNP were in all cases found to recognize one or more of the Ul snRNP-speci-
fic proteins 70K, A, or C, and were classified as anti-(U1}RNP. All sera con­
taining antibodies reactive with Ul and U2 snRNPs were found to recognize B" 
and A and sometimes also one of the U1 snRNP-specific 70K or С proteins. 
These sera were classified as anti-(U1,U2)RNP. Sera precipitating Ul, U2, U5 
and Ul/Uó were classified as anti-Sn. Sometimes sera contained both anti-Sm 
and anti-(U1)RNP antibodies. This was the case when disproportionate amounts 
of Ul snRNPs as compared to U2 snRNPs were precipitated. These sera are re-
ferred to as anti-RNPySm. 
Analysis of reccmbinant antigen and affinity purification of antibody 
Expression of reccmbinant antigen was induced with isopropyl ß-D-thioga-
lactoside as described (13,It). Bacterial lysates (14) were fractionated on 
preparative 10% acrylamide gels and blotted onto nitrocellulose. Strips con-
taining the recombinant ß-galactosidase fusion protein were cut out and used 
for affinity purification of autoantibodies according to the method described 
by Smith and Fisher (17). As a control antibodies were eluted from blot 
strips containing ß-galactosidase. These strips were cut out from blots con-
taining a bacterial lysate from induced E. coll strain BNN 97 (13). 
ELISA with synthetic peptides 
Synthetic peptides were designed fron the predicted amino acid (a.a.) 
sequences of proteins A (6) and N (18) and obtained from EVL, Biotech divisi-
on, Amsterdam, The Netherlands (A peptide) and fron the Protein and Nucleic 
Acid Chemistry Facility at Yale University (N peptides). Nunc 96 well micro-
titer plates were coated overnight at 40C with these peptides at 0.5 ug/well 
in coating buffer (15 шМ Ш2СО3, 35 mM NaHCC^, pH 9.6). Plates were washed 
five times with PBST (20 mM Na-Phosphate pH 7-3, 130 mM NaCl, 0.05% Tween 20) 
and remaining binding sites were blocked with 1% BSA in PBST for 2h at room 
temperature. Affinity purified antibodies eluted from 200 micrograms of ni­
trocellulose-bound recombinant antigen (see above) were recovered in a volume 
of 2 ml. Fifty ul was added to each well and incubated for 2 hours at room 
temperature. After washing with PBST, bound antibodies were detected as des­
cribed (19). 
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Figure 1. Epitope mapping of the U1 snRNP specific A protein. A DNAse I frag­
ment library of the full-length clone λΗΑ-4 (6) was screened with the anti-
(U1,U2)RNP serum V26. Fourteen immunoreactive clones were isolated and their 
DNA sequences were determined. Numbers at the right refer to amino acids en­
coded by the respective clones. The minimal overlapping sequences necessary 
for inmunoreactivity are indicated as epitopes. Shaded areas indicate regions 
where the A protein has extensive homology with B"(6,14). 
RESULTS 
Construction and screening of an epitope library. 
In a previous report we described the isolation and characterization of 
a cDNA clone, λΗΑ-4, that encodes the human U1 snRNP-specific A protein (6). 
This protein expresses multiple epitopes which are recognized by autoantibo­
dies in sera from patients with certain connective tissue diseases (6,19). 
Epitope-containing sequences within the A protein could be precisely mapped 
by screening a sublibrary made in Agtll that contained 50 - 250 base pair 
long random DNA fragments from the 1.2 kilobase EcoRI insert of clone λΗΑ-4. 
Screening was performed with the human anti-(U1,U2)RNP serum V26 (10). From a 
total of 2x1θ5 individual phages, 18 were found that encoded fusion proteins 
reactive with antibodies in the V26 serum. Four appeared to contain more than 
one insert and were excluded from further study. The inserts from the remai­
ning 14 were subcloned into phage M13 and their sequences determined (20). 
All clones were found to be in the correct reading frame to allow expression 
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Figure 2. Affinity purification of epitope 1-
and epitope 2-reactive antibodies. Blots con­
taining nuclear proteins from HeLa cells were 
probed with serum V26 (lane I) or antibodies 
affinity purified from V26 using epitope 1- or 
epitope 2-containlng 3-galactosidase fusion 
proteins (lanes epil and epi2, respectively). 
Bands additional to A and B" In lane epi2 are 
always observed with anti-B" sera (10,14) and 
are considered to be degradation products of 
B". 
of fusion proteins containing 3-galactosldase and parts of A. 
Definition of two autoepltopes on the A protein. 
All 14 clones from which limiunoreactlve fusion proteins could be derived 
were found to encode amino acid sequences situated in the C-terminal half of 
the A protein. When the amino acid (a.a.) sequence of an epitope is defined 
as the minimum predicted sequence shared by clones with similar limiunologl-
cally reactive properties, two separate epitopes can be identified (Figure 
1). Epitope 1 covers a.a. 165 to 185 and is situated in a sequence unique to 
the A protein (non-shaded area in Figure 1), whereas epitope 2 (a.a. 232 to 
256) lies in a region of the A protein which shows extensive homology with a 
region of the B" protein (shaded area in Figure 1, refs. 6,14). 
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Evidence that these epitopes are distinct entities was obtained from ex­
periments that show that different antibody populations bind to epitope 1 and 
2. A Xgtll clone encoding a.a. 165 to 190 of the A protein (hereafter termed 
clone λ165-190) was induced and the expressed ß-galactosidase fusion protein 
was used to affinity purify autoantibodies f rem serum V26. The affinity puri-
fied antibodies reacted exclusively with the A protein when they were used to 
probe a blot containing total nuclear proteins derived from HeLa cells (Figu-
re 2, lane epi1). Antibodies affinity purified frem serum V26 using epitope 2 
(as contained in a clone termed λ232-26ά), on the other hand, recognized a 
cross-reactive epitope on A and B" (Figure 2, lane epi2). 
As a next step we wished to establish whether the recognition of epitope 
2 was a specific feature of antibodies in serum V26 or a more general pheno­
menon. Therefore, we used a panel of 26 anti-snRNP sera composed of anti-
(UI)RNP (n=9), anti-Sm (n=9) and anti-(U1,U2)RNP sera (n=8). None of the an-
ti-(U1)RNP or Sm sera recognized epitope 2 as defined by their lack of reac­
tivity with fusion proteins encoded by clones X232-268 or X210-256. Mean­
while, four out of eight anti-(U1,U2)RNP sera recognized fusion proteins ex­
pressed by both clones. We therefore conclude that epitope 2 is exclusively 
recognized by A and B" cross-reactive antibodies in some anti-(U1,U2)RNP 
sera. 
Epitope 1-llke sequences are present in other snRNP proteins. 
Epitope 1 Was subjected to a more detailed study. The same panel of an­
ti-snRNP sera used previously was tested on imunoblots containing fusion 
proteins encoded by clones X165-19Û and X158-185. None of the nine anti-
(U1)RNP sera reacted with either of the clones, whereas six out of nine anti-
Sm sera recognized epitope 1. Four out of eight anti-(U1,U2)RNP sera also 
reacted with epitope 1, two of which (including serum V26) were already known 
to react with epitope 2 as well (see above). So epitope 1 bound antibodies 
from some anti-Sm sera as well as from sane anti-(U1,U2)RNP sera. 
When the epitope 1-binding antibodies from an anti-Sm serum called K22 
were eluted from blots containing fusion proteins encoded by either X158-185 
or X165-190 and used to reprobe blots with nuclear proteins from HeLa cells, 
these antibodies behaved differently from the anti-epitope 1 antibodies in 
serum V26. Instead of a reaction with the A protein (as was the case for V26-
derived antibodies, Figure 2) anti-epitope 1 antibodies fremi serum K22 predo-
minantly reacted with proteins B'/B and aft as yet unidentified protein with a 
molecular weight of 50,000 (50K, Figure ЗА). Almost no reaction with the A 
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Figure 3. Epitope 1 reactive Sm antibodies. (A) Immunoblots containing nu­
clear proteins from HeLa cells (nuclei) or anti-n^G affinity purified snRNPs 
(24) were probed with serum K22 (lane J) or antibodies affinity purified from 
K22 using either a full-length ß-galactosidase-A fusion protein (lanes tot.A, 
5) or an epitope 1 containing fusion protein (lanes epil). (B) RNA analysis 
of 32p_xabeled cell extracts (lane RNA) inmunoprecipitated with serum K22 
(lane £) or affinity purified fractions as in section A. 
protein was detectable suggesting a much higher affinity of these antibodies 
for proteins B'/B and 50K. Incubation of the same antibodies with blots con-
taining snRNP proteins showed that the 50K protein was not an integral part 
of snRNP particles, whereas A and B'/B were recognized in approximately the 
same ratio as observed in total nuclear protein blots (Figure ЗА). That these 
antibodies still recognized Sm is shown in Figure 3B. Epitope 1 affinity pu­
rified antibodies from serum K22 precipitated U1-U6 snRNPs from a radiola­
beled HeLa cell extract. It is interesting to note that serum K22 also recog­
nized additional epitopes on the A protein. When antibodies from K22 were 
bound to and then eluted from full-length recombinant A protein, in addition 
to recovering anti-epitope 1 antibodies, antibodies strongly reactive with 
the A protein were recovered as well (Figure ЗА, lane tot.A). 
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Figure 4. Alignment of epitope 1 and protein N. The deduced amino acid se­
quence of N (18) was compared with that of epitope 1 using the Ifasta compu­
ter program (21). Similarities better than 45% in at least 19 amino acids are 
Shown. N1 and N2 peptides were designed from a region with the highest simi­
larity. 
The most simple explanation for the observed cross-reactivities is that 
proteins A, B'/B and 50K have смшюп epitopes. Therefore, epitope 1 was com­
pared with the primary sequence of B V B and another, recently described El-
like, 24,614 Da snRNP protein called N, which is found predominantly in brain 
(3,18). In the carboxy-terminus of N, six versions of epitope 1 could be de­
tected with a similarity ranging from 47 to 63% (Figure 4). Since the primary 
sequence of N is fully contained in the В proteins (22, Dr. J. Hardin, Yale 
University, personal conmunication) these epitope 1 versions are also present 
in the В proteins, meaning that this is the region that most likely binds the 
epitope 1 purified antibodies. Proteins N and B'/B are only very poorly re­
solved on imnunoblots from SDS Polyacrylamide gels (3,18), so we employed a 
different assay to experimentally substantiate the hypothesis that epitope 1-
eluted antibodies react with protein N. We developed an ELISA with synthetic 
epitope 1 (peptide A) and three peptides designed from N (sequences shown in 
Figure 4). Figure 5 shows that epitope 1 antibodies purified from the anti-Sm 
serum K22 reacted strongly with peptide N1 (a.a. 216-238 of N) and to a les­
ser extent with peptide A (epitope 1). No reaction was observed with peptide 
N2 (a fragment of N1, a.a. 223-232) nor with peptide N3 (a.a. 49-65 of N). By 
comparison, the epitope 1-specific antibodies from V26 (the same as used to 
probe the immunoblots shown in Figure 2) were tested and these did not react 
with any of the N peptides but did bind the A peptide (Figure 5). 
Antibodies to epitope 1 also react with the С protein. 
Affinity purification experiments performed as described above with two 
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Figure 5. ELISA with epitope 1-affinity purified antibodies from anti-Sm se­
rum K22 or anti-(U1,U2)RNP serum V26. Microtiter plates were coated with four 
different peptides. Peptide A is the 21 amino acid sequence designated epito­
pe 1 in Figure 1. Peptides N1 and N2 are designed from a region on the N pro­
tein that has the highest similarity with epitope 1 (see Figure 4). Peptide 
N3 is a control containing a.a. 49-65 from the N peptide (18). 
additional anti-snRNP sera revealed that a third antibody population can oc­
cur. This population was found in both a serum containing anti-RNP/Sm (as 
represented by serum H13) and in one containing anti-(U1,U2)RNP antibodies 
(serum C03). Antibodies eluted from epitope 1 originating from either of 
these sera reacted with snRNP proteins B'/B and С and only weakly with A (Fi­
gure 6A, lane epil). To prove that the reaction was directed against authen­
tic С protein, the eluted antibodies were used to probe blots containing im-
munopurified snRNP proteins and still found to identify the С protein (W.J.H. 
unpublished data). Vice versa, antibodies eluted from cloned С protein (23) 
cross-reacted with the A and B'/B proteins (Figure 6, lane C-F.P.). Epitope 1 
antibodies from both H13 and C03 also recognized N as shown by their reacti­
vity with peptide N1 in the above described ELISA (Figure 7). A possible ex­
planation for the cross-reactivity between proteins A and С is presented in 
Figure 8. Five versions of epitope 1, ranging from 39 to 67% identity, are 
contained in the carboxy-terminal half of the С protein. 
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Figure 6. Epitope 1 eluted antibodies cross-react with the Ш snRNP specific 
С protein. Blots containing HeLa cell nuclear proteins were probed with sera 
C03 or H13 (lanes 1) or antibodies affinity purified frcm these sera using 
either full-length f5-galactosidase-C fusion protein (lanes C-F.P., ref. 23) 
or epitope 1 containing fusion protein (lanes epll). Asterisks indicate 
background binding of the peroxidase labeled second antibody. This is promi­
nent in the strips incubated with affinity purified antibodies, most probably 
because these strips require an upto 6 times longer incubation time with the 
peroxidase substrate. Only this band was present in the control blot strips 
incubated with antibodies affinity purified with ß-galactosidase (not shown). 
DISCUSSION 
We previously identified a cDNA clone, called λΗΑ-4, encoding the human 
U1 snRNP-associated A protein (6). In this study we have employed a DNAsel 
sublibrary (a so-called epitope library, ref. 11) of the original cDNA clone 
to define two regions on the A protein that interact with autoantibodies frcm 
anti-(U1,U2)RNP and anti-Sm sera. 
The region identified in this study as epitope 2 on protein A differs 
only in two amino acids from a corresponding region (a.a. 175-199) in pro-
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Figure 7- ELISA with epitope 1 affinity purified antibodies from sera C03 or 
НІЗ. For details see the legend of Figure 5. 
tein B" (6,14). It was therefore not surprising that this site was recognized 
by A and B" cross-reactive antibodies. However, this site cannot be the only 
cross-reactive epitope since 4 other anti-(U1,U2)RNP sera did not react with 
epitope 2, whereas they recognized full-length B" when expressed as ß-galac-
tosidase fusion protein (W.J.H., unpublished data). Such a polyclonal antibo-
dy response was also found in the case of proteins A and С (see below). 
Epitope 1 was particularly interesting because it was recognized by 
three different populations of autoantibodies (Table 1). The first population 
was found in the anti-(U1,U2)RNP serum V26 and reacted with a sequence within 
epitope 1 that is not present in any of the other snRNP proteins. The second 
antibody specificity was present in the anti-Sm serum K22 and also recognized 
a sequence within epitope 1 but reacted stronger with proteins B'/B and an 
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Figure 8. Alignment of epitope 1 and protein C. For details see the legend of 
Figure 4. Similarities better than 35% in at least 18 amino acids are shown. 
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TABLE 1: 
Cross-reactive antibody specificities in human autoinmune sera. 
Reactivity of antibodies eluted from 
Serum Specificity Epitope 1 Epitope 2 
V26 (U1,U2)RNP A A, B" 
K22 Sn BVB, 50K, Ν, A 
H13 RNP/Sm B'/B, C, N, A 
C03 (U1,U2)RNP B'/B, C, N, A 
unidentified 50,000 Da protein as well as a peptide representing part of N 
than they did with A. This 50,000 Da protein is not the La protein as the re­
active antibodies did not recognize cloned or natural La protein on ілішпо-
blots (W.J.H., unpublished data). Also it is probably not a snRNP protein 
since it is lost upon purification of snRNPs from cell extracts with anti-n^G 
antibodies {Figure ЗА). A third antibody specificity that could be affinity 
purified from epitope 1 reacted with proteins A, B'/B, С and a peptide repre­
senting part of N. 
It was surprising that the epitope 1 affinity purified antibodies deri­
ved from sera K22, C03, and H13 reacted only weakly with the A protein, 
whereas they reacted strongly with proteins B'/B (Figures ЗА and 6A). This 
could mean that the epitope 1 sequence is not available for immune reaction 
in the intact A protein. However, anti-epitope 1 antibodies derived from se­
rum V26 react well with the A protein. We therefore favor the alternative ex­
planation that epitope 1-reactive antibodies in sera K22, C03 and H13 have a 
higher affinity for proteins B'/B than they have for A. This is supported by 
the finding that these antibodies react more strongly with peptide N1 than 
they do with peptide A (Figures 5 and 7). 
We have further shown that the immune reaction against snRNP proteins 
B h, A and С is polyclonal. When the antibody populations purified using full-
length A and С proteins (Figure ЗА, lane tot.A and Figure 6A, lanes C-F.P.) 
are conpared with those purified using epitope 1, it is clear that the full-
length proteins bound additional antibodies which reacted strongly with A and 
C, respectively. So proteins A and С bind both monospecific and cross-reac­
tive antibodies. The finding that the anti-snRNP inmune response is polyclo­
nal together with the observed differences in affinity of the epitope 1 reac­
tive antibodies supports the intriguing hypothesis of Reuter and Liihrmann (5) 
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that anti-snRNP antibodies can be elicited against endogenous snRNP partic­
les. The repetitive proline-rich regions described here are apparently a pro­
minent target for the Imnune system in папу patients with autoinmune disea­
ses. As to the question which protein in the snRNP particle triggers the 
autoiranune response, anti-epitope 1 antibodies like the ones present in serum 
V26 are in our view most likely elicited against the endogenous A protein. 
The anti-epitope 1 antibodies in serum K22 are probably elicited against 
either proteins B'/B, N or 50K. Recent experiments have shown that such a 
supposition could be true. Antibodies with Sm specificity cross-reactive with 
proteins A, B'/B and N were raised upon imnunization of rabbits with peptide 
N1 (3f18), whereas immunization with a synthetic peptide comprising epitope 1 
(peptide A) resulted in anti-(U1)RNP antibodies exclusively reactive with the 
A protein (W.J.H., unpublished data). 
Neither epitope 1 nor epitope 2 reacted with anti-Α antibodies from pa­
tients anti-(U1)RNP sera. A limitation of most epitope mapping strategies, 
and this is also true for the method employed here, is the difficulty in de­
tecting discontinuous or conformational epitopes in which the reactive sites 
are far apart in the primary structure of the antigen. Deletion mutagenesis 
studies show that most anti-(U1)RNP sera recognize a non-linear epitope on 
the A protein (W.J.H., unpublished data). The two parts of this epitope are 
more than 125 amino acids apart so they could not be detected in the subli­
brary used in this study. 
The presence of autoantibodies in the sera of patients with SLE that are 
cross-reactive with several snRNP proteins seems to be a general phenomenon. 
Our data show that at least 5 snRNP proteins, A, B",B,,B, C, and N, are tar­
gets of cross-reactive antibody populations. This has implications for the 
use of autoimnune sera as probes to study the functions of individual snRNP 
proteins. For instance, sera that seem (almost) monospecific for the A pro­
tein on imnunoblots might contain cross-reactive antibodies against С or 
other proteins and vice versa. Therefore it is difficult to attribute the 
observed effects in assays other than Immunoblotting, to the reactivity of a 
specific autoantibody unless one has established the affinity of the auto­
antibodies for potentially cross-reactive proteins in that particular system. 
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ABSTRACT 
The human U1 snRNP-specific A protein is encoded by a single-copy gene 
and its locus has been mapped to chromosome 19· The gene, about 1Д-16 kb in 
length, consists of six exons. Previous studies on the human A protein cDNA 
revealed that, apart from a proline-rich region in the central part of the 
polypeptide, it is highly homologous to the U2 snRNP-specific B" protein. The 
regions homologous to the B" protein are not confined to single exons and 
most of their boundaries do not coincide with exon-exon junctions in the cor­
responding A protein mRNA. The characteristic proline-rich region of the A 
protein, however, is encoded by a single exon, suggesting a specific function 
for this segment of the A protein that is absent in the primary structure of 
the otherwise highly homologous B" protein. The A protein gene does not con­
tain canonical TATA or CCAAT sequences within about 200 bp upstream of the 
presumed cap site region. However, the proximal upstream region does contain 
several similarities to the promoter region of other snRNP protein genes and 
several housekeeping genes, in particular the vertebrate ribosomal protein 
genes. 
INTRODUCTION 
The U small nuclear RNAs (U snRNAs) are a class of metabolically stable 
low molecular weight RNAs found in the cell nuclei of all eukaryotic orga­
nisms. These U snRNAs are organized in ribonucleoprotein particles (U snRNPs) 
which participate in pre-mFNA splicing as components of the spliceosome (for 
reviews see refs. 1 and 2). U1 and U2 snRNPs are involved in the recognition 
of the 5' splice site and the branch point region, respectively (3-5), where­
as U5 snRNP probably interacts with the 3' splice site (6). 
U1 snRNP is the most abundant of the U snRNPs involved in the splicing 
process. It was the first 0 snRNP shown to be required for splicing (7) and 
mutational complementation experiments revealed that direct base-pairing In-
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teractions between the UI snRNA and the 5' splice sites are involved in the 
recognition of these exon-intron junctions <8,9). The protein components of 
the U1 snRNP particle seem to increase the affinity of the snRNP particle for 
the 5' splice site (3). At least 10 proteins are associated with purified Ш 
snRNP (for a review see ref. 10) and they can be divided into two classes. 
Seven of the U1 snRNP proteins are сопиоп proteins also present in other 
snRNPs. They are designated B*, B, D, D'.E, F, and G. The three remaining 
proteins, 70K, A, and C, are U1 snRNP-specific proteins. Although a role for 
the proteins in the binding of U1 snRNP to the 5' splice site has been demon­
strated (3) and molecular cDNA cloning for most U1 snRNP proteins has yielded 
information about the primary structure of these proteins (11-16) their exact 
function is still unknown. The U1 snRNP-specific proteins contain sequence 
elements also observed in other nucleic acid-binding proteins. Proteins A and 
С contain a proline-rich region, whereas the 70K and A protein contain the 
RNP consensus sequence, a motif that seems to be diagnostic of RNA binding 
proteins (17,18). 
We have previously reported the molecular cloning and sequence analysis 
of the human cDNAs for the U1 snRNP-specific A protein (12) and the U2 snRNP-
specific B" protein (19). Both proteins were shown to contain an internal se­
quence homology. Furthermore, mutual sequence comparison revealed two extre­
mely homologous regions located in the carboxy-terminal and amino-terminal 
parts of either protein (12). These structural relationships indicate that 
the genes encoding proteins A and B" have emerged from a ccmoon ancestral 
gene and that probably prior to gene duplication, giving rise to separate 
genes for the A and B" protein, an internal sequence duplication in the pro­
genitor gene has taken place. To experimentally verify this hypothesis, we 
have now extended these studies to the corresponding genes. This report des­
cribes the isolation and structural analysis of the human U1 snRNP-specific A 
protein gene, whose 5' flanking region shows several similarities and diffe­
rences with the promoter region of two other cloned snRNP protein genes, the 
Xenopus U1 snRNP-specific 70K protein (20) and the human U snRNP E protein 
(21). 
MATERIALS AND METHODS 
Screening of a genomic library. 
Plaques (5x10^) from a XEMBL3 human genomic library were lifted onto 
nitrocellulose filters (Schleicher and Schuil) and screened with ^?-labelled 
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nick-translated рНА-Ч (12) under the hybridization conditions for nylon mem­
branes as described by Church and Gilbert (22) in the presence of 100 yg/ml 
herring sperm single-stranded DNA. Hybridization was carried out for 20-24 h 
at 650C. After hybridization the blots were washed twice at бд^ for 30 min 
in 0.5 M sodium phosphate, pH 7.0, 1% SDS, 1 mM EDTA and once at бЗ^ for 30 
min in 0.25 M sodium phosphate, pH 7.0, 1% SDS, 1 mM EDTA. Positive plaques 
were purified and DNA inserts isolated. Restriction enzyme analysis and blot­
ting hybridization to compare the phage DNA inserts with total human genomic 
DNA were performed as described above. 
DNA sequence analysis. 
A library of random subfragments of two overlapping genomic inserts was 
constructed in M13mp18 as described by Deininger (23). Plaque filters were 
prepared and hybridized with the EcoRI insert of рИА-Ч (12). The DNA frag­
ments of clones containing coding sequences were sequenced by the dideoxy 
chain termination method (24). The gel readings were recorded, edited and 
conpared by the Staden programs (25). 
Southern blot analyses. 
Total genomic DNA was isolated from diverse tissues of all species des­
cribed using standard methods (26). Ten-microgram amounts were digested, 
electrophoresed on 0.7% agarose gels and transferred to nitrocellulose. Hy­
bridization of Southern blots was performed as previously described (14). 
For chromosomal mapping, DNA from ten hamster χ human somatic cell lines 
(27) and controls was digested with EcoRI. Ten-microgram amounts of each di­
gested DNA sample were electrophoresed on a 0.7% agarose gel, blotted onto 
nitrocellulose and hybridized to the 32p_i
a
t,elled nick-translated EcoRI in­
sert of pHA-4 (12). 
RESULTS 
Isolation of the human U1 snRNP-specific A protein gene. 
A human genomic library constructed in the ХЕМВІЗ replacement vector and 
containing high molecular weight DNA from human liver that was partially di­
gested with Sau3A, was screened using the EcoRI-insert of pHA-4, a human U1 
snRNP-specific A protein cDNA clone containing the entire coding information 
for this protein (IS). Initial screening of about 5x10^ plaques revealed 
eight recombinant phages bearing sequences homologous to the A protein cDNA. 
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Figure 1. Conparison of XGEN-HAI and AGEN-HA2 with total human genomic DNA. 
(A) Total human DNA was digested with a panel of restriction enzymes. The 
Southern blot was hybridized with 32р_і
а
ь
е
іі
е
^ nick-translated EcoRI insert 
of cDNA clone рНА-Ц (12). Weakly hybridizing fragments, most likely corres­
ponding to U2 snRNP-specific B" protein gene elements (see Discussion), are 
indicated by asterisks. Lanes: Genomic DNA was digested with (1) StuI; (2) 
SphI; (3) PvuII; W PstI; (5) Kpnl; (6) Hpal; (7) Hindlll; (8) EcoRI; (9) 
Bgll; (10) BamHI. (B) XGEN-HAI and XGEN-HA2 DNA inserts were digested with 
EcoRI. The Southern blot was hybridized as described in (A). Hindlll-digested 
λΟΝΑ was used as marker (M). (C) Cloning of the human U1 snRNP-specific A 
protein gene. The physical EcoRI restriction map of the A protein gene and 
flanking sequences in human genomic DNA is given in the upper line. The thick 
bars represent those regions of AGEN-HAI and AGEN-HA2 in which hybridization 
to the A protein cDNA was found. 
Restriction enzyme digestion followed by gel electrophoresis showed identical 
restriction patterns for all these phages, indicating that their genomic in­
serts originated from a single chromosomal locus. Further restriction enzyme 
and blotting analyses showed that the overlapping inserts of two genomic 
clones, termed AGEN-HAI and AGEN-HA2, contained all hybridizing sequences in 
the human genome (Figure 1). The EcoRI digest of AGEN-HAI, carrying 17 kb of 
genomic DNA, revealed two hybridizing fragments of 4.9 and 7.8 kb (Figure IB, 
lane 1). In a determination of the transcriptional orientation of the gene, 
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the smallest of these fragments turned out to contain the 5' moiety of the A 
protein gene (data not shown). The other clone, bearing 12.5 kb of genomic 
DNA, contained EcoRI-fragments of 7.1 kb and 2.8 kb, that hybidized with the 
cDNA probe (Figure IB, lane 2). The 7.1 kb fragment overlaps with the 7.8 kb 
fragment of XGEN-HAI, whereas the 2.8 kb fragment hybridized to a 3' probe of 
the A protein cDNA (data not shown). Human genomic DNA digested with EcoRI 
yielded three hybridizing fragments of 8.0 kb, 4.9 kb, and 2.8 kb (Figure 1A, 
lane 8). Taken together, these results demonstrate that all genomic A protein 
sequences are located within the two overlapping inserts of XGEN-HAI and 
XGEN-HA2. The inserts were isolated by digestion With Sail and recloned into 
the plasmid vector pSP65. Detailed analysis of the resulting pGEN-HAI and 
pGEN-HA2 (see below) revealed that the overlapping fragments contain only one 
gene. Therefore, it was concluded that the human A protein is encoded by a 
single gene per haploid genome. Both clones were further used to investigate 
the transcriptional organization and the detailed exon-intron pattern of the 
A protein gene. 
Structure of the human U1 snRNP-specific A protein gene. 
To elucidate the detailed exon-intron structure of the whole gene, the 
nucleotide sequence of all exons and parts of their flanking introns was es-
tablished using the shotgun strategy of Deininger (23). Clones containing 
exon sequences were selected by hybridization with the EcoRI insert of the 
cDNA plasmid pHA-l and subsequently subjected to dideoxy sequencing reacti-
ons. The clones contain the complete single-copy A protein gene, flanked by 
at least 4.1 kb of upstream and 3.5 kb of downstream sequences. The coding 
sequence extends over 14-16 kb and is split into 6 exons. The sequence of all 
exons was completely determined, whereas the introns were only partially se-
quenced (Figure 2). The boundaries between exons and introns were defined by 
sequence comparison with the A protein cDNA pHA-4 (12). Furthermore, compari-
son of the nucleotide sequence of the gene with that of the human cDNA clone 
did not reveal any discrepancy in their nucleotide sequences, indicating that 
the gene described here indeed corresponds to the functional A protein gene. 
The features of the exon-intron junctional regions are shown in Table 1. Exon 
lengths extend from 89 bp to 380 bp. The boundaries of all the intron sequen-
ces are consistent with the deduced 5' and 3' splice site consensus sequences 
(28) and the polypyrimidine-rich tract located between the consensus AG dinu-
cleotide at the 3' splice site and the site of lariat formation is present in 
all the introns (Table 1). 
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Figure 2. Sequence of the human U1 snRNP-specific A protein gene. Flanking 5' 
and 3' sequences and intron sequences are in lower case letters, whereas exon 
sequences are depicted in capital letters. The deduced amino acid sequence is 
given in single letter notation above the corresponding triplets. The posi-
tions of the exon-intron junctions are deduced from the A protein cDNA se-
quence (12). The polyadenylatlon signal is underlined. The position of the 
polyadenylatlon site, based upon comparison with the cDNA sequence, is indi-
cated by an arrow. The translational stop codon is marked by an asterisk. 
The 3' end of the gene was also mapped by sequence comparison of the 
gene and the pHA-4 cDNA clone, which contains the complete 3' untranslated 
region as well as a stretch of 8 adenosine residues (12). The poly(A) tract 
is added 27 nucleotides downstream of the unusual polyadenylation signal 
ATTAAA (Figure 2). 
The 5' flanking region: presence of G/C boxes and a pyrlmidine-rich segment. 
About 200 bp upstream of the cDNA sequence have been determined from the 
XGEN-HAI insert (Figure 3). In this part of the promoter region no canonical 
TATA box (29) can be found. Moreover, no obvious CCAAT box (30) is present 
between positions -100 and -Ц0 relative to the cDNA start site, although the 
sequence CCAAAT at around position -63 could represent a CCAAT-like motif. 
Three G/C boxes, often found in the promoter region of housekeeping genes 
(31), are found upstream of the cDNA start site (Figure 3). One of these G/C 
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TABLE 1 
Exon-intron junction features of the human U1 snRNP-specific A protein gene. 
Exon/intron Exon size 5' splice site 3' splice site Intron size 
number (bp) séquence sequence (kb) 
1 198 G gtgagt gctcaaaggtctttttttcccccactgcag AG ND 
2 173 ATG gtgagc.gatccccacccgccctgctctctgtttggtag CGT ND 
3 180 CCG gtaagc.gtaaccacgcactctcctccctctctccacag G ND 
И 174 CCT gtgagt gctcaccgactcccctatacccccgcag CTT 0.5 
5 89 CA gtaagt...ctgagtccctgaggtctgtcgttctctttcag G 1.9 
6 3B0 
consensus AG gtaagt cn aa 0,. ..(c)n-cag G 
g t g t t t 
Exon sequences are in upper case letters, whereas intron sequences are in lower case let­
ters. The 5' and 3' splice site consensus sequences are from Mount (20) and the branch point 
consensus from Green (44). The size of introns 1, 2, and 3 has not been determined yet (ND: 
not done). 
boxes contains the sequence CCGCCC. This motif (the inverted form of GGGCGG) 
represents a potential transcription factor Spi binding site (32). Finally, 
in the 5' flanking sequence a pyrimidine-rich region surrounding the cDNA 
start site can be identified. It is composed of pyrimidine residues inter­
spersed with some purine residues, preferentially G (Figure 3)· A segment of 
this polypyrimidine stretch, CTTCCTTTTC, beginning at position +6 relative to 
the cDNA start site, exactly matches the pyrimidine-rich structure 
CTTCCCTCCTC in which the major transcription start site of all known verte­
brate ribosomal protein genes was mapped (reviewed in ref. 33)· 
Chromosome localization of the human 01 snRNP-specific A protein gene. 
To determine on which human chromosome the A protein gene is located, a 
panel of ten hamster χ human somatic cell hybrids was used (27). The restric­
tion enzyme EcoRI gave a good resolution of the hamster and human A protein 
gene bands (compare Figure 1A, lane 8 and Figure 4, lane 7). DNA of the hy­
brid cells was digested with EcoRI, electrophoresed in an agarose gel and 
transferred to a nitrocellulose filter. The filter was hybridized to the 
nick-translated cDNA insert of pHA-4 (12). The EcoRI fragments of the human A 
protein gene were detected in four cell lines that retained human chromosome 
19 and were not detected in EcoRI digests of DNA from hybrid cells that lack­
ed chromosome 19 (Table 2). All other human chromosomes could be excluded by 
at least three discordant hybrids (Table 2). The results are consistent with 
assignment of the U1 snRNP-specific A protein gene to human chromosome 19. 
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-200 G/C box -180 "CCAAT" box -150 
tttttctccgggacggccçttcggatgcttgggcçaaatgggaatcgccatttagggtct 
G/C box -120 -90 
ccgcccaccgggtcgcgtagagcatcctggaaRtcgtagtaaatctctcgagagttctct 
G/C box -60 -40 Py box motif 
ccgcacgcgggctggagaagcgggtcctacgcacgctttgttgtcgcgctttgcctccgt 
-20 +1 Py cap motif +30 
ccttCCCcctactcccgccttacCTGACTTCCTTTTCGGAGGAAGATCCTTGAGCAGCCG 
I ^cDNA start site 
Figure 3. Sequence features of the 5' flanking region of the human U1 snRNP-
specific A protein gene. The sequence encompassing the upstream region is 
depicted in lower case letters and part of the exon 1 sequence is given in 
capital letters. Three G/C boxes, a putative CCAAT-box, and two pyrimidine-
rich motifs are in bold-type letters. 
Detection of A protein gene sequences in genomic DNAs. 
Southern blot analysis was performed to test the presence and complexity 
of A protein gene elements in the genome of other species. EcoRI-digested 
32 genomic DNA of different phylogenetic sources was hybridized using the ^ P-
labelled nick-trânslated EcoRI insert of pHA-4 as probe (Figure 4). All mam-
malian species used, showed clear hybridizing fragments under the moderate 
conditions of stringency used. In the genomic DNA of rabbit only a single 
strong hybridizing fragment was detected (Figure 4, lane 5), whereas a more 
complex pattern of bands was observed in the genome of calf, mouse, hamster, 
and guinea pig (Figure 4, lanes 2,4,7, and 9) as compared to the three EcoRI 
fragments hybridizing in the monkey (Figure 4, lane 10) and human genome (Fi-
gure 1A, lane 8). Genomic fish DNA sequences with homology to the cDNA of the 
human A protein could also be detected. Three significantly hybridizing DNA 
fragments were observed in trout genomic DNA. Only genomic DNA of the chicken 
does not contain fragments hybridizing to the human A protein cDNA (Figure 4, 
lane 6). 
DISCUSSION 
Southern blotting, molecular cloning and nucleotide sequencing of geno-
mic fragments containing sequences hybridizing to the human U1 snRNP-specific 
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TABLE 2 
Correlat ion of human pHA-4 sequences with human chromosomes 
in hamster χ human somatic c e l l hybrids, 
Human chrofflosomes 
Hybridization 1 2 3 4 5 6 7 8 9 10 11 T2 13 14 15 16 17 18 19 20 21 22 Χ Y 
+/+ 1 0 1 2 1 0 0 4 2 2 2 3 3 3 2 3 4 1 4 4 3 4 3 0 
- / - 3 4 2 2 3 4 4 2 2 3 5 4 2 2 3 3 2 3 6 2 3 3 2 5 
+ / - 3 2 4 4 3 2 2 4 4 3 1 2 4 4 3 3 4 3 0 4 3 3 4 1 
- / + 3 4 3 2 3 4 4 0 2 2 2 1 1 1 2 1 0 3 0 0 1 0 1 4 
Discordant 
hybrids 6 6 7 6 6 6 6 4 6 5 3 3 5 5 5 4 4 6 0 4 i ) 3 5 5 
The numbers of hybrids showing concordant (+/+ or -/-) and discordant (+/- or -/+) segrega­
t ion with pHA-4 sequences are given for each chromosome. 
A protein cDNA established that this protein is encoded by a single-copy gene 
in the human genome. The gene i s located on chromosome 19 and is spl i t into 
six exons. Southern hybridization analysis revealed several additional ele­
ments with much weaker homology to the A protein cDNA (Figure 1A, lanes 6,8, 
9i and 10). These probably correspond to gene elements encoding the U2 snftNP-
specific B" protein (data not shown), previously shown to contain two regions 
highly homologous to the A protein at the amino acid level (12). From these 
regions of homology i t was concluded that the genes encoding proteins A and 
B" have emerged from a coranon ancestral gene. However, due to lack of homolo­
gy in the nucleotides at s i lent positions of the codons of similar amino 
acids in the homologous regions of proteins A and BH, homology i s less at the 
DNA level and cross-hybridization is only rarely observed under the conditi­
ons of stringency used. Neither of the two homologous regions between pro­
teins A and B" i s encoded by a single exon and the boundaries of the amino-
terminal region of homology do not coincide with exon junctions in the A pro­
tein gene. The homologous region in the amino-terminal part i s encoded by 
exons 1, 2 and part of exon 3. whereas exons 5 and б encode the carboxy-ter-
minal region of homology. I t i s significant, however, that the stretch of 58 
amino acids f rem the middle part of the A protein (amino acids 143-200) that 
are not present in the B" protein, is encoded by a single exon, namely exon 
4. This exon spans the proline-rich domain of the A protein. Since i t i s 
thought that exons can represent genetic building blocks that encode discrete 
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Figure Ц. Detection of A protein gene sequences in insect and vertebrate 
DNAs. The Southern blot was hybridized with 32P-labelled nick-translated 
EcoRI insert of cDNA clone рНА-Ц (12). Lanes: The DNAs were extracted from 
the following species: (1) trout; (2) calf; (3) rat; (4) mouse; (5) rabbit; 
(6) chicken; (7) hamster; (8) Drosophila; (9) guinea pig; (10) monkey. As 
markers, Hindlll-digested XDNA fragments were run in parallel (M). 
structural or functional domains of protein (3^-36) and given the fact that 
proline-rich regions have also been found in other single-stranded nucleic 
acid-binding proteins (37-39), this protein segment might encompass a speci­
fic RNA binding capacity of the A protein, whereas the homologous regions in 
proteins A and B" fulfill identical functions. The previously noticed sequen­
ce homology between the amino-terminal and carboxy-terminal region of the A 
protein that is indicative of a sequence duplication within the progenitor 
gene from which the individual A and B" protein genes have decended (12) is 
not reflected in the exon distribution of the gene. Therefore, after sequence 
duplication in the progenitor gene initially both segments must have develo­
ped independently without high sequence conservation as could already be con­
cluded from the corresponding cDNA sequences and loss or gain of introns has 
taken place since the duplicated segments diverged. Only after the gene du­
plication event, giving rise to separate genes for the A and B" protein, at 
least parts of these regions have been evolutionary conserved. We are cur­
rently trying to clarify the structure of the U2 snRNP-specific B" protein 
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gene in order to determine whether the exon distribution of this gene resem­
bles that of the A protein gene. 
The hybridization results obtained with the A protein cDNA probe on DNAs 
from several distinct vertebrates indicates that the sequences of the corres­
ponding A protein gene in these vertebrate classes have been conserved. Only 
in the genome of chicken we were not able to detect cross-hybridizing frag­
ments. Significantly, probing with a B" protein cDNA did not reveal hybridi­
zing fragments in the chicken genome either, whereas in other vertebrates the 
evolutionary conservation on the DNA level was similar to that of the A pro­
tein (data not shown). Evolutionary conservation among vertebrates has also 
been found for the genes of other snRNP proteins, viz. E (40) and С (14). 
Whether the divergence of the chicken mRNA sequence corresponding to the A 
protein holds true for other members of the vertebrate class of birds as well 
remains to be elucidated. For the A protein, sequence homology at the DNA 
level is not limited to vertebrates. Genomic fish and insect DNA also appear 
to contain sequence elements with homology to the human A protein cDNA (Fi­
gure 4, lanes 1 and 8). For the invertebrate species Drosophila it has been 
reported that there is a protein with inmmological relations to the human A 
protein (41,42). The hybridization of three fragments in the genomic DNA of 
Drosophila indicates that the evolutionary conservation of A protein sequen­
ces need not be limited to one or more antigenic sites. A precise estimation 
of the number of A protein genes in all the species cannot be made from the 
experiment described in Figure 4. However, the presence of only a single pro­
minent band in the genomic DNA of Drosophila and rabbit and a similar pattern 
in monkey as the one observed in human genomic DNA suggest that the single-
copy nature of the A protein gene as it is encountered in the human genome, 
also applies to these species. 
Although the transcriptional start site of the A protein mRNA has not 
yet been determined exactly, several features indicate that the cap site is 
located at or near the cDNA start site in the gene sequence (Figure 2). 
First, assuming a poly(A) tail of 150 to 200 residues, the size of the cDNA 
(1.2 kb) is consistent with the size of the human A protein mRNA (1.4 kb) 
obtained by Northern blotting. Second, the cDNA start site in the gene se­
quence is located within a pyrimidine-rich region. Vertebrate ribosomal pro­
tein gene promoters as well as the promoters of several other genes in the 
housekeeping category also exhibit a remarkable bias for pyrimidine runs in 
the transcriptional start region (for a review see ref. 33). Furthermore, a 
C/T-stretch of 11 residues, starting at position +6 relative to the cDNA 
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start site in the A protein gene sequence and containing the highly conserved 
CTTCC motif, is identical to the consensus C/T sequence in which the major 
cap site of vertebrate ribosomal protein genes is located. This raises the 
possibility that the C/T box may also be involved in setting the start of 
transcription in the A protein gene. Additional similarities between the 
immediate 5' upstream region of the A protein gene and ribosomal protein gene 
promoters can be observed. The absence of a canonical TATA box and the pre­
sence of G/C blocks, one of which contains a putative transcription factor 
Spi binding site, within the proximal upstream region of the gene, are also 
general characteristics of ribosomal protein gene promoters. The presence of 
CTTCC motifs or variations thereof and a G/C-rich sequence element matching 
the consensus recognition sequence for Spi was also observed in the 5' up­
stream region of a human gene encoding the snRNP-associated E protein (21 ) 
and a Xenopus U1 snRNP-specific 70K protein gene (20). Therefore, genes enco­
ding snRNP proteins may be regulated in a common fashion, similar to the 
transcriptional control of ribosomal protein genes and several other house­
keeping genes. 
In the snRNP E protein gene promoter region a segment similar to a se­
quence element which has been implicated in fixing the start of transcription 
of U1 snRNA (for a review see ref. 43) has been found (21). In the A protein 
gene promoter sequence, however, none of the specific sequence elements of U 
snRNA gene promoters is identifiable. Thus, comparison of the promoter se­
quences of snRNP protein genes reveals some interesting similarities (no con­
sensus TATA box, presence of G/C boxes and C/T motifs) but also differences 
are observed (similarities to promoter region elements of U snRNA genes only 
in the E protein gene). Possibly these differences are characteristic for the 
two classes of snRNP proteins, i.e. the snRNP-specific and соішюп snRNP pro­
teins. Further analysis of the Â protein gene 5' flanking region and compari-
son with the sequences of promoters of other snRNP protein genes may identify 
additional sequence elements specific for promoters controlling expression of 
snRNP proteins and could give an insight into sequence motifs required for a 
putative coordinate regulation of expression for both classes of snRNP pro-
teins at the level of transcription. Certainly, the physical linkage of the 
genes encoding the U1 snRNP-specific proteins A and 70K, which both are loca-
ted on chromosome 19 (Table 2 and ref. 16), favors a coordinate expression of 
certain snRNP protein genes. 
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SUMMARY 
SAMENVATTING 

SUMiARY 
The small nuclear RNAs (snRNAs) are a family of low molecular weight RNA 
species in the cell nucleus of all eukaryotes. They are characterized by 
their metabolic stability, their unusual tri-methylated guanosine cap struc­
ture, and their association with a specific set of proteins. The most abun­
dant nucleoplasmic snRNA species are U1, U2, U4, U5, and U6. While U1, U2, 
and U5 snRNA are each complexed in individual ribonucleoprotein particles 
(snRNPs), Щ and U6 snRNAs together reside in the same snRNP particle in a 
base-paired fashion. The major snRNPs contain the same set of seven proteins, 
termed B, B', D, D·, E, F, and G. In addition to these common proteins, seve­
ral snRNPs contain species-specific polypeptides. Three specific proteins, 
70K, A, and C, are associated with U1 snRNP, while two proteins, A' and B", 
are unique to the U2 snRNP species. 
The major snRNPs function in the removal of introns and the splicing of 
exons of eukaryotic mRNA precursors. Щ and U2 snRNPs perform their functions 
in splicing at least in part by RNA-RNA base-pairing with conserved comple­
mentary sequences in the mRNA precursor. In addition, however, snRNP proteins 
are required, but their exact mode of action has not been established yet. A 
prerequisite for understanding the role snRNP proteins play in the splicing 
reaction, is the elucidation of their primary structure. Molecular cDNA clo­
ning of several human snRNP-specific proteins is the basis of this thesis. 
In addition, the structural analysis of a gene encoding one of the unique 
snRNP proteins and partial characterization of the antigenic structure of 
this protein are described, since most snRNP proteins play a role as antigens 
in several autoimmune diseases as well. 
In chapter 2, the isolation and characterization of a cDNA encoding the 
U2 snRNP-specific B" protein are described. The polypeptide sequence, deduced 
fron this cDNA, consists of 225 amino acids and contains several hydrophylic 
segments distributed over the entire protein. One of these regions, with a 
high content of lysine residues, shows extensive homology with the charged 
region of the circumsporozoite protein of Plasmodium knowlesi. 
The primary structure of the U2 snRNP-specific A' protein is reported in 
chapter 3· The open reading frame of the cDNA clone has coding capacity for a 
255-residue polypeptide. Most striking feature of the polypeptide is a leu-
cine-rich region, the function of which is not known yet. 
Chapter 4 describes the molecular cDNA cloning of the U1 snRNP-specific 
A protein. A cDNA containing the entire coding sequence encodes a polypeptide 
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of 282 amino acid residues. Comparison of the deduced amino acid sequence 
with that of the U2 snRNP-specific B" protein (chapter 2) reveals two regions 
of extensive homology between these immunologically related proteins, one 
located in the carboxy-terminal end of the proteins and the other in the ami-
no-terminal region. Furthermore, the amino-terrainal and carboxy-tenninal do­
main of either protein by itself show a significant homology. These data im­
plicate a coranon evolutionary origin for the A and B" protein and infer simi­
lar functions. Another salient feature is the presence of the so-called RNP 
consensus sequence in both proteins, a motif that thus far is diagnostic of 
RNA binding proteins. In snRNP proteins these RNP consensus sequences are 
thought to participate in RNA-protein interactions either between the protein 
and the snRNA itself or between the snRNP particle and mRNA precursors in the 
spliceosome, the large multicoraponent complex in which the splicing reaction 
takes place. 
A cDNA encoding the U1 snRNP-specific С protein is described in chapter 
5. This snRNP polypeptide is post-translationally modified as danonstrated by 
a discrepancy in the mobility of in vivo and in vitro synthesized С protein 
on SDS-polyacrylamide gels. A proline-rich region, also observed in the other 
U1 snRNP-specific proteins, A and 7QK, might play a role as an ENA binding 
domain, since similar regions of high proline content have been identified in 
several single-stranded nucleic acid-binding proteins. 
snRNP proteins not only play a role in the splicing reaction but also 
carry antigenic determinants for the so-called anti-Sm and anti-nuclear RNP 
autoantibody specificities, which are often produced by patients with connec­
tive tissue diseases. Chapter 6 deals with the partial characterization of 
the antigenic structure of the Ш snRNP-specific A protein. Two antigenic 
regions recognized by autoantibodies were identified. One of these regions 
contains an epitope that is recognized by antibodies that cross-react with 
the B" protein and is located within the carboxy-terminal region of homology 
with this Ü2 snRNP-specific protein. The other antigenic site, located in 
the proline-rich segment of the A protein, binds autoantibodies that either 
recognize the A protein alone, or cross-react with other snRNP proteins con-
taining proline-rich regions. 
Chapter 7 describes the structure of the single-copy gene that encodes 
the A protein in the human genome. Its coding domain extends over 6 exons. 
The internal sequence duplication is not reflected in the exon distribution. 
Apparently, loss or gain of intron sequences has taken place during evolu-
tion. The proline-rich region of the A protein is encoded by a single exon, 
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supporting the assumption that this protein segment encompasses a specific 
function of the A protein based on the hypothesis that exons represent gene­
tic building blocks that encode discrete functional or structural domains of 
protein. The promoter region contains sequence elements of several house­
keeping genes and shows similarities to the promoter region of other snRNP 
protein genes. Furthermore, the A protein gene was mapped to chromosome 19, 
the same chromosome on which a gene encoding the Ш snRNP-specific 70K pro­
tein is located. These data suggest a coordinate regulation of expression of 
snRNP proteins or subsets thereof. 
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SAMENVATTING 
De "small nuclear RNAs" (snRNAs) vormen een groep RNA moleculen met een 
laag molecuulgewicht die voorkomen in de celkern van alle eukaryoten. Karak­
teristiek voor deze snRNA's zijn de metabolische stabiliteit, de ongebruike­
lijke tri-gemethyleerde guanosine "cap" structuur en de associatie met een 
specifieke groep eiwitten. De meest voorkomende nucleoplasmatische snRNA spe­
cies zijn UI, U2, l№, U5 en U6. Terwijl UI, U2 en U5 snRNA ieder afzonderlijk 
geconplexeerd zijn in zogenaamde "ribonucleoprotein particles" (snRNPs), vor­
men U4 en U6 door middel van baseparing steeds samen een snRNP partikel. Deze 
groep van meest voorkomende snRNPs bevat eenzelfde set van zeven eiwitten, 
aangeduid als B, B', D, D', E, F en G. Behalve deze gemeenschappelijke eiwit­
ten bevatten een aantal snRNP's ook nog species-specifieke Polypeptiden. Drie 
specifieke eiwitten, namelijk 70K, A en С zijn geassocieerd met UI snRNP's, 
terwijl twee eiwitten, genaamd A' en B", uniek zijn voor U2 snRNP's. 
De snRNP's hebben een functie bij het verwijderen van intronsequenties 
en de "splicing" van exonen van eukaryotische boodschapper RNA (mRNA) precur­
sors. UI en U2 snRNP's vervullen hun functies in de splicingsreactie deels 
door middel van RNA-RNA baseparing met geconserveerde complementaire sequen­
ties in de mRNA precursor. Daarnaast zijn echter ook de snRNP-eiwitten van 
belang, maar de exacte wijze waarop deze bij de reactie betrokken zijn is 
nog niet achterhaald. Een eerste vereiste voor een beter begrip van de rol 
die snRNP-eiwitten spelen in de splicingsreactie is de opheldering van hun 
primaire structuur. cDNA clonering van een aantal humane snRNP-specifieke 
eiwitten vormt dan ook de basis van dit proefschrift. Bovendien wordt de 
structurele analyse van een gen dat codeert voor een van de unieke snRNP-
eiwitten beschreven naast een gedeeltelijke karakterisering van de antigene 
structuur van dit eiwit. Iraners de meeste snRNP-eiwitten spelen ook een rol 
als antigeen bij verscheidene autoiimiuunziekten. 
In hoofdstuk 2 wordt de isolatie en karakterisering van een cDNA be­
schreven dat codeert voor het U2 snRNP-specifieke B" eiwit. De eiwitsequen­
tie, die afgeleid werd van de cDNA sequentie, bestaat uit 255 aminozuren en 
bevat verscheidene hydrofiele segmenten die over het hele eiwit verspreid 
liggen. Een van deze gebieden, dat een hoog gehalte aan lysineresiduen heeft, 
vertoont in hoge mate homologie met het geladen gedeelte van het cicumsporo-
zoit eiwit van Plasmodium knowlesi. 
Hoofdstuk 3 beschrijft de primaire structuur van het U2 snRNP-specifieke 
A' eiwit. Het open leesraam van de cDNA cloon codeert voor een polypeptide 
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bestaande uit 255 residuen. Het meest opvallende kenmerk van dit polypeptide 
is een leucinerijk gebied waarvan de functie echter nog niet bekend is. 
Hoofdstuk 4 beschrijft de cDNA clonering van het U1 snRNP-specifieke A 
eiwit. Een cDNA dat de gehele coderende sequentie bevat, codeert voor een 
polypeptide van 282 aminozuurresiduen. Vergelijking van de van de cDNA se­
quentie afgeleide aminozuursequentie van het A eiwit met die van het U2 
snRNP-specifieke B" eiwit {hoofdstuk 2) resulteerde in twee gebieden van deze 
iisinunologisch verwante eiwitten die een hoge mate van homologie vertonen. Een 
van deze gebieden is gelocaliseerd in het carboxy-terminale uiteinde van de 
beide eiwitten en het andere in het amino-terminale gedeelte. Bovendien ver­
tonen het amino-terminale en carboxy-terminale domein van ieder eiwit afzon­
derlijk ook een significante homologie. Deze gegevens impliceren een gemeen­
schappelijke evolutionaire oorsprong voor de eiwitten A en B" en duiden op 
mogelijk vergelijkbare functies. Een ander opvallend aspect is de aanwezig­
heid van de zogenaamde RNP consensus sequentie in beide eiwitten, een motief 
dat tot dusverre kenmerkend is voor RNA-blndende eiwitten. Voor wat betreft 
de snRNP-eiwitten denkt men dat deze RNP consensus sequenties betrokken kun­
nen zijn bij RNA-eiwit interacties tussen ofwel het eiwit en het snRNA zelf 
ofwel tussen het snRNP partikel en de mRNA precursor in het "spliceosome", 
een groot complex bestaande uit meerdere componenten waartoe ook de snRNP's 
behoren en waarin de splicingsreactie plaatsvindt. 
Een cDNA dat codeert voor het Ut snRNP-specifieke С eiwit wordt beschre­
ven in hoofdstuk 5. Dit snRNP-polypeptide wordt posttranslationeel gemodifi­
ceerd , hetgeen blijkt uit een verschil in mobiliteit tussen in vivo en in 
vitro gesynthetiseerd С eiwit op een SDS-polyacrylamidegel. Een prolinerijk 
gebied, dat eveneens werd aangetroffen in de beide andere 01 snRNP-specifieke 
eiwitten A en 70K, vervult mogelijkerwijze de rol van een RNA-bindend domein 
van het eiwit, omdat soortgelijke gebieden met een hoog prolinegehalte werden 
aangetoond in verscheidene eiwitten die binden aan enkelstrengs nucleinezu-
ren. 
snRNP-eiwitten spelen niet alleen een rol in de splicingsreactie maar 
bevatten ook antigene determinanten voor de zogenaamde "anti-Sm" en "anti-
nuclear RNP" autoantilichamen, die vaak aangemaakt worden door patiënten met 
bindweefselaandoeningen. Hoofdstuk б handelt over de gedeeltelijke karakteri­
sering van de antigene structuur van het UI snRNP-specifieke A eiwit. Twee 
antigene gebieden die herkend worden door autoantilichamen werden geïdentifi-
ceerd. Een van deze'gebieden bevat een epitoop dat herkend wordt door anti-
lichamen die kruisreageren met het B" eiwit en is gelegen in het carboxy-ter-
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minale gedeelte van het eiwit dat homologie vertoont met dit U2 snRNP-speci-
fieke eiwit. Het andere antigene gebied, dat gelocaliseerd is in het proline-
rijke segment van het A eiwit, bindt autoantilichamen die ofwel alleen het A 
eiwit herkennen, ofwel kruisreageren met andere snRNP-eiwitten die praline-
rijke gebieden bevatten, waaronder het С eiwit. 
Hoofdstuk 7 beschrijft de structuur van het slechts éénmaal in het ha-
ploide genoom voorkomende humane gen dat codeert voor het A eiwit. Het code-
rende gebied van dit gen is verspreid over 6 exonen. De interne sequentiedu-
plicatie is niet meer terug te vinden in de exonverdeling. Blijkbaar zijn er 
in de loop van de evolutie intronen bijgekomen of verloren gegaan. Het proli-
neri jke gebied van het A eiwit wordt gecodeerd door één enkel exon, hetgeen 
de aanname dat dit eiwitsegment een specifieke functie van het A eiwit her-
bergt, versterkt gebaseerd op de hypothese dat exonen genetische bouwstenen 
zijn die coderen voor bepaalde functionele of structurele eiwitdomeinen. Het 
promotergebied bevat verscheidene sequentie-elementen van "huishoud" genen en 
vertoont gelijkenissen met het promotergebied van genen die coderen voor an-
dere snRNP-eiwitten. Bovendien is het gen voor het A eiwit gelegen op chromo-
soom 19, hetgeen hetzelfde chromosoom is waarop ook een gen dat codeert voor 
het UI snRNP-specifieke 70K eiwit gelocaliseerd is. Deze gegevens suggereren 
een gecoördineerde regulatie voor wat betreft de expressie van snRNP-eiwitten 
of een gedeelte ervan. 
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